<!DOCTYPE html><html  lang="en" data-capo=""><head><meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1">
<title>Frontiers | Functional Characterization of Two Variants at the Intron 6â€”Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes</title>
<link rel="stylesheet" href="/ap-2024/_nuxt/entry.CWBB-NGm.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/vue-core.B-WA3Vg5.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/explainer.CMppEa5M.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleDetails.B93eTAmx.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleLayoutHeader.CKWUz2Al.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/AnnouncementCard.Db7nmstV.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/FloatingButtons.xuP8gC33.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleEvent.D0PaxIW7.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/SimilarArticles.BMee4Fk4.css">
<link rel="stylesheet" href="/ap-2024/_nuxt/ArticleTemplateBanner.CXmOJ7NH.css">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/v1IBIWh4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/B674Mi_H.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BXedFy5e.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/eQMj-Fph.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Y8NTh2i4.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUyL5Z_3.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/m8mdd2tc.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DHv8pTSw.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BHPWSuhB.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/x5HZk7Le.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CNJXQ6ZR.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dss5ciUI.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Do5q9QoL.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BhVAcJSK.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/y69VltF1.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Bw-bWKkJ.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/sQBxgu5L.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/D5YKKJGW.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CSLdjdGS.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/BUN89Jk2.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CCeQzihV.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/DVDwh0-U.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/Dw4ta0fP.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/CYv-CzHi.js">
<link rel="modulepreload" as="script" crossorigin href="/ap-2024/_nuxt/U-mJlaMn.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/NhyIC1F3.js">
<link rel="prefetch" as="style" crossorigin href="/ap-2024/_nuxt/ArticleHubLayout.q6CU8_bN.css">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/CKQJuUlk.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/D3plh7Cs.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/GWtHKqLR.js">
<link rel="prefetch" as="script" crossorigin href="/ap-2024/_nuxt/DS3EY-DL.js">
<meta name="theme-color" content="#0C4DED">
<meta name="mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<script type="text/javascript" data-hid="4cd079c">window.NREUM||(NREUM={});NREUM.info = {"agent":"","beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"598a124f17","applicationID":"586843029","agentToken":null,"applicationTime":2.880823,"transactionName":"MQcDMkECCkNSW0YMWghNLwlBDgVcWkJXAWAUC04MXBYWXlJUQUpFDgMTC1IAC1xcX0tKVBQWCAVfBhcfGRdUFV0HEE9UA1FWHgsPAFMBU00HE18P","queueTime":0,"ttGuid":"04cffd49b9fdf47d"}; (window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},feature_flags:["soft_nav"],distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"594460232",accountID:"230385",trustKey:"230385",xpid:"VgUHUl5WGwYIUllWBAEFXw==",licenseKey:"598a124f17",applicationID:"586843029",browserID:"594460232"};;/*! For license information please see nr-loader-spa-1.303.0.min.js.LICENSE.txt */
(()=>{var e,t,r={384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>s,US:()=>d,Zm:()=>a,bQ:()=>u,dV:()=>c,pV:()=>l});var n=r(6154),i=r(1863),o=r(1910);const s={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function c(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate||n.gm.setInterval,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket},(0,o.i)(...Object.values(e.o))),e}function u(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:s.beacon,errorBeacon:s.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),c(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>d,K7:()=>c,P3:()=>u,XX:()=>i,Yy:()=>a,df:()=>o,qY:()=>n,v4:()=>s});const n="events",i="jserrors",o="browser/blobs",s="rum",a="browser/logs",c={ajax:"ajax",genericEvents:"generic_events",jserrors:i,logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},u={[c.pageViewEvent]:1,[c.pageViewTiming]:2,[c.metrics]:3,[c.jserrors]:4,[c.spa]:5,[c.ajax]:6,[c.sessionTrace]:7,[c.softNav]:8,[c.sessionReplay]:9,[c.logging]:10,[c.genericEvents]:11},d={[c.pageViewEvent]:s,[c.pageViewTiming]:n,[c.ajax]:n,[c.spa]:n,[c.softNav]:n,[c.metrics]:i,[c.jserrors]:i,[c.sessionTrace]:o,[c.sessionReplay]:o,[c.logging]:a,[c.genericEvents]:"ins"}},944:(e,t,r)=>{"use strict";r.d(t,{R:()=>i});var n=r(3241);function i(e,t){"function"==typeof console.debug&&(console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t),(0,n.W)({agentIdentifier:null,drained:null,type:"data",name:"warn",feature:"warn",data:{code:e,secondary:t}}))}},993:(e,t,r)=>{"use strict";r.d(t,{A$:()=>o,ET:()=>s,TZ:()=>a,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o={OFF:0,ERROR:1,WARN:2,INFO:3,DEBUG:4,TRACE:5},s="log",a=n.K7.logging},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>u,Ze:()=>f,x3:()=>d});var n=r(3241),i=r(7836),o=r(3606),s=r(860),a=r(2646);const c={};function u(e,t){const r={staged:!1,priority:s.P3[t]||0};l(e),c[e].get(t)||c[e].set(t,r)}function d(e,t){e&&c[e]&&(c[e].get(t)&&c[e].delete(t),p(e,t,!1),c[e].size&&h(e))}function l(e){if(!e)throw new Error("agentIdentifier required");c[e]||(c[e]=new Map)}function f(e="",t="feature",r=!1){if(l(e),!e||!c[e].get(t)||r)return p(e,t);c[e].get(t).staged=!0,h(e)}function h(e){const t=Array.from(c[e]);t.every(([e,t])=>t.staged)&&(t.sort((e,t)=>e[1].priority-t[1].priority),t.forEach(([t])=>{c[e].delete(t),p(e,t)}))}function p(e,t,r=!0){const s=e?i.ee.get(e):i.ee,c=o.i.handlers;if(!s.aborted&&s.backlog&&c){if((0,n.W)({agentIdentifier:e,type:"lifecycle",name:"drain",feature:t}),r){const e=s.backlog[t],r=c[t];if(r){for(let t=0;e&&t<e.length;++t)g(e[t],r);Object.entries(r).forEach(([e,t])=>{Object.values(t||{}).forEach(t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])})})}}s.isolatedBacklog||delete c[t],s.backlog[t]=null,s.emit("drain-"+t,[])}}function g(e,t){var r=e[1];Object.values(t[r]||{}).forEach(t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}})}},1741:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(944),i=r(4261);class o{#e(e,...t){if(this[e]!==o.prototype[e])return this[e](...t);(0,n.R)(35,e)}addPageAction(e,t){return this.#e(i.hG,e,t)}register(e){return this.#e(i.eY,e)}recordCustomEvent(e,t){return this.#e(i.fF,e,t)}setPageViewName(e,t){return this.#e(i.Fw,e,t)}setCustomAttribute(e,t,r){return this.#e(i.cD,e,t,r)}noticeError(e,t){return this.#e(i.o5,e,t)}setUserId(e){return this.#e(i.Dl,e)}setApplicationVersion(e){return this.#e(i.nb,e)}setErrorHandler(e){return this.#e(i.bt,e)}addRelease(e,t){return this.#e(i.k6,e,t)}log(e,t){return this.#e(i.$9,e,t)}start(){return this.#e(i.d3)}finished(e){return this.#e(i.BL,e)}recordReplay(){return this.#e(i.CH)}pauseReplay(){return this.#e(i.Tb)}addToTrace(e){return this.#e(i.U2,e)}setCurrentRouteName(e){return this.#e(i.PA,e)}interaction(e){return this.#e(i.dT,e)}wrapLogger(e,t,r){return this.#e(i.Wb,e,t,r)}measure(e,t){return this.#e(i.V1,e,t)}consent(e){return this.#e(i.Pv,e)}}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},1910:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(944);const i=new Map;function o(...e){return e.every(e=>{if(i.has(e))return i.get(e);const t="function"==typeof e&&e.toString().includes("[native code]");return t||(0,n.R)(64,e?.name||e?.toString()),i.set(e,t),t})}},2555:(e,t,r)=>{"use strict";r.d(t,{D:()=>a,f:()=>s});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0};function s(e){try{return!!e.licenseKey&&!!e.errorBeacon&&!!e.applicationID}catch(e){return!1}}const a=e=>(0,i.a)(e,o)},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>s,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>a,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,s=18e5,a={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)},r,i)}},3241:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(6154);const i="newrelic";function o(e={}){try{n.gm.dispatchEvent(new CustomEvent(i,{detail:e}))}catch(e){}}},3304:(e,t,r)=>{"use strict";r.d(t,{A:()=>o});var n=r(7836);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())??""}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}return""}}},3333:(e,t,r)=>{"use strict";r.d(t,{$v:()=>d,TZ:()=>n,Xh:()=>c,Zp:()=>i,kd:()=>u,mq:()=>a,nf:()=>s,qN:()=>o});const n=r(860).K7.genericEvents,i=["auxclick","click","copy","keydown","paste","scrollend"],o=["focus","blur"],s=4,a=1e3,c=2e3,u=["PageAction","UserAction","BrowserPerformance"],d={RESOURCES:"experimental.resources",REGISTER:"register"}},3434:(e,t,r)=>{"use strict";r.d(t,{Jt:()=>o,YM:()=>u});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W),s=50;var a=Object.prototype.hasOwnProperty,c=!1;function u(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const s="-"===n.charAt(0);for(let a=0;a<t.length;a++){const c=t[a],u=e[c];l(u)||(e[c]=r(u,s?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,c,u){return l(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach(function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})}),t}catch(e){d([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,l,f;let h;try{a=this,o=[...arguments],l="function"==typeof n?n(o,a):n||{}}catch(t){d([t,"",[o,a,c],l],e)}i(r+"start",[o,a,c],l,u);const p=performance.now();let g;try{return f=t.apply(a,o),g=performance.now(),f}catch(e){throw g=performance.now(),i(r+"err",[o,a,e],l,u),h=e,h}finally{const e=g-p,t={start:p,end:g,duration:e,isLongTask:e>=s,methodName:c,thrownError:h};t.isLongTask&&i("long-task",[t,a],l,u),i(r+"end",[o,a,f],l,u)}}}function i(r,n,i,o){if(!c||t){var s=c;c=!0;try{e.emit(r,n,i,t,o)}catch(t){d([t,r,n,i],e)}c=s}}}function d(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function l(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=s;var i=o.handlers={};function o(e,t,r,o){s(o||n.d,i,e,t,r)}function s(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var s=t[o]=t[o]||{};(s[r]=s[r]||[]).push([e,i])}},3738:(e,t,r)=>{"use strict";r.d(t,{He:()=>i,Kp:()=>a,Lc:()=>u,Rz:()=>d,TZ:()=>n,bD:()=>o,d3:()=>s,jx:()=>l,sl:()=>f,uP:()=>c});const n=r(860).K7.sessionTrace,i="bstResource",o="resource",s="-start",a="-end",c="fn"+s,u="fn"+a,d="pushState",l=1e3,f=3e4},3785:(e,t,r)=>{"use strict";r.d(t,{R:()=>c,b:()=>u});var n=r(9908),i=r(1863),o=r(860),s=r(8154),a=r(993);function c(e,t,r={},c=a.p_.INFO,u,d=(0,i.t)()){(0,n.p)(s.xV,["API/logging/".concat(c.toLowerCase(),"/called")],void 0,o.K7.metrics,e),(0,n.p)(a.ET,[d,t,r,c,u],void 0,o.K7.logging,e)}function u(e){return"string"==typeof e&&Object.values(a.p_).some(t=>t===e.toUpperCase().trim())}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},3962:(e,t,r)=>{"use strict";r.d(t,{AM:()=>s,O2:()=>l,OV:()=>o,Qu:()=>f,TZ:()=>c,ih:()=>h,pP:()=>a,t1:()=>d,tC:()=>i,wD:()=>u});var n=r(860);const i=["click","keydown","submit"],o="popstate",s="api",a="initialPageLoad",c=n.K7.softNav,u=5e3,d=500,l={INITIAL_PAGE_LOAD:"",ROUTE_CHANGE:1,UNSPECIFIED:2},f={INTERACTION:1,AJAX:2,CUSTOM_END:3,CUSTOM_TRACER:4},h={IP:"in progress",PF:"pending finish",FIN:"finished",CAN:"cancelled"}},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},4261:(e,t,r)=>{"use strict";r.d(t,{$9:()=>d,BL:()=>c,CH:()=>p,Dl:()=>R,Fw:()=>w,PA:()=>v,Pl:()=>n,Pv:()=>A,Tb:()=>f,U2:()=>s,V1:()=>E,Wb:()=>T,bt:()=>y,cD:()=>b,d3:()=>x,dT:()=>u,eY:()=>g,fF:()=>h,hG:()=>o,hw:()=>i,k6:()=>a,nb:()=>m,o5:()=>l});const n="api-",i=n+"ixn-",o="addPageAction",s="addToTrace",a="addRelease",c="finished",u="interaction",d="log",l="noticeError",f="pauseReplay",h="recordCustomEvent",p="recordReplay",g="register",m="setApplicationVersion",v="setCurrentRouteName",b="setCustomAttribute",y="setErrorHandler",w="setPageViewName",R="setUserId",x="start",T="wrapLogger",E="measure",A="consent"},4387:(e,t,r)=>{"use strict";function n(e={}){return!(!e.id||!e.name)}function i(e){return"string"==typeof e&&e.trim().length<501||"number"==typeof e}function o(e,t){if(2!==t?.harvestEndpointVersion)return{};const r=t.agentRef.runtime.appMetadata.agents[0].entityGuid;return n(e)?{"mfe.id":e.id,"mfe.name":e.name,eventSource:e.eventSource,"parent.id":e.parent?.id||r}:{"entity.guid":r,appId:t.agentRef.info.applicationID}}r.d(t,{Ux:()=>o,c7:()=>n,yo:()=>i})},5205:(e,t,r)=>{"use strict";r.d(t,{j:()=>_});var n=r(384),i=r(1741);var o=r(2555),s=r(3333);const a=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var c=r(2614),u=r(944),d=r(8122);const l="[data-nr-mask]",f=e=>(0,d.a)(e,(()=>{const e={feature_flags:[],experimental:{allow_registered_children:!1,resources:!1},mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,autoStart:!0},api:{get allow_registered_children(){return e.feature_flags.includes(s.$v.REGISTER)||e.experimental.allow_registered_children},set allow_registered_children(t){e.experimental.allow_registered_children=t},duplicate_registered_data:!1},browser_consent_mode:{enabled:!1},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},get feature_flags(){return e.feature_flags},set feature_flags(t){e.feature_flags=t},generic_events:{enabled:!0,autoStart:!0},harvest:{interval:30},jserrors:{enabled:!0,autoStart:!0},logging:{enabled:!0,autoStart:!0},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1,capture_detail:!0,resources:{get enabled(){return e.feature_flags.includes(s.$v.RESOURCES)||e.experimental.resources},set enabled(t){e.experimental.resources=t},asset_types:[],first_party_domains:[],ignore_newrelic:!0}},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:c.wk,inactiveMs:c.BB},session_replay:{autoStart:!0,enabled:!1,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){a(t)?e.mask_selector="".concat(t,",").concat(l):""===t||null===t?e.mask_selector=l:(0,u.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){a(t)?e.block_selector+=",".concat(t):""!==t&&(0,u.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,u.R)(7,t)}},session_trace:{enabled:!0,autoStart:!0},soft_navigations:{enabled:!0,autoStart:!0},spa:{enabled:!0,autoStart:!0},ssl:void 0,user_actions:{enabled:!0,elementAttributes:["id","className","tagName","type"]}}})());var h=r(6154),p=r(9324);let g=0;const m={buildEnv:p.F3,distMethod:p.Xs,version:p.xv,originTime:h.WN},v={consented:!1},b={appMetadata:{},get consented(){return this.session?.state?.consent||v.consented},set consented(e){v.consented=e},customTransaction:void 0,denyList:void 0,disabled:!1,harvester:void 0,isolatedBacklog:!1,isRecording:!1,loaderType:void 0,maxBytes:3e4,obfuscator:void 0,onerror:void 0,ptid:void 0,releaseIds:{},session:void 0,timeKeeper:void 0,registeredEntities:[],jsAttributesMetadata:{bytes:0},get harvestCount(){return++g}},y=e=>{const t=(0,d.a)(e,b),r=Object.keys(m).reduce((e,t)=>(e[t]={value:m[t],writable:!1,configurable:!0,enumerable:!0},e),{});return Object.defineProperties(t,r)};var w=r(5701);const R=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};var x=r(7836),T=r(3241);const E={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},A=e=>(0,d.a)(e,E),S=new Set;function _(e,t={},r,s){let{init:a,info:c,loader_config:u,runtime:d={},exposed:l=!0}=t;if(!c){const e=(0,n.pV)();a=e.init,c=e.info,u=e.loader_config}e.init=f(a||{}),e.loader_config=A(u||{}),c.jsAttributes??={},h.bv&&(c.jsAttributes.isWorker=!0),e.info=(0,o.D)(c);const p=e.init,g=[c.beacon,c.errorBeacon];S.has(e.agentIdentifier)||(p.proxy.assets&&(R(p.proxy.assets),g.push(p.proxy.assets)),p.proxy.beacon&&g.push(p.proxy.beacon),e.beacons=[...g],function(e){const t=(0,n.pV)();Object.getOwnPropertyNames(i.W.prototype).forEach(r=>{const n=i.W.prototype[r];if("function"!=typeof n||"constructor"===n)return;let o=t[r];e[r]&&!1!==e.exposed&&"micro-agent"!==e.runtime?.loaderType&&(t[r]=(...t)=>{const n=e[r](...t);return o?o(...t):n})})}(e),(0,n.US)("activatedFeatures",w.B),e.runSoftNavOverSpa&&=!0===p.soft_navigations.enabled&&p.feature_flags.includes("soft_nav")),d.denyList=[...p.ajax.deny_list||[],...p.ajax.block_internal?g:[]],d.ptid=e.agentIdentifier,d.loaderType=r,e.runtime=y(d),S.has(e.agentIdentifier)||(e.ee=x.ee.get(e.agentIdentifier),e.exposed=l,(0,T.W)({agentIdentifier:e.agentIdentifier,drained:!!w.B?.[e.agentIdentifier],type:"lifecycle",name:"initialize",feature:void 0,data:e.config})),S.add(e.agentIdentifier)}},5270:(e,t,r)=>{"use strict";r.d(t,{Aw:()=>s,SR:()=>o,rF:()=>a});var n=r(384),i=r(7767);function o(e){return!!(0,n.dV)().o.MO&&(0,i.V)(e)&&!0===e?.session_trace.enabled}function s(e){return!0===e?.session_replay.preload&&o(e)}function a(e,t){try{if("string"==typeof t?.type){if("password"===t.type.toLowerCase())return"*".repeat(e?.length||0);if(void 0!==t?.dataset?.nrUnmask||t?.classList?.contains("nr-unmask"))return e}}catch(e){}return"string"==typeof e?e.replace(/[\S]/g,"*"):"*".repeat(e?.length||0)}},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,Qr:()=>a,sB:()=>s});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function s(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}function a(e){if(i())return e();(0,n.sp)("popstate",e)}},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},5701:(e,t,r)=>{"use strict";r.d(t,{B:()=>o,t:()=>s});var n=r(3241);const i=new Set,o={};function s(e,t){const r=t.agentIdentifier;o[r]??={},e&&"object"==typeof e&&(i.has(r)||(t.ee.emit("rumresp",[e]),o[r]=e,i.add(r),(0,n.W)({agentIdentifier:r,loaded:!0,drained:!0,type:"lifecycle",name:"load",feature:void 0,data:e})))}},6154:(e,t,r)=>{"use strict";r.d(t,{A4:()=>a,OF:()=>d,RI:()=>i,WN:()=>h,bv:()=>o,gm:()=>s,lR:()=>f,m:()=>u,mw:()=>c,sb:()=>l});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),s=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a="complete"===s?.document?.readyState,c=Boolean("hidden"===s?.document?.visibilityState),u=""+s?.location,d=/iPad|iPhone|iPod/.test(s.navigator?.userAgent),l=d&&"undefined"==typeof SharedWorker,f=(()=>{const e=s.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),h=Date.now()-(0,n.t)()},6344:(e,t,r)=>{"use strict";r.d(t,{BB:()=>d,Qb:()=>l,TZ:()=>i,Ug:()=>s,Vh:()=>o,_s:()=>a,bc:()=>u,yP:()=>c});var n=r(2614);const i=r(860).K7.sessionReplay,o="errorDuringReplay",s=.12,a={DomContentLoaded:0,Load:1,FullSnapshot:2,IncrementalSnapshot:3,Meta:4,Custom:5},c={[n.g.ERROR]:15e3,[n.g.FULL]:3e5,[n.g.OFF]:0},u={RESET:{message:"Session was reset",sm:"Reset"},IMPORT:{message:"Recorder failed to import",sm:"Import"},TOO_MANY:{message:"429: Too Many Requests",sm:"Too-Many"},TOO_BIG:{message:"Payload was too large",sm:"Too-Big"},CROSS_TAB:{message:"Session Entity was set to OFF on another tab",sm:"Cross-Tab"},ENTITLEMENTS:{message:"Session Replay is not allowed and will not be started",sm:"Entitlement"}},d=5e3,l={API:"api",RESUME:"resume",SWITCH_TO_FULL:"switchToFull",INITIALIZE:"initialize",PRELOAD:"preload"}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout(()=>{i=clearTimeout(i)},t)),n||(clearTimeout(i),i=setTimeout(()=>{e.apply(this,r)},t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},6774:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.jserrors},7295:(e,t,r)=>{"use strict";r.d(t,{Xv:()=>s,gX:()=>i,iW:()=>o});var n=[];function i(e){if(!e||o(e))return!1;if(0===n.length)return!0;for(var t=0;t<n.length;t++){var r=n[t];if("*"===r.hostname)return!1;if(a(r.hostname,e.hostname)&&c(r.pathname,e.pathname))return!1}return!0}function o(e){return void 0===e.hostname}function s(e){if(n=[],e&&e.length)for(var t=0;t<e.length;t++){let r=e[t];if(!r)continue;0===r.indexOf("http://")?r=r.substring(7):0===r.indexOf("https://")&&(r=r.substring(8));const i=r.indexOf("/");let o,s;i>0?(o=r.substring(0,i),s=r.substring(i)):(o=r,s="");let[a]=o.split(":");n.push({hostname:a,pathname:s})}}function a(e,t){return!(e.length>t.length)&&t.indexOf(e)===t.length-e.length}function c(e,t){return 0===e.indexOf("/")&&(e=e.substring(1)),0===t.indexOf("/")&&(t=t.substring(1)),""===e||e===t}},7378:(e,t,r)=>{"use strict";r.d(t,{$p:()=>x,BR:()=>b,Kp:()=>R,L3:()=>y,Lc:()=>c,NC:()=>o,SG:()=>d,TZ:()=>i,U6:()=>p,UT:()=>m,d3:()=>w,dT:()=>f,e5:()=>E,gx:()=>v,l9:()=>l,oW:()=>h,op:()=>g,rw:()=>u,tH:()=>A,uP:()=>a,wW:()=>T,xq:()=>s});var n=r(384);const i=r(860).K7.spa,o=["click","submit","keypress","keydown","keyup","change"],s=999,a="fn-start",c="fn-end",u="cb-start",d="api-ixn-",l="remaining",f="interaction",h="spaNode",p="jsonpNode",g="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=(0,n.dV)().o.ST,w="-start",R="-end",x="-body",T="cb"+R,E="jsTime",A="fetch"},7485:(e,t,r)=>{"use strict";r.d(t,{D:()=>i});var n=r(6154);function i(e){if(0===(e||"").indexOf("data:"))return{protocol:"data"};try{const t=new URL(e,location.href),r={port:t.port,hostname:t.hostname,pathname:t.pathname,search:t.search,protocol:t.protocol.slice(0,t.protocol.indexOf(":")),sameOrigin:t.protocol===n.gm?.location?.protocol&&t.host===n.gm?.location?.host};return r.port&&""!==r.port||("http:"===t.protocol&&(r.port="80"),"https:"===t.protocol&&(r.port="443")),r.pathname&&""!==r.pathname?r.pathname.startsWith("/")||(r.pathname="/".concat(r.pathname)):r.pathname="/",r}catch(e){return{}}}},7699:(e,t,r)=>{"use strict";r.d(t,{It:()=>o,KC:()=>a,No:()=>i,qh:()=>s});var n=r(860);const i=16e3,o=1e6,s="SESSION_ERROR",a={[n.K7.logging]:!0,[n.K7.genericEvents]:!1,[n.K7.jserrors]:!1,[n.K7.ajax]:!1}},7767:(e,t,r)=>{"use strict";r.d(t,{V:()=>i});var n=r(6154);const i=e=>n.RI&&!0===e?.privacy.cookies_enabled},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>a,ee:()=>c});var n=r(384),i=r(8990),o=r(2646),s=r(5607);const a="nr@context:".concat(s.W),c=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&u.initializedAgents?.[r]?.runtime.isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(c.aborted&&!i)return;t&&o&&t.emit(e,r,n);var a=h(n);g(e).forEach(e=>{e.apply(a,r)});var u=v()[s[e]];u&&u.push([f,e,r,a]);return a},get:m,listeners:g,context:h,buffer:function(e,t){const r=v();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach(([e,n])=>{s[n]=t,t in r||(r[t]=[])})},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach(e=>{delete f.backlog[e]})},isBuffering:function(e){return!!v()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function h(e){return e&&e instanceof o.y?e:e?(0,i.I)(e,a,()=>new o.y(a)):new o.y(a)}function p(e,t){n[e]=g(e).concat(t)}function g(e){return n[e]||[]}function m(t){return d[t]=d[t]||e(f,t)}function v(){return f.backlog}}(void 0,"globalEE"),u=(0,n.Zm)();u.ee||(u.ee=c)},8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let s in o)if(void 0!==e[s])try{if(null===e[s]){r[s]=null;continue}Array.isArray(e[s])&&Array.isArray(t[s])?r[s]=Array.from(new Set([...e[s],...t[s]])):"object"==typeof e[s]&&"object"==typeof t[s]?r[s]=i(e[s],t[s]):r[s]=e[s]}catch(e){r[s]||(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},8139:(e,t,r)=>{"use strict";r.d(t,{u:()=>f});var n=r(7836),i=r(3434),o=r(8990),s=r(6154);const a={},c=s.gm.XMLHttpRequest,u="addEventListener",d="removeEventListener",l="nr@wrapped:".concat(n.P);function f(e){var t=function(e){return(e||n.ee).get("events")}(e);if(a[t.debugId]++)return t;a[t.debugId]=1;var r=(0,i.YM)(t,!0);function f(e){r.inPlace(e,[u,d],"-",p)}function p(e,t){return e[1]}return"getPrototypeOf"in Object&&(s.RI&&h(document,f),c&&h(c.prototype,f),h(s.gm,f)),t.on(u+"-start",function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)&&"newrelic"!==e[0]){var i=(0,o.I)(n,l,function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=e[1]=i}}),t.on(d+"-start",function(e){e[1]=this.wrapped||e[1]}),t}function h(e,t,...r){let n=e;for(;"object"==typeof n&&!Object.prototype.hasOwnProperty.call(n,u);)n=Object.getPrototypeOf(n);n&&t(n,...r)}},8154:(e,t,r)=>{"use strict";r.d(t,{z_:()=>o,XG:()=>a,TZ:()=>n,rs:()=>i,xV:()=>s});r(6154),r(9566),r(384);const n=r(860).K7.metrics,i="sm",o="cm",s="storeSupportabilityMetrics",a="storeEventMetrics"},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},9300:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.ajax},9324:(e,t,r)=>{"use strict";r.d(t,{AJ:()=>s,F3:()=>i,Xs:()=>o,Yq:()=>a,xv:()=>n});const n="1.303.0",i="PROD",o="CDN",s="@newrelic/rrweb",a="1.0.1"},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>a,ZF:()=>c,bz:()=>s,el:()=>u});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function s(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map(e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e).join("")}function a(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const s=[];for(var a=0;a<e;a++)s.push(o(r,i++).toString(16));return s.join("")}function c(){return a(16)}function u(){return a(32)}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce((t,r)=>(i.f[r](e,t),t),[])),i.u=e=>({212:"nr-spa-compressor",249:"nr-spa-recorder",478:"nr-spa"}[e]+"-1.303.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.303.0.PROD:",i.l=(r,n,o,s)=>{if(e[r])e[r].push(n);else{var a,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){a=l;break}}if(!a){c=!0;var f={478:"sha512-Q1pLqcoiNmLHv0rtq3wFkJBA3kofBdRJl0ExDl0mTuAoCBd0qe/1J0XWrDlQKuNlUryL6aZfVkAMPLmoikWIoQ==",249:"sha512-695ZzudsxlMtHKnpDNvkMlJd3tdMtY03IQKVCw9SX12tjUC+f7Nrx5tnWO72Vg9RFf6DSY6wVmM3cEkRM12kkQ==",212:"sha512-18Gx1wIBsppcn0AnKFhwgw4IciNgFxiw3J74W393Ape+wtg4hlg7t6SBKsIE/Dk/tfl2yltgcgBFvYRs283AFg=="};(a=document.createElement("script")).charset="utf-8",i.nc&&a.setAttribute("nonce",i.nc),a.setAttribute("data-webpack",t+o),a.src=r,0!==a.src.indexOf(window.location.origin+"/")&&(a.crossOrigin="anonymous"),f[s]&&(a.integrity=f[s])}e[r]=[n];var h=(t,n)=>{a.onerror=a.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],a.parentNode&&a.parentNode.removeChild(a),i&&i.forEach(e=>e(n)),t)return t(n)},p=setTimeout(h.bind(null,void 0,{type:"timeout",target:a}),12e4);a.onerror=h.bind(null,a.onerror),a.onload=h.bind(null,a.onload),c&&document.head.appendChild(a)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={38:0,788:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise((r,i)=>n=e[t]=[r,i]);r.push(n[2]=o);var s=i.p+i.u(t),a=new Error;i.l(s,r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),s=r&&r.target&&r.target.src;a.message="Loading chunk "+t+" failed.\n("+o+": "+s+")",a.name="ChunkLoadError",a.type=o,a.request=s,n[1](a)}},"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[s,a,c]=r,u=0;if(s.some(t=>0!==e[t])){for(n in a)i.o(a,n)&&(i.m[n]=a[n]);if(c)c(i)}for(t&&t(r);u<s.length;u++)o=s[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.303.0.PROD"]=self["webpackChunk:NRBA-1.303.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(9566),t=i(1741);class r extends t.W{agentIdentifier=(0,e.LA)(16)}var n=i(860);const o=Object.values(n.K7);var s=i(5205);var a=i(9908),c=i(1863),u=i(4261),d=i(3241),l=i(944),f=i(5701),h=i(8154);function p(e,t,i,o){const s=o||i;!s||s[e]&&s[e]!==r.prototype[e]||(s[e]=function(){(0,a.p)(h.xV,["API/"+e+"/called"],void 0,n.K7.metrics,i.ee),(0,d.W)({agentIdentifier:i.agentIdentifier,drained:!!f.B?.[i.agentIdentifier],type:"data",name:"api",feature:u.Pl+e,data:{}});try{return t.apply(this,arguments)}catch(e){(0,l.R)(23,e)}})}function g(e,t,r,n,i){const o=e.info;null===r?delete o.jsAttributes[t]:o.jsAttributes[t]=r,(i||null===r)&&(0,a.p)(u.Pl+n,[(0,c.t)(),t,r],void 0,"session",e.ee)}var m=i(1687),v=i(4234),b=i(5289),y=i(6154),w=i(5270),R=i(7767),x=i(6389),T=i(7699);class E extends v.W{constructor(e,t){super(e.agentIdentifier,t),this.agentRef=e,this.abortHandler=void 0,this.featAggregate=void 0,this.loadedSuccessfully=void 0,this.onAggregateImported=new Promise(e=>{this.loadedSuccessfully=e}),this.deferred=Promise.resolve(),!1===e.init[this.featureName].autoStart?this.deferred=new Promise((t,r)=>{this.ee.on("manual-start-all",(0,x.J)(()=>{(0,m.Ak)(e.agentIdentifier,this.featureName),t()}))}):(0,m.Ak)(e.agentIdentifier,t)}importAggregator(e,t,r={}){if(this.featAggregate)return;const n=async()=>{let n;await this.deferred;try{if((0,R.V)(e.init)){const{setupAgentSession:t}=await i.e(478).then(i.bind(i,8766));n=t(e)}}catch(e){(0,l.R)(20,e),this.ee.emit("internal-error",[e]),(0,a.p)(T.qh,[e],void 0,this.featureName,this.ee)}try{if(!this.#t(this.featureName,n,e.init))return(0,m.Ze)(this.agentIdentifier,this.featureName),void this.loadedSuccessfully(!1);const{Aggregate:i}=await t();this.featAggregate=new i(e,r),e.runtime.harvester.initializedAggregates.push(this.featAggregate),this.loadedSuccessfully(!0)}catch(e){(0,l.R)(34,e),this.abortHandler?.(),(0,m.Ze)(this.agentIdentifier,this.featureName,!0),this.loadedSuccessfully(!1),this.ee&&this.ee.abort()}};y.RI?(0,b.GG)(()=>n(),!0):n()}#t(e,t,r){if(this.blocked)return!1;switch(e){case n.K7.sessionReplay:return(0,w.SR)(r)&&!!t;case n.K7.sessionTrace:return!!t;default:return!0}}}var A=i(6630),S=i(2614);class _ extends E{static featureName=A.T;constructor(e){var t;super(e,A.T),this.setupInspectionEvents(e.agentIdentifier),t=e,p(u.Fw,function(e,r){"string"==typeof e&&("/"!==e.charAt(0)&&(e="/"+e),t.runtime.customTransaction=(r||"http://custom.transaction")+e,(0,a.p)(u.Pl+u.Fw,[(0,c.t)()],void 0,void 0,t.ee))},t),this.importAggregator(e,()=>i.e(478).then(i.bind(i,1983)))}setupInspectionEvents(e){const t=(t,r)=>{t&&(0,d.W)({agentIdentifier:e,timeStamp:t.timeStamp,loaded:"complete"===t.target.readyState,type:"window",name:r,data:t.target.location+""})};(0,b.sB)(e=>{t(e,"DOMContentLoaded")}),(0,b.GG)(e=>{t(e,"load")}),(0,b.Qr)(e=>{t(e,"navigate")}),this.ee.on(S.tS.UPDATE,(t,r)=>{(0,d.W)({agentIdentifier:e,type:"lifecycle",name:"session",data:r})})}}var O=i(384);var N=i(2843),I=i(3878),P=i(782);class j extends E{static featureName=P.T;constructor(e){super(e,P.T),y.RI&&((0,N.u)(()=>(0,a.p)("docHidden",[(0,c.t)()],void 0,P.T,this.ee),!0),(0,I.sp)("pagehide",()=>(0,a.p)("winPagehide",[(0,c.t)()],void 0,P.T,this.ee)),this.importAggregator(e,()=>i.e(478).then(i.bind(i,9917))))}}class k extends E{static featureName=h.TZ;constructor(e){super(e,h.TZ),y.RI&&document.addEventListener("securitypolicyviolation",e=>{(0,a.p)(h.xV,["Generic/CSPViolation/Detected"],void 0,this.featureName,this.ee)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,6555)))}}var C=i(6774),L=i(3304);class H{constructor(e,t,r,n,i){this.name="UncaughtError",this.message="string"==typeof e?e:(0,L.A)(e),this.sourceURL=t,this.line=r,this.column=n,this.__newrelic=i}}function M(e){return U(e)?e:new H(void 0!==e?.message?e.message:e,e?.filename||e?.sourceURL,e?.lineno||e?.line,e?.colno||e?.col,e?.__newrelic,e?.cause)}function K(e){const t="Unhandled Promise Rejection: ";if(!e?.reason)return;if(U(e.reason)){try{e.reason.message.startsWith(t)||(e.reason.message=t+e.reason.message)}catch(e){}return M(e.reason)}const r=M(e.reason);return(r.message||"").startsWith(t)||(r.message=t+r.message),r}function D(e){if(e.error instanceof SyntaxError&&!/:\d+$/.test(e.error.stack?.trim())){const t=new H(e.message,e.filename,e.lineno,e.colno,e.error.__newrelic,e.cause);return t.name=SyntaxError.name,t}return U(e.error)?e.error:M(e)}function U(e){return e instanceof Error&&!!e.stack}function F(e,t,r,i,o=(0,c.t)()){"string"==typeof e&&(e=new Error(e)),(0,a.p)("err",[e,o,!1,t,r.runtime.isRecording,void 0,i],void 0,n.K7.jserrors,r.ee),(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,r.ee)}var W=i(4387),B=i(993),V=i(3785);function G(e,{customAttributes:t={},level:r=B.p_.INFO}={},n,i,o=(0,c.t)()){(0,V.R)(n.ee,e,t,r,i,o)}function z(e,t,r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.hG,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function Z(e,t,r,i,o=(0,c.t)()){const{start:s,end:d,customAttributes:f}=t||{},h={customAttributes:f||{}};if("object"!=typeof h.customAttributes||"string"!=typeof e||0===e.length)return void(0,l.R)(57);const p=(e,t)=>null==e?t:"number"==typeof e?e:e instanceof PerformanceMark?e.startTime:Number.NaN;if(h.start=p(s,0),h.end=p(d,o),Number.isNaN(h.start)||Number.isNaN(h.end))(0,l.R)(57);else{if(h.duration=h.end-h.start,!(h.duration<0))return(0,a.p)(u.Pl+u.V1,[h,e,i],void 0,n.K7.genericEvents,r.ee),h;(0,l.R)(58)}}function q(e,t={},r,i,o=(0,c.t)()){(0,a.p)(u.Pl+u.fF,[o,e,t,i],void 0,n.K7.genericEvents,r.ee)}function X(e){p(u.eY,function(t){return Y(e,t)},e)}function Y(e,t,r){const i={};(0,l.R)(54,"newrelic.register"),t||={},t.eventSource="MicroFrontendBrowserAgent",t.licenseKey||=e.info.licenseKey,t.blocked=!1,t.parent=r||{};let o=()=>{};const s=e.runtime.registeredEntities,u=s.find(({metadata:{target:{id:e,name:r}}})=>e===t.id);if(u)return u.metadata.target.name!==t.name&&(u.metadata.target.name=t.name),u;const d=e=>{t.blocked=!0,o=e};e.init.api.allow_registered_children||d((0,x.J)(()=>(0,l.R)(55))),(0,W.c7)(t)||d((0,x.J)(()=>(0,l.R)(48,t))),(0,W.yo)(t.id)&&(0,W.yo)(t.name)||d((0,x.J)(()=>(0,l.R)(48,t)));const f={addPageAction:(r,n={})=>m(z,[r,{...i,...n},e],t),log:(r,n={})=>m(G,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),measure:(r,n={})=>m(Z,[r,{...n,customAttributes:{...i,...n.customAttributes||{}}},e],t),noticeError:(r,n={})=>m(F,[r,{...i,...n},e],t),register:(t={})=>m(Y,[e,t],f.metadata.target),recordCustomEvent:(r,n={})=>m(q,[r,{...i,...n},e],t),setApplicationVersion:e=>g("application.version",e),setCustomAttribute:(e,t)=>g(e,t),setUserId:e=>g("enduser.id",e),metadata:{customAttributes:i,target:t}},p=()=>(t.blocked&&o(),t.blocked);p()||s.push(f);const g=(e,t)=>{p()||(i[e]=t)},m=(t,r,i)=>{if(p())return;const o=(0,c.t)();(0,a.p)(h.xV,["API/register/".concat(t.name,"/called")],void 0,n.K7.metrics,e.ee);try{return e.init.api.duplicate_registered_data&&"register"!==t.name&&t(...r,void 0,o),t(...r,i,o)}catch(e){(0,l.R)(50,e)}};return f}class J extends E{static featureName=C.T;constructor(e){var t;super(e,C.T),t=e,p(u.o5,(e,r)=>F(e,r,t),t),function(e){p(u.bt,function(t){e.runtime.onerror=t},e)}(e),function(e){let t=0;p(u.k6,function(e,r){++t>10||(this.runtime.releaseIds[e.slice(-200)]=(""+r).slice(-200))},e)}(e),X(e);try{this.removeOnAbort=new AbortController}catch(e){}this.ee.on("internal-error",(t,r)=>{this.abortHandler&&(0,a.p)("ierr",[M(t),(0,c.t)(),!0,{},e.runtime.isRecording,r],void 0,this.featureName,this.ee)}),y.gm.addEventListener("unhandledrejection",t=>{this.abortHandler&&(0,a.p)("err",[K(t),(0,c.t)(),!1,{unhandledPromiseRejection:1},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),y.gm.addEventListener("error",t=>{this.abortHandler&&(0,a.p)("err",[D(t),(0,c.t)(),!1,{},e.runtime.isRecording],void 0,this.featureName,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,2176)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var Q=i(8990);let ee=1;function te(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===y.gm?0:(0,Q.I)(e,"nr@id",function(){return ee++})}function re(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,L.A)(e).length}catch(e){return}}}var ne=i(8139),ie=i(7836),oe=i(3434);const se={},ae=["open","send"];function ce(e){var t=e||ie.ee;const r=function(e){return(e||ie.ee).get("xhr")}(t);if(void 0===y.gm.XMLHttpRequest)return r;if(se[r.debugId]++)return r;se[r.debugId]=1,(0,ne.u)(t);var n=(0,oe.YM)(r),i=y.gm.XMLHttpRequest,o=y.gm.MutationObserver,s=y.gm.Promise,a=y.gm.setInterval,c="readystatechange",u=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],d=[],f=y.gm.XMLHttpRequest=function(e){const t=new i(e),o=r.context(t);try{r.emit("new-xhr",[t],o),t.addEventListener(c,(s=o,function(){var e=this;e.readyState>3&&!s.resolved&&(s.resolved=!0,r.emit("xhr-resolved",[],e)),n.inPlace(e,u,"fn-",b)}),(0,I.jT)(!1))}catch(e){(0,l.R)(15,e);try{r.emit("internal-error",[e])}catch(e){}}var s;return t};function h(e,t){n.inPlace(t,["onreadystatechange"],"fn-",b)}if(function(e,t){for(var r in e)t[r]=e[r]}(i,f),f.prototype=i.prototype,n.inPlace(f.prototype,ae,"-xhr-",b),r.on("send-xhr-start",function(e,t){h(e,t),function(e){d.push(e),o&&(p?p.then(v):a?a(v):(g=-g,m.data=g))}(t)}),r.on("open-xhr-start",h),o){var p=s&&s.resolve();if(!a&&!s){var g=1,m=document.createTextNode(g);new o(v).observe(m,{characterData:!0})}}else t.on("fn-end",function(e){e[0]&&e[0].type===c||v()});function v(){for(var e=0;e<d.length;e++)h(0,d[e]);d.length&&(d=[])}function b(e,t){return t}return r}var ue="fetch-",de=ue+"body-",le=["arrayBuffer","blob","json","text","formData"],fe=y.gm.Request,he=y.gm.Response,pe="prototype";const ge={};function me(e){const t=function(e){return(e||ie.ee).get("fetch")}(e);if(!(fe&&he&&y.gm.fetch))return t;if(ge[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[ie.P]&&o[ie.P].dt&&(e=o[ie.P].dt);var s=i.apply(this,r);return t.emit(n+"start",[r,e],s),s.then(function(e){return t.emit(n+"end",[null,e],s),e},function(e){throw t.emit(n+"end",[e],s),e})})}return ge[t.debugId]=1,le.forEach(e=>{r(fe[pe],e,de),r(he[pe],e,de)}),r(y.gm,"fetch",ue),t.on(ue+"end",function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(ue+"done",[null,r],n)}else t.emit(ue+"done",[e],n)}),t}var ve=i(7485);class be{constructor(e){this.agentRef=e}generateTracePayload(t){const r=this.agentRef.loader_config;if(!this.shouldGenerateTrace(t)||!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var s=(0,e.ZF)(),a=(0,e.el)(),c=Date.now(),u={spanId:s,traceId:a,timestamp:c};return(t.sameOrigin||this.isAllowedOrigin(t)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(s,a),u.traceContextStateHeader=this.generateTraceContextStateHeader(s,c,n,i,o)),(t.sameOrigin&&!this.excludeNewrelicHeader()||!t.sameOrigin&&this.isAllowedOrigin(t)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(s,a,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof y.gm?.btoa))return null;var s={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(s.d.tk=o),btoa((0,L.A)(s))}shouldGenerateTrace(e){return this.agentRef.init?.distributed_tracing?.enabled&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var t=!1;const r=this.agentRef.init?.distributed_tracing;if(e.sameOrigin)t=!0;else if(r?.allowed_origins instanceof Array)for(var n=0;n<r.allowed_origins.length;n++){var i=(0,ve.D)(r.allowed_origins[n]);if(e.hostname===i.hostname&&e.protocol===i.protocol&&e.port===i.port){t=!0;break}}return t}excludeNewrelicHeader(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=this.agentRef.init?.distributed_tracing;return!!e&&!!e.cors_use_tracecontext_headers}}var ye=i(9300),we=i(7295);function Re(e){return"string"==typeof e?e:e instanceof(0,O.dV)().o.REQ?e.url:y.gm?.URL&&e instanceof URL?e.href:void 0}var xe=["load","error","abort","timeout"],Te=xe.length,Ee=(0,O.dV)().o.REQ,Ae=(0,O.dV)().o.XHR;const Se="X-NewRelic-App-Data";class _e extends E{static featureName=ye.T;constructor(e){super(e,ye.T),this.dt=new be(e),this.handler=(e,t,r,n)=>(0,a.p)(e,t,r,n,this.ee);try{const e={xmlhttprequest:"xhr",fetch:"fetch",beacon:"beacon"};y.gm?.performance?.getEntriesByType("resource").forEach(t=>{if(t.initiatorType in e&&0!==t.responseStatus){const r={status:t.responseStatus},i={rxSize:t.transferSize,duration:Math.floor(t.duration),cbTime:0};Oe(r,t.name),this.handler("xhr",[r,i,t.startTime,t.responseEnd,e[t.initiatorType]],void 0,n.K7.ajax)}})}catch(e){}me(this.ee),ce(this.ee),function(e,t,r,i){function o(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},t.latestLongtaskEnd=0,e.addEventListener("load",function(r){A(t,e)},(0,I.jT)(!1)),y.lR||e.addEventListener("progress",function(e){t.lastSize=e.loaded},(0,I.jT)(!1))}function s(e){this.params={method:e[0]},Oe(this,e[1]),this.metrics={}}function u(t,r){e.loader_config.xpid&&this.sameOrigin&&r.setRequestHeader("X-NewRelic-ID",e.loader_config.xpid);var n=i.generateTracePayload(this.parsedOrigin);if(n){var o=!1;n.newrelicHeader&&(r.setRequestHeader("newrelic",n.newrelicHeader),o=!0),n.traceContextParentHeader&&(r.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&r.setRequestHeader("tracestate",n.traceContextStateHeader),o=!0),o&&(this.dt=n)}}function d(e,r){var n=this.metrics,i=e[0],o=this;if(n&&i){var s=re(i);s&&(n.txSize=s)}this.startTime=(0,c.t)(),this.body=i,this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof r.onload)&&"function"==typeof o.end)&&o.end(r)}catch(e){try{t.emit("internal-error",[e])}catch(e){}}};for(var a=0;a<Te;a++)r.addEventListener(xe[a],this.listener,(0,I.jT)(!1))}function l(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function f(e,t){var r=""+te(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function p(e,t){var r=""+te(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,c.t)()}function m(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-added",[e[1],e[2]],r)}function v(e,r){r instanceof Ae&&"load"===e[0]&&t.emit("xhr-load-removed",[e[1],e[2]],r)}function b(e,t,r){t instanceof Ae&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,c.t)()))}function w(e,r){this.xhrCbStart&&t.emit("xhr-cb-time",[(0,c.t)()-this.xhrCbStart,this.onload,r],r)}function R(e){var t,r=e[1]||{};if("string"==typeof e[0]?0===(t=e[0]).length&&y.RI&&(t=""+y.gm.location.href):e[0]&&e[0].url?t=e[0].url:y.gm?.URL&&e[0]&&e[0]instanceof URL?t=e[0].href:"function"==typeof e[0].toString&&(t=e[0].toString()),"string"==typeof t&&0!==t.length){t&&(this.parsedOrigin=(0,ve.D)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=i.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if(e[0]&&e[0].headers)a(e[0].headers,n)&&(this.dt=n);else{var o={};for(var s in r)o[s]=r[s];o.headers=new Headers(r.headers||{}),a(o.headers,n)&&(this.dt=n),e.length>1?e[1]=o:e.push(o)}}function a(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,c.t)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r=this.opts||{},n=this.target;Oe(this,Re(n));var i=(""+(n&&n instanceof Ee&&n.method||r.method||"GET")).toUpperCase();this.params.method=i,this.body=r.body,this.txSize=re(r.body)||0}function T(e,t){if(this.endTime=(0,c.t)(),this.params||(this.params={}),(0,we.iW)(this.params))return;let i;this.params.status=t?t.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(i=+this.rxSize);const o={txSize:this.txSize,rxSize:i,duration:(0,c.t)()-this.startTime};r("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,n.K7.ajax)}function E(e){const t=this.params,i=this.metrics;if(!this.ended){this.ended=!0;for(let t=0;t<Te;t++)e.removeEventListener(xe[t],this.listener,!1);t.aborted||(0,we.iW)(t)||(i.duration=(0,c.t)()-this.startTime,this.loadCaptureCalled||4!==e.readyState?null==t.status&&(t.status=0):A(this,e),i.cbTime=this.cbTime,r("xhr",[t,i,this.startTime,this.endTime,"xhr"],this,n.K7.ajax))}}function A(e,r){e.params.status=r.status;var i=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?re(e.response):"text"===r||""===r||void 0===r?re(e.responseText):void 0}(r,e.lastSize);if(i&&(e.metrics.rxSize=i),e.sameOrigin&&r.getAllResponseHeaders().indexOf(Se)>=0){var o=r.getResponseHeader(Se);o&&((0,a.p)(h.rs,["Ajax/CrossApplicationTracing/Header/Seen"],void 0,n.K7.metrics,t),e.params.cat=o.split(", ").pop())}e.loadCaptureCalled=!0}t.on("new-xhr",o),t.on("open-xhr-start",s),t.on("open-xhr-end",u),t.on("send-xhr-start",d),t.on("xhr-cb-time",l),t.on("xhr-load-added",f),t.on("xhr-load-removed",p),t.on("xhr-resolved",g),t.on("addEventListener-end",m),t.on("removeEventListener-end",v),t.on("fn-end",w),t.on("fetch-before-start",R),t.on("fetch-start",x),t.on("fn-start",b),t.on("fetch-done",T)}(e,this.ee,this.handler,this.dt),this.importAggregator(e,()=>i.e(478).then(i.bind(i,3845)))}}function Oe(e,t){var r=(0,ve.D)(t),n=e.params||e;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}const Ne={},Ie=["pushState","replaceState"];function Pe(e){const t=function(e){return(e||ie.ee).get("history")}(e);return!y.RI||Ne[t.debugId]++||(Ne[t.debugId]=1,(0,oe.YM)(t).inPlace(window.history,Ie,"-")),t}var je=i(3738);function ke(e){p(u.BL,function(t=Date.now()){const r=t-y.WN;r<0&&(0,l.R)(62,t),(0,a.p)(h.XG,[u.BL,{time:r}],void 0,n.K7.metrics,e.ee),e.addToTrace({name:u.BL,start:t,origin:"nr"}),(0,a.p)(u.Pl+u.hG,[r,u.BL],void 0,n.K7.genericEvents,e.ee)},e)}const{He:Ce,bD:Le,d3:He,Kp:Me,TZ:Ke,Lc:De,uP:Ue,Rz:Fe}=je;class We extends E{static featureName=Ke;constructor(e){var t;super(e,Ke),t=e,p(u.U2,function(e){if(!(e&&"object"==typeof e&&e.name&&e.start))return;const r={n:e.name,s:e.start-y.WN,e:(e.end||e.start)-y.WN,o:e.origin||"",t:"api"};r.s<0||r.e<0||r.e<r.s?(0,l.R)(61,{start:r.s,end:r.e}):(0,a.p)("bstApi",[r],void 0,n.K7.sessionTrace,t.ee)},t),ke(e);if(!(0,R.V)(e.init))return void this.deregisterDrain();const r=this.ee;let o;Pe(r),this.eventsEE=(0,ne.u)(r),this.eventsEE.on(Ue,function(e,t){this.bstStart=(0,c.t)()}),this.eventsEE.on(De,function(e,t){(0,a.p)("bst",[e[0],t,this.bstStart,(0,c.t)()],void 0,n.K7.sessionTrace,r)}),r.on(Fe+He,function(e){this.time=(0,c.t)(),this.startPath=location.pathname+location.hash}),r.on(Fe+Me,function(e){(0,a.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,n.K7.sessionTrace,r)});try{o=new PerformanceObserver(e=>{const t=e.getEntries();(0,a.p)(Ce,[t],void 0,n.K7.sessionTrace,r)}),o.observe({type:Le,buffered:!0})}catch(e){}this.importAggregator(e,()=>i.e(478).then(i.bind(i,6974)),{resourceObserver:o})}}var Be=i(6344);class Ve extends E{static featureName=Be.TZ;#n;recorder;constructor(e){var t;let r;super(e,Be.TZ),t=e,p(u.CH,function(){(0,a.p)(u.CH,[],void 0,n.K7.sessionReplay,t.ee)},t),function(e){p(u.Tb,function(){(0,a.p)(u.Tb,[],void 0,n.K7.sessionReplay,e.ee)},e)}(e);try{r=JSON.parse(localStorage.getItem("".concat(S.H3,"_").concat(S.uh)))}catch(e){}(0,w.SR)(e.init)&&this.ee.on(u.CH,()=>this.#i()),this.#o(r)&&this.importRecorder().then(e=>{e.startRecording(Be.Qb.PRELOAD,r?.sessionReplayMode)}),this.importAggregator(this.agentRef,()=>i.e(478).then(i.bind(i,6167)),this),this.ee.on("err",e=>{this.blocked||this.agentRef.runtime.isRecording&&(this.errorNoticed=!0,(0,a.p)(Be.Vh,[e],void 0,this.featureName,this.ee))})}#o(e){return e&&(e.sessionReplayMode===S.g.FULL||e.sessionReplayMode===S.g.ERROR)||(0,w.Aw)(this.agentRef.init)}importRecorder(){return this.recorder?Promise.resolve(this.recorder):(this.#n??=Promise.all([i.e(478),i.e(249)]).then(i.bind(i,4866)).then(({Recorder:e})=>(this.recorder=new e(this),this.recorder)).catch(e=>{throw this.ee.emit("internal-error",[e]),this.blocked=!0,e}),this.#n)}#i(){this.blocked||(this.featAggregate?this.featAggregate.mode!==S.g.FULL&&this.featAggregate.initializeRecording(S.g.FULL,!0,Be.Qb.API):this.importRecorder().then(()=>{this.recorder.startRecording(Be.Qb.API,S.g.FULL)}))}}var Ge=i(3962);function ze(e){const t=e.ee.get("tracer");function r(){}p(u.dT,function(e){return(new r).get("object"==typeof e?e:{})},e);const i=r.prototype={createTracer:function(r,i){var o={},s=this,d="function"==typeof i;return(0,a.p)(h.xV,["API/createTracer/called"],void 0,n.K7.metrics,e.ee),e.runSoftNavOverSpa||(0,a.p)(u.hw+"tracer",[(0,c.t)(),r,o],s,n.K7.spa,e.ee),function(){if(t.emit((d?"":"no-")+"fn-start",[(0,c.t)(),s,d],o),d)try{return i.apply(this,arguments)}catch(e){const r="string"==typeof e?new Error(e):e;throw t.emit("fn-err",[arguments,this,r],o),r}finally{t.emit("fn-end",[(0,c.t)()],o)}}}};["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach(t=>{p.apply(this,[t,function(){return(0,a.p)(u.hw+t,[(0,c.t)(),...arguments],this,e.runSoftNavOverSpa?n.K7.softNav:n.K7.spa,e.ee),this},e,i])}),p(u.PA,function(){e.runSoftNavOverSpa?(0,a.p)(u.hw+"routeName",[performance.now(),...arguments],void 0,n.K7.softNav,e.ee):(0,a.p)(u.Pl+"routeName",[(0,c.t)(),...arguments],this,n.K7.spa,e.ee)},e)}class Ze extends E{static featureName=Ge.TZ;constructor(e){if(super(e,Ge.TZ),ze(e),!y.RI||!(0,O.dV)().o.MO)return;const t=Pe(this.ee);try{this.removeOnAbort=new AbortController}catch(e){}Ge.tC.forEach(e=>{(0,I.sp)(e,e=>{s(e)},!0,this.removeOnAbort?.signal)});const r=()=>(0,a.p)("newURL",[(0,c.t)(),""+window.location],void 0,this.featureName,this.ee);t.on("pushState-end",r),t.on("replaceState-end",r),(0,I.sp)(Ge.OV,e=>{s(e),(0,a.p)("newURL",[e.timeStamp,""+window.location],void 0,this.featureName,this.ee)},!0,this.removeOnAbort?.signal);let n=!1;const o=new((0,O.dV)().o.MO)((e,t)=>{n||(n=!0,requestAnimationFrame(()=>{(0,a.p)("newDom",[(0,c.t)()],void 0,this.featureName,this.ee),n=!1}))}),s=(0,x.s)(e=>{(0,a.p)("newUIEvent",[e],void 0,this.featureName,this.ee),o.observe(document.body,{attributes:!0,childList:!0,subtree:!0,characterData:!0})},100,{leading:!0});this.abortHandler=function(){this.removeOnAbort?.abort(),o.disconnect(),this.abortHandler=void 0},this.importAggregator(e,()=>i.e(478).then(i.bind(i,4393)),{domObserver:o})}}var qe=i(7378);const Xe={},Ye=["appendChild","insertBefore","replaceChild"];function Je(e){const t=function(e){return(e||ie.ee).get("jsonp")}(e);if(!y.RI||Xe[t.debugId])return t;Xe[t.debugId]=!0;var r=(0,oe.YM)(t),n=/[?&](?:callback|cb)=([^&#]+)/,i=/(.*)\.([^.]+)/,o=/^(\w+)(\.|$)(.*)$/;function s(e,t){if(!e)return t;const r=e.match(o),n=r[1];return s(r[3],t[n])}return r.inPlace(Node.prototype,Ye,"dom-"),t.on("dom-start",function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var o=(a=e.src,c=a.match(n),c?c[1]:null);var a,c;if(!o)return;var u=function(e){var t=e.match(i);if(t&&t.length>=3)return{key:t[2],parent:s(t[1],window)};return{key:e,parent:window}}(o);if("function"!=typeof u.parent[u.key])return;var d={};function l(){t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}function f(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",l,(0,I.jT)(!1)),e.removeEventListener("error",f,(0,I.jT)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",l,(0,I.jT)(!1)),e.addEventListener("error",f,(0,I.jT)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])}),t}const $e={};function Qe(e){const t=function(e){return(e||ie.ee).get("promise")}(e);if($e[t.debugId])return t;$e[t.debugId]=!0;var r=t.context,n=(0,oe.YM)(t),i=y.gm.Promise;return i&&function(){function e(r){var o=t.context(),s=n(r,"executor-",o,null,!1);const a=Reflect.construct(i,[s],e);return t.context(a).getCtx=function(){return o},a}y.gm.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return i.toString()},Object.setPrototypeOf(e,i),["all","race"].forEach(function(r){const n=i[r];e[r]=function(e){let i=!1;[...e||[]].forEach(e=>{this.resolve(e).then(s("all"===r),s(!1))});const o=n.apply(this,arguments);return o;function s(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}}),["resolve","reject"].forEach(function(r){const n=i[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}}),e.prototype=i.prototype;const o=i.prototype.then;i.prototype.then=function(...e){var i=this,s=r(i);s.promise=i,e[0]=n(e[0],"cb-",s,null,!1),e[1]=n(e[1],"cb-",s,null,!1);const a=o.apply(this,e);return s.nextPromise=a,t.emit("propagate",[i,!0],a,!1,!1),a},i.prototype.then[oe.Jt]=o,t.on("executor-start",function(e){e[0]=n(e[0],"resolve-",this,null,!1),e[1]=n(e[1],"resolve-",this,null,!1)}),t.on("executor-err",function(e,t,r){e[1](r)}),t.on("cb-end",function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),t.on("propagate",function(e,r,n){if(!this.getCtx||r){const r=this,n=e instanceof Promise?t.context(e):null;let i;this.getCtx=function(){return i||(i=n&&n!==r?"function"==typeof n.getCtx?n.getCtx():n:r,i)}}})}(),t}const et={},tt="setTimeout",rt="setInterval",nt="clearTimeout",it="-start",ot=[tt,"setImmediate",rt,nt,"clearImmediate"];function st(e){const t=function(e){return(e||ie.ee).get("timer")}(e);if(et[t.debugId]++)return t;et[t.debugId]=1;var r=(0,oe.YM)(t);return r.inPlace(y.gm,ot.slice(0,2),tt+"-"),r.inPlace(y.gm,ot.slice(2,3),rt+"-"),r.inPlace(y.gm,ot.slice(3),nt+"-"),t.on(rt+it,function(e,t,n){e[0]=r(e[0],"fn-",null,n)}),t.on(tt+it,function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)}),t}const at={};function ct(e){const t=function(e){return(e||ie.ee).get("mutation")}(e);if(!y.RI||at[t.debugId])return t;at[t.debugId]=!0;var r=(0,oe.YM)(t),n=y.gm.MutationObserver;return n&&(window.MutationObserver=function(e){return this instanceof n?new n(r(e,"fn-")):n.apply(this,arguments)},MutationObserver.prototype=n.prototype),t}const{TZ:ut,d3:dt,Kp:lt,$p:ft,wW:ht,e5:pt,tH:gt,uP:mt,rw:vt,Lc:bt}=qe;class yt extends E{static featureName=ut;constructor(e){if(super(e,ut),ze(e),!y.RI)return;try{this.removeOnAbort=new AbortController}catch(e){}let t,r=0;const n=this.ee.get("tracer"),o=Je(this.ee),s=Qe(this.ee),u=st(this.ee),d=ce(this.ee),l=this.ee.get("events"),f=me(this.ee),h=Pe(this.ee),p=ct(this.ee);function g(e,t){h.emit("newURL",[""+window.location,t])}function m(){r++,t=window.location.hash,this[mt]=(0,c.t)()}function v(){r--,window.location.hash!==t&&g(0,!0);var e=(0,c.t)();this[pt]=~~this[pt]+e-this[mt],this[bt]=e}function b(e,t){e.on(t,function(){this[t]=(0,c.t)()})}this.ee.on(mt,m),s.on(vt,m),o.on(vt,m),this.ee.on(bt,v),s.on(ht,v),o.on(ht,v),this.ee.on("fn-err",(...t)=>{t[2]?.__newrelic?.[e.agentIdentifier]||(0,a.p)("function-err",[...t],void 0,this.featureName,this.ee)}),this.ee.buffer([mt,bt,"xhr-resolved"],this.featureName),l.buffer([mt],this.featureName),u.buffer(["setTimeout"+lt,"clearTimeout"+dt,mt],this.featureName),d.buffer([mt,"new-xhr","send-xhr"+dt],this.featureName),f.buffer([gt+dt,gt+"-done",gt+ft+dt,gt+ft+lt],this.featureName),h.buffer(["newURL"],this.featureName),p.buffer([mt],this.featureName),s.buffer(["propagate",vt,ht,"executor-err","resolve"+dt],this.featureName),n.buffer([mt,"no-"+mt],this.featureName),o.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),b(f,gt+dt),b(f,gt+"-done"),b(o,"new-jsonp"),b(o,"jsonp-end"),b(o,"cb-start"),h.on("pushState-end",g),h.on("replaceState-end",g),window.addEventListener("hashchange",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",g,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",function(){g(0,r>1)},(0,I.jT)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#r,this.importAggregator(e,()=>i.e(478).then(i.bind(i,5592)))}#r(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}var wt=i(3333);class Rt extends E{static featureName=wt.TZ;constructor(e){super(e,wt.TZ);const t=[e.init.page_action.enabled,e.init.performance.capture_marks,e.init.performance.capture_measures,e.init.user_actions.enabled,e.init.performance.resources.enabled];var r;r=e,p(u.hG,(e,t)=>z(e,t,r),r),function(e){p(u.fF,(t,r)=>q(t,r,e),e)}(e),ke(e),X(e),function(e){p(u.V1,(t,r)=>Z(t,r,e),e)}(e);const o=e.init.feature_flags.includes("user_frustrations");let s;if(y.RI&&o&&(me(this.ee),ce(this.ee),s=Pe(this.ee)),y.RI){if(e.init.user_actions.enabled&&(wt.Zp.forEach(e=>(0,I.sp)(e,e=>(0,a.p)("ua",[e],void 0,this.featureName,this.ee),!0)),wt.qN.forEach(e=>{const t=(0,x.s)(e=>{(0,a.p)("ua",[e],void 0,this.featureName,this.ee)},500,{leading:!0});(0,I.sp)(e,t)}),o)){function c(t){const r=(0,ve.D)(t);return e.beacons.includes(r.hostname+":"+r.port)}function d(){s.emit("navChange")}y.gm.addEventListener("error",()=>{(0,a.p)("uaErr",[],void 0,n.K7.genericEvents,this.ee)},(0,I.jT)(!1,this.removeOnAbort?.signal)),this.ee.on("open-xhr-start",(e,t)=>{c(e[1])||t.addEventListener("readystatechange",()=>{2===t.readyState&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)})}),this.ee.on("fetch-start",e=>{e.length>=1&&!c(Re(e[0]))&&(0,a.p)("uaXhr",[],void 0,n.K7.genericEvents,this.ee)}),s.on("pushState-end",d),s.on("replaceState-end",d),window.addEventListener("hashchange",d,(0,I.jT)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",d,(0,I.jT)(!0,this.removeOnAbort?.signal))}if(e.init.performance.resources.enabled&&y.gm.PerformanceObserver?.supportedEntryTypes.includes("resource")){new PerformanceObserver(e=>{e.getEntries().forEach(e=>{(0,a.p)("browserPerformance.resource",[e],void 0,this.featureName,this.ee)})}).observe({type:"resource",buffered:!0})}}try{this.removeOnAbort=new AbortController}catch(l){}this.abortHandler=()=>{this.removeOnAbort?.abort(),this.abortHandler=void 0},t.some(e=>e)?this.importAggregator(e,()=>i.e(478).then(i.bind(i,8019))):this.deregisterDrain()}}var xt=i(2646);const Tt=new Map;function Et(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||ie.ee).get("logger")}(e),o=(0,oe.YM)(i),s=new xt.y(ie.P);s.level=n.level,s.customAttributes=n.customAttributes;const a=t[r]?.[oe.Jt]||t[r];return Tt.set(a,s),o.inPlace(t,[r],"wrap-logger-",()=>Tt.get(a)),i}var At=i(1910);class St extends E{static featureName=B.TZ;constructor(e){var t;super(e,B.TZ),t=e,p(u.$9,(e,r)=>G(e,r,t),t),function(e){p(u.Wb,(t,r,{customAttributes:n={},level:i=B.p_.INFO}={})=>{Et(e.ee,t,r,{customAttributes:n,level:i})},e)}(e),X(e);const r=this.ee;["log","error","warn","info","debug","trace"].forEach(e=>{(0,At.i)(y.gm.console[e]),Et(r,y.gm.console,e,{level:"log"===e?"info":e})}),this.ee.on("wrap-logger-end",function([e]){const{level:t,customAttributes:n}=this;(0,V.R)(r,e,n,t)}),this.importAggregator(e,()=>i.e(478).then(i.bind(i,5288)))}}new class extends r{constructor(e){var t;(super(),y.gm)?(this.features={},(0,O.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(_),this.runSoftNavOverSpa=[...this.desiredFeatures].some(e=>e.featureName===n.K7.softNav),(0,s.j)(this,e,e.loaderType||"agent"),t=this,p(u.cD,function(e,r,n=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof r)||null===r)return g(t,e,r,u.cD,n);(0,l.R)(40,typeof r)}else(0,l.R)(39,typeof e)},t),function(e){p(u.Dl,function(t){if("string"==typeof t||null===t)return g(e,"enduser.id",t,u.Dl,!0);(0,l.R)(41,typeof t)},e)}(this),function(e){p(u.nb,function(t){if("string"==typeof t||null===t)return g(e,"application.version",t,u.nb,!1);(0,l.R)(42,typeof t)},e)}(this),function(e){p(u.d3,function(){e.ee.emit("manual-start-all")},e)}(this),function(e){p(u.Pv,function(t=!0){if("boolean"==typeof t){if((0,a.p)(u.Pl+u.Pv,[t],void 0,"session",e.ee),e.runtime.consented=t,t){const t=e.features.page_view_event;t.onAggregateImported.then(e=>{const r=t.featAggregate;e&&!r.sentRum&&r.sendRum()})}}else(0,l.R)(65,typeof t)},e)}(this),this.run()):(0,l.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}get api(){return this}run(){try{const e=function(e){const t={};return o.forEach(r=>{t[r]=!!e[r]?.enabled}),t}(this.init),t=[...this.desiredFeatures];t.sort((e,t)=>n.P3[e.featureName]-n.P3[t.featureName]),t.forEach(t=>{if(!e[t.featureName]&&t.featureName!==n.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&t.featureName===n.K7.spa)return;if(!this.runSoftNavOverSpa&&t.featureName===n.K7.softNav)return;const r=function(e){switch(e){case n.K7.ajax:return[n.K7.jserrors];case n.K7.sessionTrace:return[n.K7.ajax,n.K7.pageViewEvent];case n.K7.sessionReplay:return[n.K7.sessionTrace];case n.K7.pageViewTiming:return[n.K7.pageViewEvent];default:return[]}}(t.featureName).filter(e=>!(e in this.features));r.length>0&&(0,l.R)(36,{targetFeature:t.featureName,missingDependencies:r}),this.features[t.featureName]=new t(this)})}catch(e){(0,l.R)(22,e);for(const e in this.features)this.features[e].abortHandler?.();const t=(0,O.Zm)();delete t.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return t.ee.get(this.agentIdentifier).abort(),!1}}}({features:[_e,_,j,We,Ve,k,J,Rt,St,Ze,yt],loaderType:"spa"})})()})();</script>
<link rel="icon" type="image/png" sizes="16x16" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png">
<meta name="apple-mobile-web-app-title" content="Frontiers | Articles">
<link rel="manifest" href="/manifest.json">
<link rel="canonical" href="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full">
<meta property="description" name="description" content="Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ran...">
<meta property="og:title" name="title" content="Frontiers | Functional Characterization of Two Variants at the Intron 6â€”Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes">
<meta property="og:description" name="description" content="Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ran...">
<meta name="keywords" content="Alternative Splicing,Kv7.2 channels,epileptic encephalopathy,PIP2,Calmodulin">
<meta property="og:site_name" name="site_name" content="Frontiers">
<meta property="og:image" name="image" content="https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg">
<meta property="og:type" name="type" content="article">
<meta property="og:url" name="url" content="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full">
<meta name="twitter:card" content="summary_large_image">
<meta name="citation_volume" content="13">
<meta name="citation_journal_title" content="Frontiers in Pharmacology">
<meta name="citation_publisher" content="Frontiers">
<meta name="citation_journal_abbrev" content="Front. Pharmacol.">
<meta name="citation_issn" content="1663-9812">
<meta name="citation_doi" content="10.3389/fphar.2022.872645">
<meta name="citation_firstpage" content="872645">
<meta name="citation_language" content="English">
<meta name="citation_title" content="Functional Characterization of Two Variants at the Intron 6â€”Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes">
<meta name="citation_keywords" content="Alternative Splicing; Kv7.2 channels; epileptic encephalopathy; PIP2; Calmodulin">
<meta name="citation_abstract" content="Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE) to severe Developmental and Epileptic Encephalopathy (DEE). Thus, understanding the pathogenic molecular mechanisms of Kv7.2 variants and their correlation with clinical phenotypes has a relevant impact on the clinical management of these patients. In the present study, the genetic, biochemical, and functional effects prompted by two variants, each found in a non-familial SLNE or a DEE patient but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in these patients. Analysis of KCNQ2 mRNA splicing in patient-derived lymphoblasts revealed that the SLNE-causing intronic variant (c.928-1G>C) impeded the use of the natural splice site, thus leading to a 10-aa Kv7.2 in frame deletion (Kv7.2 p.G310delta10); by contrast, the DEE-causing exonic variant (c.928G>A) only had subtle effects on the splicing process at this site, thus leading to the synthesis of a full-length subunit carrying the G310S missense variant (Kv7.2 p.G310S). Patch-clamp recordings in transiently-transfected CHO cells and primary neurons revealed that both variants fully impeded Kv7.2 channel function, and exerted strong dominant-negative effects when co-expressed with Kv7.2 and/or Kv7.3 subunits. Notably, Kv7.2 p.G310S, but not Kv7.2 p.G310delta10, currents were recovered upon overexpression of the PIP2-synthesizing enzyme PIP5K, and/or CaM; moreover, currents from heteromeric Kv7.2/Kv7.3 channels incorporating either Kv7.2 mutant subunits were differentially regulated by changes in PIP2 availability, with Kv7.2/Kv7.2 G310S/Kv7.3 currents showing  a greater sensitivity to PIP2 depletion when compared to those from Kv7.2/Kv7.2 G310delta10/Kv7.3 channels. Altogether, these results suggest that the two variants investigated differentially affected the splicing process at the intron 6-exon 7 boundary, and led to the synthesis of Kv7.2 subunits showing a differential sensitivity to PIP2 and CaM regulation; more studies are needed to clarify how such different functional properties contribute to the widely-divergent clinical phenotypes.">
<meta name="citation_article_type" content="Original Research">
<meta name="citation_pdf_url" content="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/pdf">
<meta name="citation_xml_url" content="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/xml">
<meta name="citation_fulltext_world_readable" content="yes">
<meta name="citation_online_date" content="2022/05/10">
<meta name="citation_publication_date" content="2022/06/13">
<meta name="citation_author" content="Mosca, Ilaria ">
<meta name="citation_author_institution" content="Department of Medicine and Health Science â€œV. Tiberioâ€, Italy">
<meta name="citation_author" content="Rivolta, Ilaria ">
<meta name="citation_author_institution" content="School of Medicine and Surgery, Italy">
<meta name="citation_author" content="Labalme, Audrey ">
<meta name="citation_author_institution" content="Department of Medical Genetics, France">
<meta name="citation_author" content="Ambrosino, Paolo ">
<meta name="citation_author_institution" content="Department of Science and Technology (DST), Italy">
<meta name="citation_author" content="Castellotti, Barbara ">
<meta name="citation_author_institution" content="Unit of Medical Genetics and Neurogenetics, Italy">
<meta name="citation_author" content="Gellera, Cinzia ">
<meta name="citation_author_institution" content="Unit of Medical Genetics and Neurogenetics, Italy">
<meta name="citation_author" content="Granata, Tiziana ">
<meta name="citation_author_institution" content="Department of Pediatric Neuroscience, Italy">
<meta name="citation_author" content="Freri, Elena ">
<meta name="citation_author_institution" content="Department of Pediatric Neuroscience, Italy">
<meta name="citation_author" content="Binda, Anna ">
<meta name="citation_author_institution" content="School of Medicine and Surgery, Italy">
<meta name="citation_author" content="Lesca, Gaetan ">
<meta name="citation_author_institution" content="Department of Medical Genetics, France">
<meta name="citation_author" content="DiFrancesco, Jacopo C. ">
<meta name="citation_author_institution" content="Department of Pediatric Neuroscience, Italy">
<meta name="citation_author" content="Soldovieri, Maria Virginia ">
<meta name="citation_author_institution" content="Department of Medicine and Health Science â€œV. Tiberioâ€, Italy">
<meta name="citation_author" content="Taglialatela, Maurizio ">
<meta name="citation_author_institution" content="Department of Neuroscience, Italy">
<meta name="dc.identifier" content="doi:10.3389/fphar.2022.872645">
<script type="application/ld+json">{"@context":"https://schema.org","@type":"ScholarlyArticle","headline":"Functional Characterization of Two Variants at the Intron 6â€”Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes","author":[{"@type":"Person","name":"Ilaria Mosca","affiliation":["Department of Medicine and Health Science â€œV. Tiberioâ€, Italy"]},{"@type":"Person","name":"Ilaria Rivolta","affiliation":["School of Medicine and Surgery, Italy"]},{"@type":"Person","name":"Audrey Labalme","affiliation":["Department of Medical Genetics, France"]},{"@type":"Person","name":"Paolo Ambrosino","affiliation":["Department of Science and Technology (DST), Italy"]},{"@type":"Person","name":"Barbara Castellotti","affiliation":["Unit of Medical Genetics and Neurogenetics, Italy"]},{"@type":"Person","name":"Cinzia Gellera","affiliation":["Unit of Medical Genetics and Neurogenetics, Italy"]},{"@type":"Person","name":"Tiziana Granata","affiliation":["Department of Pediatric Neuroscience, Italy"]},{"@type":"Person","name":"Elena Freri","affiliation":["Department of Pediatric Neuroscience, Italy"]},{"@type":"Person","name":"Anna Binda","affiliation":["School of Medicine and Surgery, Italy"]},{"@type":"Person","name":"Gaetan Lesca","affiliation":["Department of Medical Genetics, France"]},{"@type":"Person","name":"Jacopo C. DiFrancesco","affiliation":["Department of Pediatric Neuroscience, Italy","Department of Neurology, Italy"]},{"@type":"Person","name":"Maria Virginia Soldovieri","affiliation":["Department of Medicine and Health Science â€œV. Tiberioâ€, Italy"]},{"@type":"Person","name":"Maurizio Taglialatela","affiliation":["Department of Neuroscience, Italy"]}],"datePublished":"2022-06-13","dateModified":"2025-11-26","publisher":{"@type":"Organization","name":"Frontiers"},"isPartOf":{"@type":"PublicationIssue","datePublished":"2022","isPartOf":{"@type":"PublicationVolume","volumeNumber":"13","isPartOf":{"@type":"Periodical","name":"Frontiers in Pharmacology"}}},"citation":["https://doi.org/10.3389/fphar.2022.872645"],"inLanguage":"en"}</script>
<script type="module" src="/ap-2024/_nuxt/v1IBIWh4.js" crossorigin></script>
<script id="unhead:payload" type="application/json">{"title":"Frontiers | Articles"}</script></head><body  class="body--v3"><div id="__nuxt"><!--[--><!----><div theme="purple"><nav class="Ibar"><div class="Ibar__main"><div class="Ibar__wrapper"><button class="Ibar__burger" aria-label="Open Menu" data-event="iBar-btn-openMenu"></button><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/pharmacology" class="Ibar__journalName" data-event="iBar-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Pharmacology</span></div></div></a><div class="Ibar__dropdown--aboutUs" parent-data-event="iBar"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIRÂ² Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=62&amp;specialtyid=0&amp;entitytype=2&amp;entityid=176" data-event="iBar-a-submit">Submit your research</a><div class="Ibar__spacer"></div><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><div><div class="Ibar__menu Ibar__menu--journal"><div class="Ibar__menu__header"><div class="Ibar__logo"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div></div><button class="Ibar__close" aria-label="Close Menu" data-event="iBarMenu-btn-closeMenu"></button></div><div class="Ibar__menu__wrapper"><div class="Ibar__menu__journal"><a href="//www.frontiersin.org/journals/pharmacology" data-event="iBarMenu-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Pharmacology</span></div></div></a><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/cardiovascular-and-smooth-muscle-pharmacology" data-event="iBarJournal-sections-a_id_182">Cardiovascular and Smooth Muscle Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/drug-metabolism-and-transport" data-event="iBarJournal-sections-a_id_199">Drug Metabolism and Transport</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/drugs-outcomes-research-and-policies" data-event="iBarJournal-sections-a_id_202">Drugs Outcomes Research and Policies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/ethnopharmacology" data-event="iBarJournal-sections-a_id_184">Ethnopharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/experimental-pharmacology-and-drug-discovery" data-event="iBarJournal-sections-a_id_183">Experimental Pharmacology and Drug Discovery</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/gastrointestinal-and-hepatic-pharmacology" data-event="iBarJournal-sections-a_id_186">Gastrointestinal and Hepatic Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/inflammation-pharmacology" data-event="iBarJournal-sections-a_id_188">Inflammation Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/integrative-and-regenerative-pharmacology" data-event="iBarJournal-sections-a_id_178">Integrative and Regenerative Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/neuropharmacology" data-event="iBarJournal-sections-a_id_26">Neuropharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/obstetric-and-pediatric-pharmacology" data-event="iBarJournal-sections-a_id_196">Obstetric and Pediatric Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacoepidemiology" data-event="iBarJournal-sections-a_id_2186">Pharmacoepidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-anti-cancer-drugs" data-event="iBarJournal-sections-a_id_192">Pharmacology of Anti-Cancer Drugs</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-infectious-diseases" data-event="iBarJournal-sections-a_id_2216">Pharmacology of Infectious Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-ion-channels-and-channelopathies" data-event="iBarJournal-sections-a_id_179">Pharmacology of Ion Channels and Channelopathies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/predictive-toxicology" data-event="iBarJournal-sections-a_id_195">Predictive Toxicology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/renal-pharmacology" data-event="iBarJournal-sections-a_id_1357">Renal Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/respiratory-pharmacology" data-event="iBarJournal-sections-a_id_190">Respiratory Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/translational-pharmacology" data-event="iBarJournal-sections-a_id_1251">Translational Pharmacology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div></div><div class="Ibar__dropdown--aboutUs" parent-data-event="iBarMenu"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About us</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About us</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Who we are</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/mission" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Mission and values</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/history" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">History</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/leadership" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Leadership</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/awards" target="_self" data-event="iBar-aboutUs_0-a_whoWeAre">Awards</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Impact and progress</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/impact" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Frontiers&#39; impact</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/annual-reports" target="_self" data-event="iBar-aboutUs_1-a_impactAndProgress">Our annual reports</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Publishing model</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">How we publish</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Open access</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/peer-review" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Peer review</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-integrity" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research integrity</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/research-topics" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Research Topics</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fair-data-management" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">FAIRÂ² Data Management</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="iBar-aboutUs_2-a_publishingModel">Fee policy</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">Services</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://publishingpartnerships.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_3-a_services">Societies</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/open-access-agreements/consortia" target="_self" data-event="iBar-aboutUs_3-a_services">National consortia</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/open-access-agreements" target="_self" data-event="iBar-aboutUs_3-a_services">Institutional partnerships</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/collaborators" target="_self" data-event="iBar-aboutUs_3-a_services">Collaborators</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title">More from Frontiers</li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://forum.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Forum</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Frontiers Planet Prize</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://pressoffice.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Press office</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/sustainability" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Sustainability</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://careers.frontiersin.org/" target="_blank" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Career opportunities</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="iBar-aboutUs_4-a_moreFromFrontiers">Contact us</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><!--[--><a class="Ibar__link" href="https://www.frontiersin.org/journals" data-event="iBar-a-allJournals">All journals</a><a class="Ibar__link" href="https://www.frontiersin.org/articles" data-event="iBar-a-allArticles">All articles</a><!--]--><!----><!----><!----><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=62&amp;specialtyid=0&amp;entitytype=2&amp;entityid=176" data-event="iBarMenu-a-submit">Submit your research</a></div></div></div><!--[--><div class="Ibar__journal Ibar__journal--main"><div class="Ibar__wrapper Ibar__wrapper--journal"><a href="//www.frontiersin.org/journals/pharmacology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Pharmacology</span></div></div></a><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/cardiovascular-and-smooth-muscle-pharmacology" data-event="iBarJournal-sections-a_id_182">Cardiovascular and Smooth Muscle Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/drug-metabolism-and-transport" data-event="iBarJournal-sections-a_id_199">Drug Metabolism and Transport</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/drugs-outcomes-research-and-policies" data-event="iBarJournal-sections-a_id_202">Drugs Outcomes Research and Policies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/ethnopharmacology" data-event="iBarJournal-sections-a_id_184">Ethnopharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/experimental-pharmacology-and-drug-discovery" data-event="iBarJournal-sections-a_id_183">Experimental Pharmacology and Drug Discovery</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/gastrointestinal-and-hepatic-pharmacology" data-event="iBarJournal-sections-a_id_186">Gastrointestinal and Hepatic Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/inflammation-pharmacology" data-event="iBarJournal-sections-a_id_188">Inflammation Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/integrative-and-regenerative-pharmacology" data-event="iBarJournal-sections-a_id_178">Integrative and Regenerative Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/neuropharmacology" data-event="iBarJournal-sections-a_id_26">Neuropharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/obstetric-and-pediatric-pharmacology" data-event="iBarJournal-sections-a_id_196">Obstetric and Pediatric Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacoepidemiology" data-event="iBarJournal-sections-a_id_2186">Pharmacoepidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-anti-cancer-drugs" data-event="iBarJournal-sections-a_id_192">Pharmacology of Anti-Cancer Drugs</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-infectious-diseases" data-event="iBarJournal-sections-a_id_2216">Pharmacology of Infectious Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-ion-channels-and-channelopathies" data-event="iBarJournal-sections-a_id_179">Pharmacology of Ion Channels and Channelopathies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/predictive-toxicology" data-event="iBarJournal-sections-a_id_195">Predictive Toxicology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/renal-pharmacology" data-event="iBarJournal-sections-a_id_1357">Renal Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/respiratory-pharmacology" data-event="iBarJournal-sections-a_id_190">Respiratory Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/translational-pharmacology" data-event="iBarJournal-sections-a_id_1251">Translational Pharmacology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div></div></div><div class="Ibar__journal Ibar__journal--mix"><div class="Ibar__wrapper Ibar__wrapper--journal"><div class="Ibar__logo"><a href="//www.frontiersin.org/" aria-label="Frontiershome" data-event="iBar-a-home" class="Ibar__logo__link"><svg class="Ibar__logo__svg" viewBox="0 0 2811 590" fill="none" xmlns="http://www.w3.org/2000/svg"><path class="Ibar__logo__text" d="M633.872 234.191h-42.674v-57.246h42.674c0-19.776 2.082-35.389 5.204-48.92 4.164-13.53 9.368-23.939 17.695-31.225 8.326-8.326 18.735-13.53 32.266-16.653 13.531-3.123 29.143-5.204 47.878-5.204h21.858c7.286 0 14.572 1.04 21.857 1.04v62.451c-8.326-1.041-16.653-2.082-23.939-2.082-10.408 0-17.694 1.041-23.939 4.164-6.245 3.122-9.368 10.408-9.368 22.898v13.531h53.083v57.246h-53.083v213.372h-89.512V234.191zM794.161 176.945h86.39v47.879h1.041c6.245-17.694 16.653-30.185 31.225-39.552 14.572-9.368 31.225-13.531 49.96-13.531h10.409c3.122 0 7.286 1.041 10.408 2.082v81.185c-6.245-2.082-11.449-3.122-16.653-4.163-5.204-1.041-11.449-1.041-16.654-1.041-11.449 0-20.816 2.082-29.143 5.204-8.327 3.123-15.613 8.327-20.817 14.572-5.204 6.245-10.408 12.49-12.49 20.817-3.123 8.326-4.163 15.612-4.163 23.939v133.228h-88.472V176.945h-1.041zM989.84 312.254c0-19.776 3.122-39.552 10.41-56.205 7.28-17.695 16.65-32.266 29.14-45.797 12.49-13.531 27.06-22.899 44.76-30.185 17.69-7.285 36.43-11.449 57.24-11.449 20.82 0 39.56 4.164 57.25 11.449 17.69 7.286 32.27 17.695 45.8 30.185 12.49 12.49 22.9 28.102 29.14 45.797 7.29 17.694 10.41 36.429 10.41 56.205 0 20.817-3.12 39.552-10.41 57.246-7.29 17.695-16.65 32.266-29.14 44.756-12.49 12.49-28.11 22.899-45.8 30.185-17.69 7.286-36.43 11.449-57.25 11.449-20.81 0-40.59-4.163-57.24-11.449-17.7-7.286-32.27-17.695-44.76-30.185-12.49-12.49-21.86-28.102-29.14-44.756-7.288-17.694-10.41-36.429-10.41-57.246zm88.47 0c0 8.327 1.04 17.694 3.12 26.021 2.09 9.368 5.21 16.653 9.37 23.939 4.16 7.286 9.37 13.531 16.65 17.695 7.29 4.163 15.62 7.285 26.03 7.285 10.4 0 18.73-2.081 26.02-7.285 7.28-4.164 12.49-10.409 16.65-17.695 4.16-7.286 7.29-15.612 9.37-23.939 2.08-9.368 3.12-17.694 3.12-26.021 0-8.327-1.04-17.694-3.12-26.021-2.08-9.368-5.21-16.653-9.37-23.939-4.16-7.286-9.37-13.531-16.65-17.695-7.29-5.204-15.62-7.285-26.02-7.285-10.41 0-18.74 2.081-26.03 7.285-7.28 5.205-12.49 10.409-16.65 17.695-4.16 7.286-7.28 15.612-9.37 23.939-2.08 9.368-3.12 17.694-3.12 26.021zM1306.25 176.945h86.39v37.47h1.04c4.17-7.286 9.37-13.531 15.62-18.735 6.24-5.204 13.53-10.408 20.81-14.572 7.29-4.163 15.62-7.286 23.94-9.367 8.33-2.082 16.66-3.123 24.98-3.123 22.9 0 40.6 4.164 53.09 11.449 13.53 7.286 22.89 16.654 29.14 27.062 6.24 10.409 10.41 21.858 12.49 34.348 2.08 12.49 2.08 22.898 2.08 33.307v172.779h-88.47V316.417v-27.061c0-9.368-1.04-16.654-4.16-23.94-3.13-7.286-7.29-12.49-13.53-16.653-6.25-4.164-15.62-6.245-27.07-6.245-8.32 0-15.61 2.081-21.85 5.204-6.25 3.122-11.45 7.286-14.58 13.531-4.16 5.204-6.24 11.449-8.32 18.735s-3.12 14.572-3.12 21.858v145.717h-88.48V176.945zM1780.88 234.19h-55.17v122.819c0 10.408 3.12 17.694 8.33 20.817 6.24 3.122 13.53 5.204 22.9 5.204 4.16 0 7.28 0 11.45-1.041h11.45v65.573c-8.33 0-15.62 1.041-23.94 2.082-8.33 1.04-16.66 1.041-23.94 1.041-18.74 0-34.35-2.082-46.84-5.205-12.49-3.122-21.86-8.326-29.14-15.612-7.29-7.286-12.49-16.654-14.58-29.144-3.12-12.49-4.16-27.062-4.16-45.797V234.19h-44.76v-57.246h44.76V94.717h88.47v82.227h55.17v57.246zM1902.66 143.639h-88.48V75.984h88.48v67.655zm-89.52 33.307h88.48v270.618h-88.48V176.946zM2024.43 334.111c1.04 18.735 6.25 33.307 16.66 44.756 10.4 11.449 24.98 16.653 43.71 16.653 10.41 0 20.82-2.081 30.19-7.286 9.36-5.204 16.65-12.49 20.81-22.898h83.27c-4.16 15.613-10.41 29.144-19.78 40.593-9.36 11.449-19.77 20.817-31.22 28.102-12.49 7.286-24.98 12.491-39.55 16.654-14.57 3.122-29.15 5.204-43.72 5.204-21.86 0-41.63-3.122-60.37-9.367-18.73-6.246-34.34-15.613-46.83-28.103-12.49-12.49-22.9-27.062-30.19-45.797-7.28-17.694-10.41-38.511-10.41-60.369 0-20.817 4.17-39.552 11.45-57.246 7.29-17.694 17.7-32.266 31.23-44.756 13.53-12.49 29.14-21.858 46.83-29.144 17.7-7.286 36.43-10.408 56.21-10.408 23.94 0 45.8 4.163 63.49 12.49 17.7 8.327 33.31 19.776 44.76 35.389 11.45 15.612 20.81 32.266 26.02 52.042 5.2 19.776 8.33 41.633 7.28 64.532h-199.84v-1.041zm110.33-49.961c-1.04-15.612-6.24-28.102-15.61-39.551-9.37-10.409-21.86-16.654-37.47-16.654s-28.1 5.204-38.51 15.613c-10.41 10.408-16.66 23.939-18.74 40.592h110.33zM2254.46 176.945h86.39v47.879h1.04c6.25-17.694 16.65-30.185 31.23-39.552 14.57-9.368 31.22-13.531 49.96-13.531h10.4c3.13 0 7.29 1.041 10.41 2.082v81.185c-6.24-2.082-11.45-3.122-16.65-4.163-5.21-1.041-11.45-1.041-16.65-1.041-11.45 0-20.82 2.082-29.15 5.204-8.32 3.123-15.61 8.327-20.81 14.572-6.25 6.245-10.41 12.49-12.49 20.817-3.13 8.326-4.17 15.612-4.17 23.939v133.228h-88.47V176.945h-1.04zM2534.45 359.091c0 7.286 1.04 12.49 4.16 17.694 3.12 5.204 6.24 9.368 10.41 12.49 4.16 3.123 9.36 5.204 14.57 7.286 6.24 2.082 11.45 2.082 17.69 2.082 4.17 0 8.33 0 13.53-2.082 5.21-1.041 9.37-3.123 13.53-5.204 4.17-2.082 7.29-5.204 10.41-9.368 3.13-4.163 4.17-8.327 4.17-13.531 0-5.204-2.09-9.367-5.21-12.49-3.12-3.122-7.28-6.245-11.45-8.327-4.16-2.081-9.36-4.163-14.57-5.204-5.2-1.041-9.37-2.081-13.53-3.122-13.53-3.123-28.1-6.245-42.67-9.368-14.58-3.122-28.11-7.286-40.6-12.49-12.49-6.245-22.9-13.531-30.18-23.939-8.33-10.409-11.45-23.94-11.45-42.675 0-16.653 4.16-30.184 11.45-40.592 8.33-10.409 17.69-18.736 30.18-24.981 12.49-6.245 26.02-10.408 40.6-13.53 14.57-3.123 28.1-4.164 41.63-4.164 14.57 0 29.14 1.041 43.71 4.164 14.58 2.081 27.07 7.285 39.56 13.53 12.49 6.245 21.85 15.613 29.14 27.062 7.29 11.45 11.45 26.021 12.49 43.716h-82.23c0-10.409-4.16-18.736-11.45-23.94-7.28-4.163-16.65-7.286-28.1-7.286-4.16 0-8.32 0-12.49 1.041-4.16 1.041-8.32 1.041-12.49 2.082-4.16 1.041-7.28 3.122-9.37 6.245-2.08 3.122-4.16 6.245-4.16 11.449 0 6.245 3.12 11.449 10.41 15.613 6.24 4.163 14.57 7.286 24.98 10.408 10.41 2.082 20.82 5.204 32.27 7.286 11.44 2.082 22.89 4.163 33.3 6.245 13.53 3.123 24.98 7.286 33.31 13.531 9.37 6.245 15.61 12.49 20.82 19.776 5.2 7.286 9.36 14.572 11.45 21.858 2.08 7.285 3.12 13.53 3.12 19.776 0 17.694-4.17 33.306-11.45 45.796-8.33 12.491-17.7 21.858-30.19 30.185-12.49 7.286-26.02 12.49-41.63 16.653-15.61 3.123-31.22 5.204-45.8 5.204-15.61 0-32.26-1.04-47.87-4.163-15.62-3.122-29.15-8.327-41.64-15.612a83.855 83.855 0 01-30.18-30.185c-8.33-12.49-12.49-28.102-12.49-46.838h84.31v-2.081z" fill="#FFFFFF"></path><path d="M0 481.911V281.028l187.351-58.287v200.882L0 481.911z" fill="#8BC53F"></path><path d="M187.351 423.623V222.741l126.983 87.431v200.882l-126.983-87.431z" fill="#EBD417"></path><path d="M126.982 569.341L0 481.911l187.351-58.287 126.983 87.43-187.352 58.287z" fill="#034EA1"></path><path d="M183.188 212.331l51.001-116.574 65.573 155.085-51.001 116.574-65.573-155.085z" fill="#712E74"></path><path d="M248.761 367.415l51.001-116.574 171.739-28.102-49.96 115.533-172.78 29.143z" fill="#009FD1"></path><path d="M299.762 250.842L234.189 95.757l171.739-28.103 65.573 155.085-171.739 28.103z" fill="#F6921E"></path><path d="M187.352 222.741L59.328 198.802 44.757 71.819 172.78 95.76l14.572 126.982z" fill="#DA2128"></path><path d="M172.78 95.758L44.757 71.818l70.777-70.776 128.023 23.94-70.777 70.776z" fill="#25BCBD"></path><path d="M258.129 153.005l-70.777 69.736-14.571-126.982 70.777-70.778 14.571 128.024z" fill="#00844A"></path></svg></a></div><a href="//www.frontiersin.org/journals/pharmacology" class="Ibar__journalName" data-event="iBarJournal-a-journalHome"><div class="Ibar__journalName__container" logoclass="Ibar__logo--mixed"><div class="Ibar__journal__maskLogo" style="display:none;"><img class="Ibar__journal__logo" src></div><div class="Ibar__journalName"><span>Frontiers in</span><span> Pharmacology</span></div></div></a><div class="Ibar__spacer"></div><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> Sections</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">Sections</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><ul class="Ibar__dropdown__sections"><!--[--><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/cardiovascular-and-smooth-muscle-pharmacology" data-event="iBarJournal-sections-a_id_182">Cardiovascular and Smooth Muscle Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/drug-metabolism-and-transport" data-event="iBarJournal-sections-a_id_199">Drug Metabolism and Transport</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/drugs-outcomes-research-and-policies" data-event="iBarJournal-sections-a_id_202">Drugs Outcomes Research and Policies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/ethnopharmacology" data-event="iBarJournal-sections-a_id_184">Ethnopharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/experimental-pharmacology-and-drug-discovery" data-event="iBarJournal-sections-a_id_183">Experimental Pharmacology and Drug Discovery</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/gastrointestinal-and-hepatic-pharmacology" data-event="iBarJournal-sections-a_id_186">Gastrointestinal and Hepatic Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/inflammation-pharmacology" data-event="iBarJournal-sections-a_id_188">Inflammation Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/integrative-and-regenerative-pharmacology" data-event="iBarJournal-sections-a_id_178">Integrative and Regenerative Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/neuropharmacology" data-event="iBarJournal-sections-a_id_26">Neuropharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/obstetric-and-pediatric-pharmacology" data-event="iBarJournal-sections-a_id_196">Obstetric and Pediatric Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacoepidemiology" data-event="iBarJournal-sections-a_id_2186">Pharmacoepidemiology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacogenetics-and-pharmacogenomics" data-event="iBarJournal-sections-a_id_198">Pharmacogenetics and Pharmacogenomics</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-anti-cancer-drugs" data-event="iBarJournal-sections-a_id_192">Pharmacology of Anti-Cancer Drugs</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-infectious-diseases" data-event="iBarJournal-sections-a_id_2216">Pharmacology of Infectious Diseases</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/pharmacology-of-ion-channels-and-channelopathies" data-event="iBarJournal-sections-a_id_179">Pharmacology of Ion Channels and Channelopathies</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/predictive-toxicology" data-event="iBarJournal-sections-a_id_195">Predictive Toxicology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/renal-pharmacology" data-event="iBarJournal-sections-a_id_1357">Renal Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/respiratory-pharmacology" data-event="iBarJournal-sections-a_id_190">Respiratory Pharmacology</a></li><li class="Ibar__dropdown__sections__item"><a href="/journals/pharmacology/sections/translational-pharmacology" data-event="iBarJournal-sections-a_id_1251">Translational Pharmacology</a></li><!--]--></ul><!--]--></div></div></div><!--[--><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/articles" target="_self" data-event="iBar-a-articles">Articles</a><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/research-topics" target="_self" data-event="iBar-a-researchTopics">Research Topics</a><a class="Ibar__link" href="//www.frontiersin.org/journals/pharmacology/editors" target="_self" data-event="iBar-a-editorialBoard">Editorial board</a><!--]--><div parent-data-event="iBarJournal"><div class="Ibar__dropdown"><button class="Ibar__dropdown__trigger"><!----> About journal</button><div class="Ibar__dropdown__menu"><div class="Ibar__dropdown__menu__header"><button class="Ibar__dropdown__menu__header__title" aria-label="Close Dropdown">About journal</button><button class="Ibar__close" aria-label="Close Dropdown"></button></div><!--[--><div class="Ibar__dropdown__about"><!--[--><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>Scope</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-editors" target="_self" data-event="iBar-aboutJournal_0-a_fieldChiefEditors">Field chief editors</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-scope" target="_self" data-event="iBar-aboutJournal_1-a_mission &amp;Scope">Mission &amp; scope</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-facts" target="_self" data-event="iBar-aboutJournal_2-a_facts">Facts</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-submission" target="_self" data-event="iBar-aboutJournal_3-a_journalSections">Journal sections</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-open" target="_self" data-event="iBar-aboutJournal_4-a_openAccessStatemen">Open access statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#copyright-statement" target="_self" data-event="iBar-aboutJournal_5-a_copyrightStatement">Copyright statement</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/about#about-quality" target="_self" data-event="iBar-aboutJournal_6-a_quality">Quality</a></li><!--]--></ul><ul class="Ibar__dropdown__about__block"><li class="Ibar__dropdown__about__block__title"><span>For authors</span></li><!--[--><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/why-submit" target="_self" data-event="iBar-aboutJournal_0-a_whySubmit?">Why submit?</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/article-types" target="_self" data-event="iBar-aboutJournal_1-a_articleTypes">Article types</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/author-guidelines" target="_self" data-event="iBar-aboutJournal_2-a_authorGuidelines">Author guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/editor-guidelines" target="_self" data-event="iBar-aboutJournal_3-a_editorGuidelines">Editor guidelines</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/publishing-fees" target="_self" data-event="iBar-aboutJournal_4-a_publishingFees">Publishing fees</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/submission-checklist" target="_self" data-event="iBar-aboutJournal_5-a_submissionChecklis">Submission checklist</a></li><li class="Ibar__dropdown__about__block__item"><a href="https://www.frontiersin.org/journals/pharmacology/for-authors/contact-editorial-office" target="_self" data-event="iBar-aboutJournal_6-a_contactEditorialOf">Contact editorial office</a></li><!--]--></ul><!--]--></div><!--]--></div></div></div><div class="Ibar__spacer"></div><a class="Ibar__button Ibar__submit" href="https://www.frontiersin.org/submission/submit?domainid=1&amp;fieldid=62&amp;specialtyid=0&amp;entitytype=2&amp;entityid=176" data-event="iBarJournal-a-submit"><span>Submit</span><span>Â your research</span></a><a class="Ibar__icon Ibar__icon--search" href="//www.frontiersin.org/search" aria-label="Search" target="_self" data-event="iBar-a-search"><span>Search</span></a><!----><!----><!----><div class="Ibar__userArea"></div></div></div><!--]--></nav><div class="ArticlePage"><!--[--><div class="Layout Layout--withAside Layout--withIbarMix"><div class="Alert Alert--info Alert--noInfo ArticleTemplateBanner"><div class="Alert__icon"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" class="FeedbackIcon"><path fill="#fff" d="M10 10h28v28H10z"></path><path fill="var(--blue50)" d="M24 2.88a21.12 21.12 0 1 0 0 42.24 21.12 21.12 0 0 0 0-42.24ZM22.08 13.4a.96.96 0 0 1 .96-.96h1.92a.96.96 0 0 1 .96.96v1.92a.96.96 0 0 1-.96.96h-1.92a.96.96 0 0 1-.96-.96V13.4Zm5.76 21.2a.96.96 0 0 1-.96.97h-5.76a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h.96v-7.68h-.96a.96.96 0 0 1-.96-.96v-1.92a.96.96 0 0 1 .96-.96h3.84a.96.96 0 0 1 .96.96v10.56h.96a.96.96 0 0 1 .96.96v1.92Z"></path></svg></div><div class="Alert__main"><p class="Alert__message">Your new experience awaits. Try the new design now and help us make it even better</p><!--[--><button type="button" class="Button Button--outline Button--grey80 Button--small ArticleTemplateBanner__switchButton" data-event="btn-action"><span>Switch to the new experience</span></button><!--]--><!----></div><ol class="Alert__info"><!--[--><!--]--></ol></div><!----><main class="Layout__main"><!----><div class="ArticleDetails"><div class="ArticleLayoutHeader"><div class="ArticleLayoutHeader__info"><p class="ArticleLayoutHeader__info__title">ORIGINAL RESEARCH article</p><p class="ArticleLayoutHeader__info__journalDate"><span>Front. Pharmacol.</span><span>, 13 June 2022</span></p><p class="ArticleLayoutHeader__info__journalDate"> Sec. Pharmacology of Ion Channels and Channelopathies</p><p class="ArticleLayoutHeader__info__doiVolume"><span>Volume 13 - 2022 | </span><a class="ArticleLayoutHeader__info__doi" href="https://doi.org/10.3389/fphar.2022.872645">https://doi.org/10.3389/fphar.2022.872645</a></p><!----></div><!----><p class="ArticleLayoutHeader__isPartOfRT"><span class="ArticleLayoutHeader__isPartOfRT__label">This article is part of the Research Topic</span><span class="ArticleLayoutHeader__isPartOfRT__title">â€‹Ion Channels in Health and Disease</span><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View all 7 articles" href="https://www.frontiersin.org/research-topics/26272/ion-channels-in-health-and-disease/magazine" target="_self" data-event="customLink-linkType-a_viewAll7Articles"><span>View all 7 articles</span></a></span></p></div><div class="ArticleDetails__main__content"><div class="ArticleDetails__main__content__main ArticleDetails__main__content__main--fullArticle"><div class="JournalAbstract"><div class="JournalAbstract__titleWrapper"><h1>Functional Characterization of Two Variants at the Intron 6&#x02014;Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes</h1><!----></div><!----></div><div class="JournalFullText"><div class="JournalAbstract"><a id="h1" name="h1"></a><div class="authors"><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Ilaria Mosca&#x;" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Ilaria Mosca<sup>1</sup><sup>&#x02020;</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/381848" class="user-id-381848"><img class="pr5" src="https://loop.frontiersin.org/images/profile/381848/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Ilaria Rivolta&#x;">Ilaria Rivolta</a><sup>2</sup><sup>&#x02020;</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Audrey Labalme&#x;" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Audrey Labalme<sup>3</sup><sup>&#x02020;</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Paolo Ambrosino" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Paolo Ambrosino<sup>4</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Barbara Castellotti" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Barbara Castellotti<sup>5</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Cinzia Gellera" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Cinzia Gellera<sup>5</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/594028" class="user-id-594028"><img class="pr5" src="https://loop.frontiersin.org/images/profile/594028/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Tiziana Granata">Tiziana Granata</a><sup>6</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/592870" class="user-id-592870"><img class="pr5" src="https://loop.frontiersin.org/images/profile/592870/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Elena Freri">Elena Freri</a><sup>6</sup></span><span class="author-wrapper notranslate"><img class="pr5" src="https://loop.frontiersin.org/cdn/images/profile/default_32.jpg" alt="Anna Binda" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';">Anna Binda<sup>2</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/195337" class="user-id-195337"><img class="pr5" src="https://loop.frontiersin.org/images/profile/195337/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Gaetan Lesca">Gaetan Lesca</a><sup>3</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/257119" class="user-id-257119"><img class="pr5" src="https://loop.frontiersin.org/images/profile/257119/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Jacopo C. DiFrancesco,">Jacopo C. DiFrancesco</a><sup>6,7</sup></span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/25389" class="user-id-25389"><img class="pr5" src="https://loop.frontiersin.org/images/profile/25389/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Maria Virginia Soldovieri&#xa;">Maria Virginia Soldovieri</a><sup>1</sup>&#x0002a;</span><span class="author-wrapper notranslate"><a href="https://loop.frontiersin.org/people/432607" class="user-id-432607"><img class="pr5" src="https://loop.frontiersin.org/images/profile/432607/74" onerror="this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';" alt="Maurizio Taglialatela&#xa;">Maurizio Taglialatela</a><sup>8</sup>&#x0002a;</span></div><ul class="notes"><li><span><sup>1</sup></span>Department of Medicine and Health Science &#x0201c;V. Tiberio&#x0201d;, University of Molise, Campobasso, Italy</li><li><span><sup>2</sup></span>School of Medicine and Surgery, University of Milano-Bicocca, Monza-Center for Neuroscience (NeuroMI), Milan, Italy</li><li><span><sup>3</sup></span>Department of Medical Genetics, Hospices Civils de Lyon, Universit&#x000e9; Claude Bernard Lyon 1, Lyon, France</li><li><span><sup>4</sup></span>Department of Science and Technology (DST), University of Sannio, Benevento, Italy</li><li><span><sup>5</sup></span>Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy</li><li><span><sup>6</sup></span>Department of Pediatric Neuroscience, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy</li><li><span><sup>7</sup></span>Department of Neurology, ASST &#x0201c;San Gerardo&#x0201d; Hospital, University of Milano-Bicocca, Monza, Italy</li><li><span><sup>8</sup></span>Department of Neuroscience, University of Naples &#x0201c;Federico II&#x0201d;, Naples, Italy</li></ul><p class="mb15">Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE) to severe Developmental and Epileptic Encephalopathy (DEE). Thus, understanding the pathogenic molecular mechanisms of KCNQ2 variants and their correlation with clinical phenotypes has a relevant impact on the clinical management of these patients. In the present study, the genetic, biochemical, and functional effects prompted by two variants, each found in a non-familial SLNE or a DEE patient but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in these patients. Analysis of KCNQ2 mRNA splicing in patient-derived lymphoblasts revealed that the SLNE-causing intronic variant (c.928-1G &#x0003e; C) impeded the use of the natural splice site, but lead to a 10-aa Kv7.2 in frame deletion (Kv7.2 p.G310&#x00394;10); by contrast, the DEE-causing exonic variant (c.928G &#x0003e; A) only had subtle effects on the splicing process at this site, thus leading to the synthesis of a full-length subunit carrying the G310S missense variant (Kv7.2 p.G310S). Patch-clamp recordings in transiently-transfected CHO cells and primary neurons revealed that both variants fully impeded Kv7.2 channel function, and exerted strong dominant-negative effects when co-expressed with Kv7.2 and/or Kv7.3 subunits. Notably, Kv7.2 p.G310S, but not Kv7.2 p.G310&#x00394;10, currents were recovered upon overexpression of the PIP<sub>2</sub>-synthesizing enzyme PIP5K, and/or CaM; moreover, currents from heteromeric Kv7.2/Kv7.3 channels incorporating either Kv7.2 mutant subunits were differentially regulated by changes in PIP<sub>2</sub> availability, with Kv7.2/Kv7.2 G310S/Kv7.3 currents showing a greater sensitivity to PIP<sub>2</sub> depletion when compared to those from Kv7.2/Kv7.2 G310&#x00394;10/Kv7.3 channels. Altogether, these results suggest that the two variants investigated differentially affected the splicing process at the intron 6-exon 7 boundary, and led to the synthesis of Kv7.2 subunits showing a differential sensitivity to PIP<sub>2</sub> and CaM regulation; more studies are needed to clarify how such different functional properties contribute to the widely-divergent clinical phenotypes.</p><div class="clear"></div></div><div class="JournalFullText"><a id="h2" name="h2"></a><h2>Introduction</h2><p class="mb15">KCNQ2 and KCNQ3 genes encode for Kv7.2 and Kv7.3 voltage-gated K<sup>&#x0002b;</sup> channel subunits each showing six transmembrane segments (S<sub>1</sub>-S<sub>6</sub>) and cytoplasmic N- and C-termini of variable length; the pore domain is encompassed by the S<sub>5</sub>-S<sub>6</sub> segments and the intervening linker of each subunit, whereas the transmembrane segments between S<sub>1</sub> and S<sub>4</sub> form the voltage-sensing domain (VSD). The C-terminal region of Kv7 subunits contains domains (called from A to D) required for homo- or heteromeric subunit assembly and for a complex network of mutually interacting molecules, such as phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>), calmodulin, syntaxyn, A-kinase-anchoring proteins, which allow Kv7 channel regulation by pKC, and ankyrin-G (<a href="#B26">Soldovieri et al., 2011</a>). Kv7.2/Kv7.3 channels are mainly expressed in neuronal cells, where they contribute to a slowly activating and deactivating K<sup>&#x0002b;</sup> current called I<sub>KM</sub> (or M-current) as it is inhibited by the activation of M<sub>1</sub> receptors (<a href="#B21">Selyanko et al., 2000</a>). The molecular pathways leading to M-current inhibition include pKC phosphorylation of the Kv7.2 subunits, dissociation of CaM from the channel and a consequent reduced affinity towards PIP<sub>2</sub> (<a href="#B10">Kosenko et al., 2012</a>).</p><p class="mb15">I<sub>KM</sub> controls neuronal excitability in the sub-threshold range for action potential generation (<a href="#B13">Marrion, 1997</a>; <a href="#B28">Wang et al., 1998</a>); thus, it is not surprising that pathogenic variants in KCNQ2 and KCNQ3 genes have been identified in epileptic disorders, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE), characterized by seizures occurring in the first days of life and disappearing after few months, without significant effects on the subsequent neuropsychomotor development, to developmental and epileptic encephalopathies (DEEs), most often characterized by severe epileptic conditions, associated to variable degrees of social, cognitive, motor, language, and behavioral impairments, and pharmacoresistance (<a href="#B30">Weckhuysen et al., 2012</a>; <a href="#B29">Weckhuysen et al., 2013</a>). Although the causes for this differential developmental trajectories are still largely unknown, some genotype-phenotype correlations have emerged; in fact, while most variants causing SLFNE are nonsense, splice, or frameshifts randomly distributed throughout the gene, those causing DEE are almost invariably missense and cluster in four hot-spots channel domains exerting critical functional roles (<a href="#B18">Millichap et al., 2016</a>).</p><p class="mb15">Characterization of the specific effects prompted by each KCNQ2 variant on channel function could allow to identify distinct pathogenetic mechanisms, thus corroborating genotype-phenotype correlations between novel KCNQ2 variants and disease severity, with a potentially-relevant impact on the clinical management of these patients. Functional studies, mainly performed with missense variants, have revealed that, when compared with SLFNE-causing variants, associated with haploinsufficiency, most of the DEE-causing substitutions prompt strong loss-of-function (LoF) (<a href="#B14">Miceli et al., 2013</a>), dominant-negative (<a href="#B19">Orhan et al., 2014</a>) or gain-of-function (GoF) (<a href="#B15">Miceli et al., 2015</a>; <a href="#B17">Millichap et al., 2017</a>) effects. No study has yet been performed in KCNQ2 splice-site variants. Therefore, the genetic, biochemical, and functional effects prompted by two variants, each found in a SLNE (<a href="#B23">Soldovieri et al., 2014</a>) or a DEE patient (<a href="#B25">Soldovieri et al., 2020</a>) but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated in the present study to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in the probands carrying these two variants.</p><a id="h3" name="h3"></a><h2>Materials and Methods</h2><h3 class="pt0">Patients</h3><p class="mb0">Parents of each patient signed an informed consent for the participation, according to the French bioethics law. The clinical features of the two patients herein investigated have been previously described (<a href="#B23">Soldovieri et al., 2014</a>; <a href="#B25">Soldovieri et al., 2020</a>).</p><p class="mb0">Briefly, the girl with early-onset DEE caused by the heterozygous NM_172107.4:c.928 G &#x0003e; A mutation described in <a href="#B25">Soldovieri et al. (2020)</a> showed burst-suppression pattern at the EEG, recurrent seizures with multifocal onset occurring during the first days of life, and was refractory to different therapeutic trials with phenobarbital, phenytoin, levetiracetam, vigabatrin and pyridoxine. The neurologic evolution was characterized by severe psychomotor delay, absent speech, apostural tetraparesis, and strabismus. A significant decrease of the epileptiform activity was observed following introduction of gabapentin, a newly-identified Kv7 activator (<a href="#B12">Manville and Abbott, 2018</a>) able to counteract <em>in vitro</em> mutation-induced LoF effects (<a href="#B25">Soldovieri et al., 2020</a>).</p><p class="mb0">The male patient carrying a heterozygous NM_172107.4:c.928-1G &#x0003e; C mutation described in Soldovieri et al. (2014; Individual II-I in family 9) had seizures in the neonatal period but no recurrence thereafter, normal EEG and normal neurodevelopment; the variant was not detected in either parent, and occurred <em>de novo</em>, thus confirming the diagnosis of non-familial Self-Limiting Neonatal Epilepsy (SLNE; <a href="#B23">Soldovieri et al., 2014</a>).</p><h3 class="pt0">Genetic Analysis on Immortalized Lymphoblasts</h3><p class="mb0">For the c.928-1G &#x0003e; C variant, the validation of the effects on Kv7.2 mRNAs splicing was performed as previously described (<a href="#B23">Soldovieri et al., 2014</a>). Briefly, mRNA was extracted from Epstein-Barr Virus-immortalized lymphoblastoid cells with the RNeasy minikit (Qiagen, Courtaboeuf, France). Retrotranscription was performed using the Expand RT kit (Invitrogen, Saint Aubin, France). PCR was performed with primers in exon 5 (forward: 5&#x02032;-TAC&#x0200b;GCG&#x0200b;GAT&#x0200b;GCA&#x0200b;CTC&#x0200b;TGG-3&#x02032;) and exon 8 (reverse: 5&#x02032;-GTG&#x0200b;GAG&#x0200b;TGC&#x0200b;AGG&#x0200b;TCT&#x0200b;GTG&#x0200b;C-3&#x02032;); PCR products were subsequently sequenced.</p><p class="mb0">For the c.928G &#x0003e; A variant, RNA was extracted from Blood samples collected on PAXgene Blood Tube using the PAXgene Blood RNA Kit (Qiagen). cDNA was synthesized from RNA using the SuperScriptTM II RT (ThermoFisher Scientific) according to the manufacturer instructions with primers in exon 6 (forward: 5&#x02032;-CCT&#x0200b;TGC&#x0200b;GGC&#x0200b;AAC&#x0200b;CTT&#x0200b;CAC-3&#x02032;) and exon 8 (reverse: 5&#x02032;- GCT&#x0200b;CGT&#x0200b;AGT&#x0200b;ACT&#x0200b;GCC&#x0200b;ACG-3&#x02032;). cDNA amplicons were separated on a gel electrophoresis using a Labchip GX (Perkin Elmer). Both variants were submitted to ClinVar database (SCV001423824.1 and SCV000484597.1).</p><h3 class="pt0">Mutagenesis and Heterologous Expression of Channel Subunits</h3><p class="mb0">As reported (<a href="#B25">Soldovieri et al., 2020</a>), c.928G &#x0003e; A/p.G310S variant was engineered in a pcDNA3.1-Kv7.2 plasmid for electrophysiological and western-blot experiments, as well as in a dual-tagged Enhanced Green Fluorescent Protein-Kv7.2-hemagglutinin (EGFP-Kv7.2-HA) plasmid used for experiments in neurons, by Quick-change mutagenesis (Agilent Technologies), accordingly to previously described procedure (<a href="#B16">Miceli et al., 2012</a>). In the EGFP-Kv7.2-HA chimeric construct, in addition to an EGFP at the cytoplasmic N-terminus, an HA epitope was inserted in the extracellular loop that connects transmembrane domains S<sub>1</sub> and S<sub>2</sub> of Kv7.2 subunits (<a href="#B20">Schwake et al., 2000</a>; <a href="#B24">Soldovieri et al., 2006</a>). By contrast, the cDNA for the Kv7.2 p.G310&#x00394;10 variant was engineered by Eurofins service (Eurofins Genomics, Germany); then, a BspeEI/BstXI restriction cassette encompassing variant position was extracted and inserted into the dual-tagged EGFP-Kv7.2-HA plasmid, previously reacted with the same enzymes. Successful cloning was checked by direct sequencing.</p><p class="mb0">Methods for CHO cell growth and primary cortical neurons isolation, as well as protocols for wild-type and mutant cDNAs expression by transient transfection have been previously described (<a href="#B22">Soldovieri et al., 2016</a>; <a href="#B25">Soldovieri et al., 2020</a>). Total cDNA in the transfection mixture was kept constant at 4&#x000a0;&#x003bc;g (for electrophysiological recordings in CHO cells), 2&#x000a0;&#x003bc;g (for electrophysiological recordings in neurons), or 6&#x000a0;&#x003bc;g (for Western-blotting experiments).</p><h3 class="pt0">Cell Surface Biotinylation and Western-Blot</h3><p class="mb0">Expression of wild-type or variant Kv7.2 subunits in CHO cells in total lysate or plasma membrane-enriched fractions was investigated by surface biotinylation and western-blotting analysis, as described (<a href="#B23">Soldovieri et al., 2014</a>). Channel subunits were identified using mouse monoclonal anti-Kv7.2 primary antibodies (clone N26A/23, dilution 1:1,000; Antibodies Inc., Davis, CA), followed by horseradish peroxidase (HRP)-conjugated anti-mouse secondary antibodies (clone NA931V; dilution 1:5,000; GE Healthcare, Little Chalfont, United Kingdom).</p><h3 class="pt0">Patch-Clamp Recordings</h3><p class="mb0">Macroscopic current recordings were performed in CHO cells (24&#x000a0;h after transfection) or in neurons (48&#x000a0;h after transfection), as previously reported (<a href="#B14">Miceli et al., 2013</a>; <a href="#B3">Binda et al., 2018</a>). Current densities were obtained dividing the current amplitude measured at each test voltage by the cell capacitance (pA/pF). The conductance was calculated by normalizing the currents measured at the end of each pulse to the driving force. Experimental data were fitted to a Boltzmann equation of the following form: <em>y</em>&#x0003d;max/[1&#x0002b;exp(<em>V</em><sub>1/2</sub>&#x02212;<em>V</em>)/<em>k</em>] to obtain the voltage of half activation (V<sub>&#x000bd;</sub>) and the slope factor (<em>k</em>).</p><p class="mb0">Experiments on primary cortical neurons were performed either in voltage-clamp mode, using protocols similar to those applied on CHO cells, or in current-clamp mode, to record membrane resting potential. Data were acquired with a Multiclamp 700B amplifier and Digidata 1440A (Axon Instruments, Molecular Device) and pClamp 10.3 software (Molecular Devices) and analyzed with Clampfit 10.3 software (Molecular Devices).</p><p class="mb0">Experiments with the Danio rerio voltage-sensing phosphatase (DrVSP) were performed as previously reported (<a href="#B2">Ambrosino et al., 2018</a>). Briefly, a 0&#x000a0;mV step lasting 1.5&#x000a0;s was used to activate Kv7 currents, followed by a &#x0002b;100&#x000a0;mV step of variable length (from 0.1 to 1&#x000a0;s, with increments of 0.1&#x000a0;s) to activate DrVSP, and by a second 0&#x000a0;mV step, causing DrVSP switch off and Kv7 current recovery (25&#x000a0;s). Time-dependent current decline following DrVSP activation was quantified as the ratio between the current size measured at the beginning of the second 0&#x000a0;mV step (after DrVSP activation) versus that measured at the end of the first 0&#x000a0;mV step (before DrVSP activation), expressed as a function of the duration of the &#x0002b;100&#x000a0;mV step; these values were then fitted to a Boltzmann function of the following form: y &#x0003d; 1/[1&#x0002b;(x/t<sub>&#x000bd;</sub>)-Hill slope], where t<sub>&#x000bd;</sub> was the duration of the &#x0002b;100&#x000a0;mV step required to inhibit 50% of maximal currents. Kv7 current recovery was instead quantified by normalizing current values recorded during the entire second step at 0&#x000a0;mV to the currents measured at the end of the first 0&#x000a0;mV step. The kinetics of DrVSP-induced Kv7 current inhibition and of Kv7 current recovery after DrVSP switch off were measured by fitting the current traces to a single exponential function of the following form: y &#x0003d; amp&#x000d7;e(&#x02212;t/&#x003c4;)&#x0002b;c, where &#x003c4; was the time constant of the function.</p><h3 class="pt0">Statistics</h3><p class="mb0">Each data point shown in figures or in the text is the Mean &#x000b1; SEM of at least 4 determinations, each performed in a single cell or in a separate experiment. Statistically significant differences were evaluated with the Student&#x02019;s t-test or with the ANOVA followed by the Student-Newman-Keuls test, with the threshold set at <em>p</em> &#x0003c; 0.05.</p><a id="h4" name="h4"></a><h2>Results</h2><h3 class="pt0">Analysis of Kv7.2 mRNAs Expressed in Patient-Derived Lymphoblasts</h3><p class="mb0">Both variants herein reported fall at the intron 6-exon 7 boundary of the KCNQ2 gene (<a href="#F1">Figure 1A</a>). Four in silico tools provided by Alamut software (SpliceSiteFinder-like, MaxEntScan, NNSPLICE, and Gene Splicer; Suppl. <a href="#F1">Figure 1A</a>) revealed that the SLNE-causing c.Kv7.2 c.928-1G &#x0003e; C intronic variant (affecting the g of the ag acceptor site located at the end of intron 6; <a href="#F1">Figure 1A</a>) drastically reduced the strength of the affected splice site (<a href="#SM1">Supplementary Figure S1A</a>; <a href="#B23">Soldovieri et al., 2014</a>); similar results were obtained with the software spliceAI (acceptor loss score: 0.96). In keeping with this prediction, while Kv7.2 mRNAs analysis in lymphoblasts from the unaffected, non-carrier father revealed the presence of only wild-type fragments (295 bp), transcript analysis in lymphoblasts from the proband carrying the c.928-1G &#x0003e; C variant revealed the presence of both wild-type (295 bp) and shorter (265 bp) fragments (<a href="#F1">Figure 1B</a>), the latter corresponding to the variant-induced use of a cryptic ag site located 30 bp downstream in exon 7, thus causing the removal of encompassed nucleotides (<a href="#F1">Figure 1A</a>). The intensity of this low molecular weight band was much stronger than that corresponding to the full-length band of the wild-type allele, leading to an intensity ratio higher than the 1:1 expected from the heterozygous state of the patient; this result, possibly explained by the more efficient amplification of shorter amplicons, suggests that the effect of the variant on the splicing is complete. Expression of shorter mRNAs causes a 10 aminoacid in-frame deletion (Kv7.2 p.G310_K319del10, herein referred as Kv7.2 p.G310&#x00394;10), affecting the end of S6 domain and the beginning of the C-terminus of Kv7.2 subunits (<a href="#F1">Figure 1D</a>).</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE 1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg" name="Figure1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg" alt="www.frontiersin.org" id="F1" loading="lazy">
  </picture>
</a><p><strong>FIGURE 1</strong>. Localization of KCNQ2 variants herein investigated and effects on KCNQ2 mRNAs expression. <strong>(A)</strong> Localization of the two variants herein investigated in the KCNQ2 gene, falling at the last nucleotide of intron 6 (KCNQ2 <strong>(C)</strong>928-1G &#x0003e; C; blue circle; already reported in <a href="#B23">Soldovieri et al., 2014</a>) or at the first nucleotide of exon 7 (KCNQ2 <strong>(C)</strong>928G &#x0003e; <strong>(A)</strong>; already reported in <a href="#B25">Soldovieri et al., 2020</a>). <strong>(B)</strong> Representative agarose gel run and <strong>(C)</strong> electrophoresis profiles of major bands obtained from RT-PCR experiments performed on Kv7.2 mRNAs expressed in father- or probands-deriving lymphoblasts, as indicated; the mRNA fragment of 295 bp <strong>(B)</strong> or 218&#x000a0;bp <strong>(C)</strong> are expected when the ag acceptor site at the end of intron 6 is used, while those of 265&#x000a0;bp <strong>(B)</strong> or 188&#x000a0;bp <strong>(C)</strong> bands are obtained using the alternative splice site in the exon 7. Panels in C have been obtained cropping the regions of interest from the complete electrophoresis profiles, reported in <a href="#SM1">Supplementary Figure S2</a> Topology of a Kv7.2 subunit showing the 6 transmembrane segments (called from S1 to S6) and four intracellular domains at the C-terminus (called from A to D), binding many regulatory molecules. Middle and left panels show the structural alterations prompted by the Kv7.2 G310&#x00394;10 in-frame deletion or by the missense Kv7.2 G310S variant, respectively.</p></div><div class="clear"></div><div class="DottedLine"></div><p class="mb0">By contrast, in the case of the DEE-causing exonic c.928G &#x0003e; A variant, affecting the first nucleotide of exon 7 (<a href="#F1">Figure 1A</a>), prediction tools provided by Alamut (SpliceSiteFinder-like, MaxEntScan, NNSPLICE, and Gene Splicer) were in favor of only a slight reduction of the strength of the splice site (<a href="#SM1">Supplementary Figure S1A</a>); similar results were obtained with the software spliceAI (acceptor loss score: 0.06). Accordingly, PCR analysis performed in lymphoblasts from the patient carrying this variant revealed that, while only the expected 218 bp-long fragments were detected in samples from the father (used as a control), a shorter (188&#x000a0;bp) Kv7.2 mRNA fragment was also detected in the patient carrying the c.928G &#x0003e; A variant (<a href="#F1">Figure 1C</a>), with the first being much more abundant than the latter (90:10, respectively) (<a href="#F1">Figure 1C</a>). The most abundant mRNA incorporates the c.928G &#x0003e; A substitution in exon 7, causing the missense substitution p.G310S (<a href="#F1">Figures 1A&#x02013;D</a>).</p><h3 class="pt0">Functional Characterization of Kv7.2 Channels Carrying p.G310S or p.G310&#x00394;10 Variants in CHO Cells</h3><p class="mb0">The functional consequences of p.G310&#x00394;10 or p.G310S Kv7.2 subunits were investigated by electrophysiological recordings upon their expression in CHO cells by transient transfection. Expression of Kv7.2 channels in these cells elicited robust voltage-gated outward K<sup>&#x0002b;</sup> currents with slow activation and deactivation kinetics, lack of inactivation and activating at about &#x02212;40&#x000a0;mV, with a current density of about 30&#x000a0;pA/pF (<a href="#F2">Figure 2A</a>; <a href="#T1">Table 1</a>). By contrast, K<sup>&#x0002b;</sup> current densities recorded from CHO cells transfected with either mutant plasmids were identical to those of non-transfected cells (<a href="#F2">Figure 2A</a>; <a href="#T1">Table 1</a>).</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE 2</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg" name="Figure2" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg" alt="www.frontiersin.org" id="F2" loading="lazy">
  </picture>
</a><p><strong>FIGURE 2</strong>. Functional and biochemical characterization of Kv7.2 G310S and Kv7.2 G310&#x00394;10 subunits. <strong>(A)</strong> Maximal current densities measured in non transfected cells (NT) or in cells expressing wild-type or mutant Kv7.2 subunits, as indicated. &#x0002a; &#x0003d; <em>p</em> &#x0003c; 0.05 versus NT cells. <strong>(B)</strong> Western blot analysis of proteins from total lysates (upper panels) or biotinylated plasma membrane fractions (lower panels) from CHO cells transfected with the indicated constructs. Higher and lower blots were probed with anti-Kv7.2 or anti-&#x003b1;-tubulin antibodies, as indicated. Numbers on the left correspond to the molecular masses of the protein markers. ODKv7.2 TOT/ODTUB ratios were 1.00 &#x000b1; 0.20, 1.54 &#x000b1; 0.19, or 0.66 &#x000b1; 0.25; n &#x0003d; 4; <em>p</em> &#x0003e; 0.05 among each other; ODKv7.2 BIOT/ODTUB ratios were 1.00 &#x000b1; 0.50, 5.2 &#x000b1; 1.50, or 3.33 &#x000b1; 0.45 in Kv7.2-, Kv7.2 p.G310S-, or Kv7.2 p.G310&#x00394;10-transfected cells, respectively; n &#x0003d; 4; <em>p</em> &#x0003c; 0.05 versus Kv7.2. <strong>(C,D)</strong> Quantification of maximal currents measured in CHO cells expressing either Kv7.2 variant with Kv7.2 <strong>(C)</strong> and/or Kv7.3 <strong>(D)</strong> subunits, as indicated. &#x0002a; &#x0003d; <em>p</em> &#x0003c; 0.05 versus the black bar in each panel; &#x0002a;&#x0002a; &#x0003d; <em>p</em> &#x0003c; 0.05 versus Kv7.3; &#x0002a;&#x0002a;&#x0002a; &#x0003d; <em>p</em> &#x0003c; 0.05 Kv7.2 &#x0002b; Kv7.3 (0.5:1). <strong>(E)</strong> Representative current traces recorded upon application of the ramp protocol (shown below the first traces) on CHO cells expressing the indicated constructs in control solution <strong>(C)</strong>, after 2-min 3&#x000a0;mM TEA perfusion, or upon drug washout (W). Current scale: 100&#x000a0;pA; time scale: 1&#x000a0;s.</p></div><div class="clear"></div><div class="DottedLine"></div><div class="Imageheaders">TABLE 1</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg" name="Table1" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg" alt="www.frontiersin.org" id="T1" loading="lazy">
  </picture>
</a><p><strong>TABLE 1</strong>. Functional properties of currents of wild-type or mutant Kv7.2 subunits when expressed in CHO cells or cortical neurons.</p></div><div class="clear"></div><div class="DottedLine"></div><p class="mb0">To investigate possible variant-induced changes in Kv7.2 subunits trafficking to the plasma membrane, Western-blot experiments were performed in both total lysates and plasma membrane-enriched fractions from CHO cells expressing Kv7.2, Kv7.2&#x000a0;G310S, or Kv7.2 G310&#x00394;10 subunits. The results obtained showed that either substitutions did not interfere with whole-cell expression of Kv7.2 subunits (<a href="#F2">Figure 2B</a>; <em>p</em> &#x0003e; 0.05 among each other), whilst both significantly increased Kv7.2 subunit expression at the plasma membrane (<a href="#F2">Figure 2B</a>; <em>p</em> &#x0003c; 0.05 versus Kv7.2). Although this increase in plasma membrane abundance, quantitatively similar for both variants, was not further investigated, these results suggested that the functional impairment observed in electrophysiological experiments upon transfection with plasmids carrying either variant was not due to the inability of Kv7.2 mutant subunits to efficiently traffic to the plasma membrane.</p><p class="mb0">Having detected non-functional mutant subunits at the plasma membrane, we also investigated whether they interfered with the function of wild-type Kv7.2 and/or Kv7.2 subunits, as Kv7.2/3 heteromers underlie most of the M-current in adult neurons (<a href="#B28">Wang et al., 1998</a>). Notably, co-expression of Kv7.2 subunits carrying either variant with Kv7.2 or Kv7.3 &#x0002b; Kv7.3 subunits significantly reduced maximal currents, thus indicating mutation-induced dominant-negative effects on Kv7.2 (<a href="#F2">Figure 2C</a>; <a href="#T1">Table 1</a>) or Kv7.2/Kv7.3 (<a href="#F2">Figure 2D</a>; <a href="#T1">Table 1</a>) currents. By contrast, significant dominant-negative effects on Kv7.3 currents only occurred upon co-expression of Kv7.2 p.G310&#x00394;10, but not Kv7.2 p.G310S subunits, whereas currents levels in Kv7.3- or Kv7.2 G310S/Kv7.3-expressing cells were identical (<a href="#F2">Figure 2D</a>; <a href="#T1">Table 1</a>). To discern whether currents measured in Kv7.2 G310S/Kv7.3-expressing cells were carried by homomeric Kv7.3 or Kv7.2 G310S/Kv7.3 heteromeric channels, pharmacological experiments using tetraethylammonium (TEA, 3&#x000a0;mM) were performed; in fact, TEA is widely used to discriminate among Kv7 channel of distinct subunit composition since it blocks homomeric Kv7.2, homomeric Kv7.3 or heteromeric Kv7.2/Kv7.3 channels with a high, low, or intermediate potency, respectively (<a href="#B8">Hadley et al., 2000</a>). In these experiments, currents from cells expressing Kv7.2 G310S/Kv7.3 channels were blocked by TEA to a similar extent as Kv7.2/Kv7.3 channels (<a href="#F2">Figure 2E</a>; <a href="#T1">Table 1</a>), thus suggesting that Kv7.2 p.G310S subunits form functional heteromeric channels with Kv7.3 subunits.</p><h3 class="pt0">Functional Characterization of Kv7.2 Channels Carrying p.G310S or p.G310&#x00394;10 Variants in Cortical Neurons</h3><p class="mb0">Co-expression of Kv7.2 &#x0002b; Kv7.3 subunits in cortical neurons yielded robust outward currents with gating properties very similar to those measured in CHO cells (<a href="#F3">Figure 3A</a>; <a href="#T1">Table 1</a>). Notably, the co-expression of Kv7.2 p.G310S or Kv7.2 p.G310&#x00394;10 subunits with wild-type Kv7.3 subunits reduced current densities to background (non-transfected) levels (<a href="#T1">Table 1</a>). Moreover, cells co-expressing either Kv7.2 variant subunits with Kv7.2 &#x0002b; Kv7.3 subunits channels carried currents whose size was roughly intermediate between that of non-transfected neurons and those expressing Kv7.2 &#x0002b; Kv7.3 channels (<a href="#F3">Figures 3B,C</a>; <a href="#T1">Table 1</a>). When compared to non-transfected neurons, neuronal resting membrane potential was hyperpolarized upon Kv7.2 &#x0002b; Kv7.3 co-expression; by contrast, co-expression of either variant failed to cause membrane hyperpolarization (<a href="#T1">Table 1</a>). Altogether, these results validate the results obtained in CHO cells and suggest that both p.G310&#x00394;10 and p.G310S Kv7.2 variants strongly suppress Kv7.2 and/or Kv7.3 channel function.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE 3</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg" name="Figure3" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg" alt="www.frontiersin.org" id="F3" loading="lazy">
  </picture>
</a><p><strong>FIGURE 3</strong>. Functional characterization of heteromeric Kv7.2 &#x0002b; Kv7.3 channels incorporating Kv7.2 G310S or Kv7.2 G310&#x00394;10 subunits expressed in neurons. <strong>(A)</strong> Macroscopic currents from neurons expressing wild-type or mutant Kv7.2 &#x0002b; Kv7.3 subunits, as indicated. <strong>(B,C)</strong> Current density/voltage curves measured in non transfected neurons (NT) or expressing the indicated channels incorporating Kv7.2 G310&#x00394;10 <strong>(B)</strong> or Kv7.2 G310S <strong>(C)</strong> subunits, as indicated.</p></div><div class="clear"></div><div class="DottedLine"></div><h3 class="pt0">p.G310S and p.G310&#x00394;10 Kv7.2 Subunits Show Distinct Changes in PIP<sub>2</sub>/CaM Regulation</h3><p class="mb0">Both Kv7.2 variants herein investigated affect bottom end of the S<sub>6</sub> segment in the pore of Kv7.2 subunits (<a href="#F1">Figure 1C</a>); this region is critical for PIP<sub>2</sub>-dependent regulation of Kv7.2 subunit function (<a href="#B34">Zhang et al., 2003</a>; <a href="#B27">Telezhkin et al., 2013</a>; <a href="#B35">Zhang et al., 2013</a>; <a href="#B22">Soldovieri et al., 2016</a>), and is located just prior helix A in the C-terminus (<a href="#F1">Figure 1C</a>), a major anchoring site for CaM (<a href="#B33">Yus-Najera et al., 2002</a>; <a href="#B5">Gamper and Shapiro, 2003</a>).</p><p class="mb0">Both PIP<sub>2</sub> and CaM positively affect Kv7.2 subunit function (<a href="#B27">Telezhkin et al., 2013</a>; <a href="#B1">Ambrosino et al., 2015</a>). To investigate whether the loss-of-function effects caused by either Kv7.2 variant were dependent on changes in PIP<sub>2</sub>- and/or CaM-dependent modulation, patch-clamp recordings were performed in CHO cells in which PIP<sub>2</sub> levels were either increased by the co-expression of the PIP<sub>2</sub>-synthesizing enzyme PIP5K (<a href="#B31">Wenk et al., 2001</a>; <a href="#B32">Winks et al., 2005</a>), or decreased by a voltage-dependent phosphatase (DrVSP) (<a href="#B4">Falkenburger et al., 2010</a>); in addition, CaM regulation was tested by measuring the functional consequences of an enhanced CaM availability, achieved by co-expressing wild-type CaM or CaM<sub>1234</sub>, a CaM variant unable to bind Ca2&#x0002b; (<a href="#B7">Geiser et al., 1991</a>).</p><p class="mb0">The results obtained suggest that Kv7.2 currents were significantly increased upon co-expression of PIP5K, CaM, or CaM<sub>1234</sub> (<a href="#F4">Figure 4A</a>; <a href="#T2">Table 2</a>); notably, potentiation by PIP5K, CaM, or CaM<sub>1234</sub> was non-additive in the present experimental conditions. Instead, Kv7.2 p.G310S channels showed strong functional recovery in the presence of PIP5K and CaM<sub>1234</sub>, but not wild-type CaM (<a href="#F4">Figure 4A</a>; <a href="#T2">Table 2</a>); notably, the effects of PIP5K and CaM<sub>1234</sub> were synergistic (<a href="#F4">Figure 4B</a>; <a href="#T1">Table 1</a>). By contrast, none of the previously mentioned experimental condition (alone or in combination) was able to recover Kv7.2 p.G310&#x00394;10 function (<a href="#F4">Figures 4A,B</a>; <a href="#T1">Table 1</a>), possibly suggesting that the G310-K319 region deleted by the mutation is critically involved in Kv7.2 currents functional modulation by PIP<sub>2</sub> and/or CaM.</p><div class="DottedLine"></div><div class="Imageheaders">FIGURE 4</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg" name="Figure4" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg" alt="www.frontiersin.org" id="F4" loading="lazy">
  </picture>
</a><p><strong>FIGURE 4</strong>. Functional study of the modulation of Kv7.2 G310S or Kv7.2 G310&#x00394;10 subunits by PIP<sub>2</sub> and calmodulin. <strong>(A,B)</strong> Representative traces <strong>(A)</strong> and quantification <strong>(B)</strong> of currents measured in CHO cells co-expressing homomeric wild-type or mutant Kv7.2 subunits with PIP5K, CaM, and/or CaM<sub>1234</sub>, as indicated. &#x0002a; &#x0003d; <em>p</em> &#x0003c; 0.05 versus Kv7.2. <strong>(C)</strong> Time-dependence of current decrease (left panel) and recovery (right panel) of currents measured in CHO cells co-expressing the indicated channels with DrVSP.</p></div><div class="clear"></div><div class="DottedLine"></div><div class="Imageheaders">TABLE 2</div><div class="FigureDesc"><a href="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg" name="Table2" target="_blank">
  <picture>
    <source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg" media="(max-width: 563px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg" media="(max-width: 1024px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg" media="(max-width: 1441px)"><source type="image/webp" srcset="https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg" media=""><source type="image/jpg" srcset="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg" media=""> <img src="https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg" alt="www.frontiersin.org" id="T2" loading="lazy">
  </picture>
</a><p><strong>TABLE 2</strong>. Functional properties of currents measured in CHO cells expressing wild-type or mutant Kv7.2 subunits upon modulation of PIP<sub>2</sub> or CaM levels.</p></div><div class="clear"></div><div class="DottedLine"></div><p class="mb0">To further investigate variant-induced changes in PIP<sub>2</sub>-dependent Kv7.2 currents modulation, PIP<sub>2</sub> levels were decreased upon co-expression of the voltage-dependent phosphatase DrVSP. As reported in <a href="#F4">Figure 4C</a>, Kv7.2 &#x0002b; Kv7.3 currents were time-dependently inhibited when &#x0002b;100&#x000a0;mV depolarizing pulses lasting &#x0003e;0.2&#x000a0;s were used to activate DrVSP (t<sub>&#x000bd;</sub> was 0.298 &#x000b1; 0.003 s, n &#x0003d; 16), with a time constant of current inhibition (<em>&#x003c4;</em>) of 0.24 &#x000b1; 0.03&#x000a0;s (n &#x0003d; 13). Membrane repolarization at 0&#x000a0;mV, a membrane potential value at which the DrVSP is switched off, led to a complete time-dependent recovery of Kv7.2 &#x0002b; Kv7.3 currents with a time constant of 26.8 &#x000b1; 3.27&#x000a0;s (n &#x0003d; 15). Notably, currents expressed by Kv7.2 &#x0002b; Kv7.2 G310S &#x0002b; Kv7.3 or Kv7.2 &#x0002b; Kv7.2 G310&#x00394;10 &#x0002b; Kv7.3 channels were more easily inhibited upon DrVSP activation: in fact, t<sub>&#x000bd;</sub> were 0.185 &#x000b1; 0.008 or 0.214 &#x000b1; 0.003 s, respectively (n &#x0003d; 12&#x02013;15; <em>p</em> &#x0003c; 0.05 versus control and among each other; <a href="#F4">Figure 4C</a>); in addition, a faster time constant was measured in cells expressing Kv7.2 &#x0002b; Kv7.2 G310S &#x0002b; Kv7.3 (&#x003c4; &#x0003d; 0.15 &#x000b1; 0.02 s; n &#x0003d; 9; <em>p</em> &#x0003c; 0.05 versus wild-type channels), but not Kv7.2 &#x0002b; Kv7.2 G310&#x00394;10 &#x0002b; Kv7.3 subunits (&#x003c4; &#x0003d; 0.24 &#x000b1; 0.02 s; n &#x0003d; 10; <em>p</em> &#x0003e; 0.05 versus wild-type channels). No difference in time constant of current recovery was measured for Kv7.2 &#x0002b; Kv7.2 G310S &#x0002b; Kv7.3 or Kv7.2 &#x0002b; Kv7.2 G310&#x00394;10 &#x0002b; Kv7.3 channels when compared to wild-type channels (&#x003c4; &#x0003d; 26.5 &#x000b1; 3.85 or 33.1 &#x000b1; 4.77 s, respectively; n &#x0003d; 9&#x02013;10; <em>p</em> &#x0003e; 0.05 versus wild-type channels).</p><p class="mb0">Altogether, these results suggest that both variants herein studied prompted significant alterations in CaM- and PIP<sub>2</sub>-dependent Kv7.2 current modulation, with a greater functional derangement in the presence of the DEE-causing p.G310S variant when compared to the SLNE-causing p.G310&#x00394;10 variant.</p><a id="h5" name="h5"></a><h2>Discussion</h2><p class="mb15">Pathogenic variants in Kv7.2 potassium channels have been found in patients affected by widely diverging epileptic phenotypes, ranging from self-limiting (SLFNE) to very severe DEEs (<a href="#B30">Weckhuysen et al., 2012</a>; <a href="#B29">Weckhuysen et al., 2013</a>). Given the rarity of KCNQ2-related disorders, genotype-phenotype correlations are difficult to establish; in general, haploinsufficiency caused by the loss of function of a single KCNQ2 allele (by nonsense, splice, or frameshift variants) is the most common cause of familial KCNQ2-SLFNE, while pathogenic variants so far identified in KCNQ2-DEE are all <em>de novo</em> missense variants, and are thought to exert more severe functional defects on potassium current function (<a href="#B14">Miceli et al., 2013</a>; <a href="#B19">Orhan et al., 2014</a>). No studies have yet been performed on KCNQ2 variants affecting splice sites (<a href="http://www.rikee.org">www.rikee.org</a>).</p><p class="mb15">In the present study, we have characterized the genetic, biochemical, and functional consequences prompted by two known variants in the KCNQ2 gene falling at the intron 6-exon 7 boundary: the SLNE-causing c.Kv7.2 c.928-1G &#x0003e; C intronic variant, and the DEE-causing exonic c.928G &#x0003e; A variant, to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in the probands carrying these two variants.</p><p class="mb15">Kv7.2 mRNAs analysis from patient-derived immortalized lymphoblasts revealed that the SLNE-causing Kv7.2 c.928-1G &#x0003e; C substitution abolished the physiological &#x0201c;ag&#x0201d; acceptor site, and promoted the use of a cryptic site located 30 bp downstream, thus leading to a 10 aminoacid in-frame deletion (p.G310_K319&#x00394;10); in the proband samples, comparison of the intensity of the new, mutation-induced, lower molecular weight band with that corresponding to the wild-type full-length band suggested that the mutation-induced effect of the variant on the splicing process is complete. By contrast, in the case of the c.928G &#x0003e; A substitution, mRNAs analysis revealed more complex effects, with most of the mRNAs (&#x0003e;90%) resulting from the use of the natural &#x0201c;ag&#x0201d; acceptor site localized at the end of intron 6, and leading to Kv7.2 mRNAs of the same length as wild-type, but encoding for the missense substitution p.G310S; in addition, the same splicing alteration described above and leading to the 10 aminoacid in-frame deletion (p.Gly310_Lys319&#x00394;10) was also detected in this patient, although this component only accounted for &#x0003c;10% of total Kv7.2 mRNAs. Although splicing in lymphoblasts might not fully recapitulate that occurring at neuronal level, based on these results we have investigated the functional consequences of Kv7.2 p.G310&#x00394;10 subunits produced by the intronic Kv7.2 c.928-1G &#x0003e; C variant, and those of Kv7.2 p.G310S subunits occurring as a result of the Kv7.2 c.928G &#x0003e; A exonic mutation.</p><p class="mb15">Both Kv7.2 p.G310S and Kv7.2 p.G310&#x00394;10 mutant subunits failed to elicit measurable currents and prompted dominant-negative effects in heteromeric configuration with Kv7.2 and/or Kv7.3 subunits when transiently-transfected in CHO cells. A similar lack of function was also observed when these subunits were co-expressed with Kv7.2/Kv7.3 subunits in primary culture of neonatal rat cortical neurons, a more physiological cellular context.</p><p class="mb15">Kv7.2 currents are regulated by a complex network of mutually-interacting intracellular molecules (<a href="#B9">Hernandez et al., 2008</a>); mutations herein investigated are located slightly upstream of the C-terminal helix A, a critical anchoring site for CaM (<a href="#B33">Yus-Najera et al., 2002</a>; <a href="#B5">Gamper and Shapiro, 2003</a>), and of one of the binding sites for the Kv7 activator PIP<sub>2</sub> (<a href="#B34">Zhang et al., 2003</a>; <a href="#B11">Li et al., 2005</a>; <a href="#B6">Gamper and Shapiro, 2007</a>; <a href="#B27">Telezhkin et al., 2013</a>; <a href="#B35">Zhang et al., 2013</a>; <a href="#B22">Soldovieri et al., 2016</a>). Both CaM and PIP<sub>2</sub> potentiate Kv7.2 currents; thus, the possibility existed that the observed mutation-induced LoF effects were dependent on alterations in the PIP<sub>2</sub>/CaM-dependent Kv7.2 current regulation. To test this hypothesis, the intracellular levels of these mediators were modified by overexpressing CaM (either in a wild-type or unable to bind Ca<sup>2&#x0002b;</sup> isoform; <a href="#B7">Geiser et al., 1991</a>), the PIP<sub>2</sub>-synthesizing enzyme PIP5K (thus increasing PIP<sub>2</sub> levels; <a href="#B31">Wenk et al., 2001</a>) or the PIP<sub>2</sub>-degrading voltage-dependent phosphatase from Danio rerio (<a href="#B4">Falkenburger et al., 2010</a>).</p><p class="mb15">In most of these experimental conditions (overexpression of PIP5K and/or CaM<sub>1234</sub>), currents carried by Kv7.2 subunits carrying the DEE-causing variant p.G310S were recovered to levels identical to those of wild-type Kv7.2 channels, suggesting that the LoF effects prompted by this variant on Kv7.2 currents are dependent to an alteration in the affinity of both mediators. By contrast, none of these experimental conditions (alone or in combination) were able to recover channel function in the case of Kv7.2 subunits incorporating the SLNE-causing variant p.G310&#x00394;10, possibly because of a complete inability of CaM and/or PIP<sub>2</sub> to bind Kv7.2 channels as a consequence of the variant-induced in-frame deletion. This could lead to a reduced incorporation of Kv7.2 subunits carrying the SLNE-causing variant in functional heterotetrameric channels and therefore in a reduction of dominant-negative effects prompted on Kv7.2/Kv7.3 currents at high CaM and/or PIP<sub>2</sub> levels, thus providing a plausible molecular explanation for the more benign clinical phenotypes observed in the individual carrying this variant. Moreover, both Kv7.2/Kv7.2 G310S/Kv7.3 and Kv7.2/Kv7.2 G310&#x00394;10/Kv7.3 currents were more sensitive than wild-type Kv7.2/Kv7.3 channels to PIP<sub>2</sub> depletion; notably, the p.G310S variant prompted slightly stronger functional derangement when compared to the p.G310&#x00394;10 variant, which could further contribute to the divergent clinical phenotypes observed in the two probands.</p><p class="mb15">These results also suggest that a quantitative threshold level exists in terms of tolerance of Kv7.2 to variant-dependent changes in PIP<sub>2</sub>-dependent current regulation, with smaller effects (such those of the Kv7.2 p.G310&#x00394;10 variant) leading to more benign forms of the clinical spectrum, and stronger derangements (as those caused by the Kv7.2 p.G310S variant) to more severe phenotypes. A similar hypothesis seems to provide a reasonable explanation for the results obtained in a DEE-affected patient carrying two variants in compound heterozygosity in KCNQ3, each inherited by a healthy parent; in this case, Kv7.2/Kv7.3 channels incorporating either KCNQ3 variant showed a smaller alteration in PIP<sub>2</sub>-dependent current regulation when compared to channels incorporating both KCNQ3 variants (<a href="#B2">Ambrosino et al., 2018</a>). The fact that, in this latter case, parents were asymptomatic could be explained by the fact that, when compared to KCNQ2, KCNQ3 shows a greater &#x0201c;mutation tolerance,&#x0201d; as also suggested by the higher incidence of KCNQ2-DEE when compared to KCNQ3-DEE cases.</p><p class="mb15">Altogether, the present results suggest that differences in both the alternative splicing process and in PIP<sub>2</sub>/CaM-dependent Kv7.2 current regulation may contribute to the divergent clinical phenotypes caused by the two KCNQ2 variants herein studied.</p><a id="h6" name="h6"></a><h2>Data Availability Statement</h2><p class="mb15">The original contributions presented in the study are included in the article/<a href="#SM1">Supplementary Material</a>, further inquiries can be directed to the corresponding authors.</p><a id="h7" name="h7"></a><h2>Ethics Statement</h2><p class="mb0">The procedures involving animals were conducted according to European (EEC Council Directive 86/609, OJ L 358, 1, December 12 1987) and Italian (D.L. n. 26/2014) laws and policies and approved by the University of Milano-Bicocca Animal Care and Use Ethic Commitee (n.02/2019) and by the Italian Ministry of Health (DGSAF 0017710-P-26/07/2017).</p><a id="h8" name="h8"></a><h2>Author Contributions</h2><p class="mb0">MVS, TG, EF, GL, JCD, and MT designed research; MVS, PA, IM, IR, AL, BC, CG, AB, and MT performed research and analysed data; MVS and MT wrote the paper.</p><a id="h9" name="h9"></a><h2>Funding</h2><p class="mb0">The present study was supported by grants, from the Department of Medicine and Health Science of the University of Molise to MVS, from the Italian Ministry for University and Research (PRIN 2017ALCR7C) to MT and MVS, from the Italian Ministry of Health (Project RF-2019-12370491) to MT and BC, the European Commission H2020 (UNICOM &#x02013; 875299), and the European Joint Programme on Rare Disease JTC 2020 to MT, and from the Italian Ministry of Health Ricerca Finalizzata Giovani Ricercatori 2016 (Project GR-2016-02363337) to JCD and MVS.</p><a id="h10" name="h10"></a><h2>Conflict of Interest</h2><p class="mb0">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p><a id="h11" name="h11"></a><h2>Publisher&#x02019;s Note</h2><p class="mb15">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p><a id="h12" name="h12"></a><h2>Acknowledgments</h2><p class="mb03">We are deeply grateful to: Dr. Thomas J. Jentsch, Leibniz-Institut f&#x000fc;r Molekulare Pharmakologie (FMP), Berlin (Germany) for Kv7.2 and Kv7.3 cDNAs; Dr. Mark S. Shapiro for pcDNA3.1-CaM and pcDNA3.1-CaM<sub>1234</sub> plasmids; Dr. Alvaro Villarroel, UPV-CSIC, Leioa (ES) for PIP(4)5Kly; Dr. Yasushi Okamura, Osaka University, Suita, Osaka (JP) for Dr. VSP-IRES-GFP cDNA</p><a id="h13" name="h13"></a><h2>Supplementary Material</h2><p class="mb15" id="SM1">The Supplementary Material for this article can be found online at: <a href="https://www.frontiersin.org/articles/10.3389/fphar.2022.872645/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2022.872645/full&#x00023;supplementary-material</a></p><a id="h14" name="h14"></a><h2>References</h2><div class="References"><p class="ReferencesCopy1"><a name="B1" id="B1"></a>Ambrosino, P., Alaimo, A., Bartollino, S., Manocchio, L., De Maria, M., Mosca, I., et al. (2015). Epilepsy-Causing Mutations in Kv7.2 C-Terminus Affect Binding and Functional Modulation by Calmodulin. <em>Biochim. Biophys. Acta</em> 1852 (9), 1856&#x02013;1866. doi:10.1016/j.bbadis.2015.06.012</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/26073431/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.bbadis.2015.06.012">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Epilepsy-Causing+Mutations+in+Kv7.2+C-Terminus+Affect+Binding+and+Functional+Modulation+by+Calmodulin&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B2" id="B2"></a>Ambrosino, P., Freri, E., Castellotti, B., Soldovieri, M. V., Mosca, I., Manocchio, L., et al. (2018). Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP<sub>2</sub>-Dependent K<sup>&#x0002b;</sup> Channel Gating. <em>Mol. Neurobiol.</em> 55 (8), 7009&#x02013;7024. doi:10.1007/s12035-018-0883-5</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/29383681/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s12035-018-0883-5">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Kv7.3+Compound+Heterozygous+Variants+in+Early+Onset+Encephalopathy+Reveal+Additive+Contribution+of+C-Terminal+Residues+to+PIP2-Dependent+K++Channel+Gating&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B3" id="B3"></a>Binda, A., Panariti, A., Barbuti, A., Murano, C., Dal Magro, R., Masserini, M., et al. (2018). Modulation of the Intrinsic Neuronal Excitability by Multifunctional Liposomes Tailored for the Treatment of Alzheimer&#x00027;s Disease. <em>Int. J. Nanomedicine</em> 13, 4059&#x02013;4071. doi:10.2147/IJN.S161563</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30034232/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.2147/IJN.S161563">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modulation+of+the+Intrinsic+Neuronal+Excitability+by+Multifunctional+Liposomes+Tailored+for+the+Treatment+of+Alzheimer's+Disease&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B4" id="B4"></a>Falkenburger, B. H., Jensen, J. B., and Hille, B. (2010). Kinetics of PIP<sub>2</sub> Metabolism and KCNQ2/3 Channel Regulation Studied with a Voltage-Sensitive Phosphatase in Living Cells. <em>J. Gen. Physiol.</em> 135, 99&#x02013;114. doi:10.1085/jgp.200910345</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/20100891/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1085/jgp.200910345">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Kinetics+of+PIP2+Metabolism+and+KCNQ2/3+Channel+Regulation+Studied+with+a+Voltage-Sensitive+Phosphatase+in+Living+Cells&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B5" id="B5"></a>Gamper, N., and Shapiro, M. S. (2003). Calmodulin Mediates Ca2&#x0002b;-Dependent Modulation of M-Type K<sup>&#x0002b;</sup> Channels. <em>J. Gen. Physiol.</em> 122, 17&#x02013;31. doi:10.1085/jgp.200208783</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/12810850/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1085/jgp.200208783">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Calmodulin+Mediates+Ca2+-Dependent+Modulation+of+M-Type+K++Channels&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B6" id="B6"></a>Gamper, N., and Shapiro, M. S. (2007). Regulation of Ion Transport Proteins by Membrane Phosphoinositides. <em>Nat. Rev. Neurosci.</em> 8, 921&#x02013;934. doi:10.1038/nrn2257</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/17971783/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/nrn2257">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Regulation+of+Ion+Transport+Proteins+by+Membrane+Phosphoinositides&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B7" id="B7"></a>Geiser, J. R., van Tuinen, D., Brockerhoff, S. E., Neff, M. M., and Davis, T. N. (1991). Can Calmodulin Function Without Binding Calcium? <em>Cell</em> 65, 949&#x02013;959. doi:10.1016/0092-8674(91)90547-c</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/2044154/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/0092-8674(91)90547-c">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Can+Calmodulin+Function+Without+Binding+Calcium?&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B8" id="B8"></a>Hadley, J. K., Noda, M., Selyanko, A. A., Wood, I. C., Abogadie, F. C., and Brown, D. A. (2000). Differential Tetraethylammonium Sensitivity of KCNQ1-4 Potassium Channels. <em>Br. J. Pharmacol.</em> 129, 413&#x02013;415. doi:10.1038/sj.bjp.0703086</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/10711337/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/sj.bjp.0703086">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Differential+Tetraethylammonium+Sensitivity+of+KCNQ1-4+Potassium+Channels&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B9" id="B9"></a>Hernandez, C. C., Zaika, O., Tolstykh, G. P., and Shapiro, M. S. (2008). Regulation of Neural KCNQ Channels: Signalling Pathways, Structural Motifs and Functional Implications. <em>J. Physiol.</em> 586 (7), 1811&#x02013;1821. doi:10.1113/jphysiol.2007.14830410.1113/jphysiol.2007.148304</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/18238808/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1113/jphysiol.2007.14830410.1113/jphysiol.2007.148304">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Regulation+of+Neural+KCNQ+Channels:+Signalling+Pathways,+Structural+Motifs+and+Functional+Implications&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B10" id="B10"></a>Kosenko, A., Kang, S., Smith, I. M., Greene, D. L., Langeberg, L. K., Scott, J. D., et al. (2012). Coordinated Signal Integration at the M-Type Potassium Channel Upon Muscarinic Stimulation. <em>EMBO J.</em> 31 (14), 3147&#x02013;3156. doi:10.1038/emboj.2012.156</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22643219/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/emboj.2012.156">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Coordinated+Signal+Integration+at+the+M-Type+Potassium+Channel+Upon+Muscarinic+Stimulation&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B11" id="B11"></a>Li, Y., Gamper, N., Hilgemann, D. W., and Shapiro, M. S. (2005). Regulation of Kv7 (KCNQ) K<sup>&#x0002b;</sup> Channel Open Probability by Phosphatidylinositol 4,5-Bisphosphate. <em>J. Neurosci.</em> 25, 9825&#x02013;9835. doi:10.1523/JNEUROSCI.2597-05.2005</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/16251430/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1523/JNEUROSCI.2597-05.2005">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Regulation+of+Kv7+(KCNQ)+K++Channel+Open+Probability+by+Phosphatidylinositol+4,5-Bisphosphate&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B12" id="B12"></a>Manville, R. W., and Abbott, G. W. (2018). Gabapentin is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels. <em>Mol. Pharmacol.</em> 94 (4), 1155&#x02013;1163. doi:10.1124/mol.118.112953</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/30021858/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1124/mol.118.112953">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Gabapentin+is+a+Potent+Activator+of+KCNQ3+and+KCNQ5+Potassium+Channels&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B13" id="B13"></a>Marrion, N. V. (1997). Control of M-Current. <em>Annu. Rev. Physiol.</em> 59, 483&#x02013;504. doi:10.1146/annurev.physiol.59.1.483</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/9074774/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1146/annurev.physiol.59.1.483">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Control+of+M-Current&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B14" id="B14"></a>Miceli, F., Soldovieri, M. V., Ambrosino, P., Barrese, V., Migliore, M., Cilio, M. R., et al. (2013). Genotype-Phenotype Correlations in Neonatal Epilepsies Caused by Mutations in the Voltage Sensor of K(v)7.2 Potassium Channel Subunits. <em>Proc. Natl. Acad. Sci. U. S. A.</em> 110 (11), 4386&#x02013;4391. doi:10.1073/pnas.1216867110</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23440208/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1073/pnas.1216867110">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genotype-Phenotype+Correlations+in+Neonatal+Epilepsies+Caused+by+Mutations+in+the+Voltage+Sensor+of+K(v)7.2+Potassium+Channel+Subunits&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B15" id="B15"></a>Miceli, F., Soldovieri, M. V., Ambrosino, P., De Maria, M., Migliore, M., Migliore, R., et al. (2015). Early-Onset Epileptic Encephalopathy Caused by Gain-Of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. <em>J. Neurosci.</em> 35 (9), 3782&#x02013;3793. doi:10.1523/JNEUROSCI.4423-14.2015</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/25740509/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1523/JNEUROSCI.4423-14.2015">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Early-Onset+Epileptic+Encephalopathy+Caused+by+Gain-Of-Function+Mutations+in+the+Voltage+Sensor+of+Kv7.2+and+Kv7.3+Potassium+Channel+Subunits&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B16" id="B16"></a>Miceli, F., Vargas, E., Bezanilla, F., and Taglialatela, M. (2012). Gating Currents From Kv7 Channels Carrying Neuronal Hyperexcitability Mutations in the Voltage-Sensing Domain. <em>Biophys. J.</em> 102 (6), 1372&#x02013;1382. doi:10.1016/j.bpj.2012.02.004</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22455920/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.bpj.2012.02.004">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Gating+Currents+From+Kv7+Channels+Carrying+Neuronal+Hyperexcitability+Mutations+in+the+Voltage-Sensing+Domain&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B17" id="B17"></a>Millichap, J. J., Miceli, F., De Maria, M., Keator, C., Joshi, N., Tran, B., et al. (2017). Infantile Spasms and Encephalopathy Without Preceding Neonatal Seizures Caused by KCNQ2 R198Q, a Gain-Of-Function Variant. <em>Epilepsia</em> 58 (1), e10&#x02013;e15. doi:10.1111/epi.13601</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27861786/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1111/epi.13601">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Infantile+Spasms+and+Encephalopathy+Without+Preceding+Neonatal+Seizures+Caused+by+KCNQ2+R198Q,+a+Gain-Of-Function+Variant&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B18" id="B18"></a>Millichap, J. J., Park, K. L., Tsuchida, T., Ben-Zeev, B., Carmant, L., Flamini, R., et al. (2016). KCNQ2 Encephalopathy: Features, Mutational Hot Spots, and Ezogabine Treatment of 11 Patients. <em>Neurol. Genet.</em> 2 (5), e96. doi:10.1212/NXG.0000000000000096</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27602407/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1212/NXG.0000000000000096">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=KCNQ2+Encephalopathy:+Features,+Mutational+Hot+Spots,+and+Ezogabine+Treatment+of+11+Patients&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B19" id="B19"></a>Orhan, G., Bock, M., Schepers, D., Ilina, E. I., Reichel, S. N., L&#x000f6;ffler, H., et al. (2014). Dominant-Negative Effects of KCNQ2 Mutations are Associated with Epileptic Encephalopathy. <em>Ann. Neurol.</em> 75, 382&#x02013;394. doi:10.1002/ana.24080</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24318194/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/ana.24080">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Dominant-Negative+Effects+of+KCNQ2+Mutations+are+Associated+with+Epileptic+Encephalopathy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B20" id="B20"></a>Schwake, M., Pusch, M., Kharkovets, T., and Jentsch, T. J. (2000). Surface Expression and Single Channel Properties of KCNQ2/KCNQ3, M-Type K<sup>&#x0002b;</sup> Channels Involved in Epilepsy. <em>J. Biol. Chem.</em> 275 (18), 13343&#x02013;13348. doi:10.1074/jbc.275.18.13343</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/10788442/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1074/jbc.275.18.13343">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Surface+Expression+and+Single+Channel+Properties+of+KCNQ2/KCNQ3,+M-Type+K++Channels+Involved+in+Epilepsy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B21" id="B21"></a>Selyanko, A. A., Hadley, J. K., Wood, I. C., Abogadie, F. C., Jentsch, T. J., and Brown, D. A. (2000). Inhibition of KCNQ1-4 Potassium Channels Expressed in Mammalian Cells via M1 Muscarinic Acetylcholine Receptors. <em>J. Physiol.</em> 522 (Pt 3), 349&#x02013;355. doi:10.1111/j.1469-7793.2000.t01-2-00349.x</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/10713961/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1111/j.1469-7793.2000.t01-2-00349.x">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Inhibition+of+KCNQ1-4+Potassium+Channels+Expressed+in+Mammalian+Cells+via+M1+Muscarinic+Acetylcholine+Receptors&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B22" id="B22"></a>Soldovieri, M. V., Ambrosino, P., Mosca, I., De Maria, M., Moretto, E., Miceli, F., et al. (2016). Early-Onset Epileptic Encephalopathy Caused by a Reduced Sensitivity of Kv7.2 Potassium Channels to Phosphatidylinositol 4,5-Bisphosphate. <em>Sci. Rep.</em> 6, 38167. doi:10.1038/srep38167</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/27905566/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1038/srep38167">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Early-Onset+Epileptic+Encephalopathy+Caused+by+a+Reduced+Sensitivity+of+Kv7.2+Potassium+Channels+to+Phosphatidylinositol+4,5-Bisphosphate&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B23" id="B23"></a>Soldovieri, M. V., Boutry-Kryza, N., Milh, M., Doummar, D., Heron, B., Bourel, E., et al. (2014). Novel KCNQ2 and KCNQ3 Mutations in a Large Cohort of Families with Benign Neonatal Epilepsy: First Evidence for an Altered Channel Regulation by Syntaxin-1A. <em>Hum. Mutat.</em> 35, 356&#x02013;367. doi:10.1002/humu.22500</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24375629/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/humu.22500">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Novel+KCNQ2+and+KCNQ3+Mutations+in+a+Large+Cohort+of+Families+with+Benign+Neonatal+Epilepsy:+First+Evidence+for+an+Altered+Channel+Regulation+by+Syntaxin-1A&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B24" id="B24"></a>Soldovieri, M. V., Castaldo, P., Iodice, L., Miceli, F., Barrese, V., Bellini, G., et al. (2006). Decreased Subunit Stability as a Novel Mechanism for Potassium Current Impairment by a KCNQ2 C Terminus Mutation Causing Benign Familial Neonatal Convulsions. <em>J. Biol. Chem.</em> 281 (1), 418&#x02013;428. doi:10.1074/jbc.M510980200</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/16260777/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1074/jbc.M510980200">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Decreased+Subunit+Stability+as+a+Novel+Mechanism+for+Potassium+Current+Impairment+by+a+KCNQ2+C+Terminus+Mutation+Causing+Benign+Familial+Neonatal+Convulsions&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B25" id="B25"></a>Soldovieri, M. V., Freri, E., Ambrosino, P., Rivolta, I., Mosca, I., Binda, A., et al. (2020). Gabapentin Treatment in a Patient with KCNQ2 Developmental Epileptic Encephalopathy. <em>Pharmacol. Res.</em> 160, 105200. doi:10.1016/j.phrs.2020.105200</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/32942014/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/j.phrs.2020.105200">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Gabapentin+Treatment+in+a+Patient+with+KCNQ2+Developmental+Epileptic+Encephalopathy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B26" id="B26"></a>Soldovieri, M. V., Miceli, F., and Taglialatela, M. (2011). Driving with No Brakes: Molecular Pathophysiology of Kv7 Potassium Channels. <em>Physiology (Bethesda)</em> 26 (5), 365&#x02013;376. doi:10.1152/physiol.00009.2011</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22013194/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1152/physiol.00009.2011">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Driving+with+No+Brakes:+Molecular+Pathophysiology+of+Kv7+Potassium+Channels&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B27" id="B27"></a>Telezhkin, V., Thomas, A. M., Harmer, S. C., Tinker, A., and Brown, D. A. (2013). A Basic Residue in the Proximal C-Terminus Is Necessary for Efficient Activation of the M-Channel Subunit Kv7.2 by PI(4,5)P&#x02082;. <em>Pflugers Arch.</em> 465 (7), 945&#x02013;953. doi:10.1007/s00424-012-1199-3</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/23291709/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1007/s00424-012-1199-3">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+Basic+Residue+in+the+Proximal+C-Terminus+Is+Necessary+for+Efficient+Activation+of+the+M-Channel+Subunit+Kv7.2+by+PI(4,5)PÃ¢Â‚Â‚&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B28" id="B28"></a>Wang, H. S., Pan, Z., Shi, W., Brown, B. S., Wymore, R. S., Cohen, I. S., et al. (1998). KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel. <em>Science</em> 282 (5395), 1890&#x02013;1893. doi:10.1126/science.282.5395.1890</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/9836639/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1126/science.282.5395.1890">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=KCNQ2+and+KCNQ3+Potassium+Channel+Subunits:+Molecular+Correlates+of+the+M-Channel&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B29" id="B29"></a>Weckhuysen, S., Ivanovic, V., Hendrickx, R., Van Coster, R., Hjalgrim, H., M&#x000f8;ller, R. S., et al. (2013). Extending the KCNQ2 Encephalopathy Spectrum: Clinical and Neuroimaging Findings in 17 Patients. <em>Neurology</em> 81 (19), 1697&#x02013;1703. doi:10.1212/01.wnl.0000435296.72400.a1</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24107868/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1212/01.wnl.0000435296.72400.a1">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Extending+the+KCNQ2+Encephalopathy+Spectrum:+Clinical+and+Neuroimaging+Findings+in+17+Patients&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B30" id="B30"></a>Weckhuysen, S., Mandelstam, S., Suls, A., Audenaert, D., Deconinck, T., Claes, L. R., et al. (2012). KCNQ2 Encephalopathy: Emerging Phenotype of a Neonatal Epileptic Encephalopathy. <em>Ann. Neurol.</em> 71 (1), 15&#x02013;25. doi:10.1002/ana.22644</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/22275249/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1002/ana.22644">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=KCNQ2+Encephalopathy:+Emerging+Phenotype+of+a+Neonatal+Epileptic+Encephalopathy&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B31" id="B31"></a>Wenk, M. R., Pellegrini, L., Klenchin, V. A., Di Paolo, G., Chang, S., Daniell, L., et al. (2001). PIP Kinase Igamma is the Major PI(4,5)P(2) Synthesizing Enzyme at the Synapse. <em>Neuron</em> 32, 79&#x02013;88. doi:10.1016/s0896-6273(01)00456-1</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/11604140/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/s0896-6273(01)00456-1">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=PIP+Kinase+Igamma+is+the+Major+PI(4,5)P(2)+Synthesizing+Enzyme+at+the+Synapse&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B32" id="B32"></a>Winks, J. S., Hughes, S., Filippov, A. K., Tatulian, L., Abogadie, F. C., Brown, D. A., et al. (2005). Relationship Between Membrane Phosphatidylinositol-4,5-Bisphosphate and Receptor-Mediated Inhibition of Native Neuronal M Channels. <em>J. Neurosci.</em> 25, 3400&#x02013;3413. doi:10.1523/JNEUROSCI.3231-04.2005</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/15800195/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1523/JNEUROSCI.3231-04.2005">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Relationship+Between+Membrane+Phosphatidylinositol-4,5-Bisphosphate+and+Receptor-Mediated+Inhibition+of+Native+Neuronal+M+Channels&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B33" id="B33"></a>Yus-Najera, E., Santana-Castro, I., and Villarroel, A. (2002). The Identification and Characterization of a Noncontinuous Calmodulin-Binding Site in Noninactivating Voltage-Dependent KCNQ Potassium Channels. <em>J. Biol. Chem.</em> 277 (32), 28545&#x02013;28553. doi:10.1074/jbc.M204130200</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/12032157/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1074/jbc.M204130200">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Identification+and+Characterization+of+a+Noncontinuous+Calmodulin-Binding+Site+in+Noninactivating+Voltage-Dependent+KCNQ+Potassium+Channels&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B34" id="B34"></a>Zhang, H., Craciun, L. C., Mirshahi, T., Roh&#x000e1;cs, T., Lopes, C. M., Jin, T., et al. (2003). PIP(2) Activates KCNQ Channels, and its Hydrolysis Underlies Receptor-Mediated Inhibition of M Currents. <em>Neuron</em> 37 (6), 963&#x02013;975. doi:10.1016/s0896-6273(03)00125-9</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/12670425/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1016/s0896-6273(03)00125-9">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=PIP(2)+Activates+KCNQ+Channels,+and+its+Hydrolysis+Underlies+Receptor-Mediated+Inhibition+of+M+Currents&amp;btnG=">Google Scholar</a></p></div><div class="References"><p class="ReferencesCopy1"><a name="B35" id="B35"></a>Zhang, Q., Zhou, P., Chen, Z., Li, M., Jiang, H., Gao, Z., et al. (2013). Dynamic PIP<sub>2</sub> Interactions with Voltage Sensor Elements Contribute to KCNQ2 Channel Gating. <em>Proc. Natl. Acad. Sci. U. S. A.</em> 110 (50), 20093&#x02013;20098. doi:10.1073/pnas.1312483110</p><p class="ReferencesCopy2"><a href="https://pubmed.ncbi.nlm.nih.gov/24277843/">PubMed Abstract</a> &#x0007c; <a href="https://doi.org/10.1073/pnas.1312483110">CrossRef Full Text</a> &#x0007c; <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Dynamic+PIP2+Interactions+with+Voltage+Sensor+Elements+Contribute+to+KCNQ2+Channel+Gating&amp;btnG=">Google Scholar</a></p></div></div><div class="thinLineM20"></div><div class="AbstractSummary"><p><span>Keywords:</span> alternative splicing, Kv7.2 subunits, epileptic encephalopathy, PIP<sub>2</sub>, calmodulin, KCNQ2</p><p><span>Citation:</span> Mosca I, Rivolta I, Labalme A, Ambrosino P, Castellotti B, Gellera C, Granata T, Freri E, Binda A, Lesca G, DiFrancesco JC, Soldovieri MV and Taglialatela M (2022) Functional Characterization of Two Variants at the Intron 6&#x02014;Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes. <em>Front. Pharmacol.</em> 13:872645. doi: 10.3389/fphar.2022.872645</p><p id="timestamps"><span>Received:</span> 09 February 2022; <span>Accepted:</span> 10 May 2022;<br><span>Published:</span> 13 June 2022.</p><div><p>Edited by:</p> <a href="https://loop.frontiersin.org/people/945653/overview">Tarek Mohamed Abd El-Aziz</a>, The University of Texas Health Science Center at San Antonio, United States</div><div><p>Reviewed by:</p> <a href="https://loop.frontiersin.org/people/808359/overview">Marina Trivisano</a>, Bambino Ges&#x000f9; Children&#x02019;s Hospital (IRCCS), Italy<br><a href="https://loop.frontiersin.org/people/639939/overview">Peter Sparber</a>, Federal State Budgetary Scientific Institution Research Centre for Medical Genetics (RCMG), Russia</div><p><span>Copyright</span> &#x000a9; 2022 Mosca, Rivolta, Labalme, Ambrosino, Castellotti, Gellera, Granata, Freri, Binda, Lesca, DiFrancesco, Soldovieri and Taglialatela. This is an open-access article distributed under the terms of the <a rel="license" href="http://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons Attribution License (CC BY).</a> The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p><p><span>&#x0002a;Correspondence:</span> Maria Virginia Soldovieri, <a id="encmail">bWFyaWF2aXJnaW5pYS5zb2xkb3ZpZXJpQHVuaW1vbC5pdA==</a>; Maurizio Taglialatela, <a id="encmail">bXRhZ2xpYWxAdW5pbmEuaXQ=</a></p><p><span><sup>&#x02020;</sup></span>These authors share first authorship</p><div class="clear"></div></div></div></div><p class="AbstractSummary__disclaimer"><span>Disclaimer: </span> All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. </p></div></div><!----></main><aside class="Layout__aside"><div class="ArticleDetails__wrapper"><div class="ArticleDetails__aside"><div class="ArticleDetails__aside__responsiveButtons"><div class="ActionsDropDown" id="FloatingButtonsEl"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--icon ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fphar.2022.872645" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="ArticleDetails__aside__responsiveButtons__items"><span></span><div class="ArticleDetailsShare__responsive"><button class="ArticleDetailsShare__trigger" aria-label="Open share options"></button><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div></div><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeIconButton ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><!----></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Export citation</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div></div></div><div class="TotalViews"><div class="TotalViews__data"><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">2,1K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Total views</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">1,1K</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Downloads</div></div></div><div class="TotalViews__data__metrics"><div class="TotalViews__data__metrics__number">5</div><div class="TotalViews__data__metrics__text"><div class="TotalViews__data__metrics__label">Citations</div></div></div><div class="ImpactMetricsInfoPopover"><button aria-label="Open impact metrics info" class="ImpactMetricsInfoPopover__button"></button><div class="ImpactMetricsInfoPopover__tooltip"><button aria-label="Close impact metrics info" class="ImpactMetricsInfoPopover__tooltip__closeButton"></button><div class="ImpactMetricsInfoPopover__tooltip__text"> Citation numbers are available from Dimensions </div></div></div></div><div class="TotalViews__viewImpactLink"><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View article impact" href="http://loop-impact.frontiersin.org/impact/article/872645#totalviews/views" target="_blank" data-event="customLink-link-a_viewArticleImpact"><span>View article impact</span></a></span></div><div class="TotalViews__altmetric"><div data-badge-popover="bottom" data-badge-type="donut" data-doi="10.3389/fphar.2022.872645" data-condensed="true" data-link-target="new" class="altmetric-embed"></div><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--medium Link--icon Link--chevronRight Link--right" aria-label="View altmetric score" href="https://www.altmetric.com/details/doi/10.3389/fphar.2022.872645" target="_blank" data-event="customLink-link-a_viewAltmetricScore"><span>View altmetric score</span></a></span></div></div><div class="ArticleDetailsShare"><p class="ArticleDetailsShare__title">Share on</p><ul class="ArticleDetailsShare__list"><!--[--><li class="ArticleDetailsShare__item"><a href="https://www.twitter.com/share?url=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full" target="_blank" class="ArticleDetailsShare__link--x ArticleDetailsShare__link" title="Share on X" aria-label="Share on X"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.linkedin.com/share?url=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full" target="_blank" class="ArticleDetailsShare__link--linkedin ArticleDetailsShare__link" title="Share on Linkedin" aria-label="Share on Linkedin"></a></li><li class="ArticleDetailsShare__item"><a href="https://www.facebook.com/sharer/sharer.php?u=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full" target="_blank" class="ArticleDetailsShare__link--facebook ArticleDetailsShare__link" title="Share on Facebook" aria-label="Share on Facebook"></a></li><!--]--></ul></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Edited by</div><!--[--><a href="https://loop.frontiersin.org/people/945653/overview" data-event="editorInfo-a-tarekMohamedAbdElAziz" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">T</span><span class="notranslate">M</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Tarek  Mohamed Abd El-Aziz</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">The University of Texas Health Science Center at San Antonio, United States</div></div></a><!--]--></div></div><div class="ArticleDetailsEditors"><div class="ArticleDetailsEditors__editors"><div class="ArticleDetailsEditors__title">Reviewed by</div><!--[--><a href="https://loop.frontiersin.org/people/808359/overview" data-event="editorInfo-a-marinaTrivisano" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">M</span><span class="notranslate">T</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Marina  Trivisano</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Bambino GesÃ¹ Children&#39;s Hospital (IRCCS), Italy</div></div></a><a href="https://loop.frontiersin.org/people/639939/overview" data-event="editorInfo-a-peterSparber" class="ArticleDetailsEditors__ediorInfo"><div class="Avatar Avatar--size-32 Avatar--text Avatar--grey"><!--[--><span class="notranslate">P</span><span class="notranslate">S</span><!--]--></div><div class="ArticleDetailsEditors__ediorInfo__info"><div class="ArticleDetailsEditors__ediorInfo__name notranslate">Peter  Sparber</div><div class="ArticleDetailsEditors__ediorInfo__affiliation notranslate">Research Centre for Medical Genetics, Russia</div></div></a><!--]--></div></div><div class="ArticleDetailsGlossary ArticleDetailsGlossary--open"><button class="ArticleDetailsGlossary__header"><div class="ArticleDetailsGlossary__header__title">Table of contents</div><div class="ArticleDetailsGlossary__header__arrow"></div></button><div class="ArticleDetailsGlossary__content"><ul class="flyoutJournal"><li><a href="#h1">Abstract</a></li><li><a href="#h2">Introduction</a></li><li><a href="#h3">Materials and Methods</a></li><li><a href="#h4">Results</a></li><li><a href="#h5">Discussion</a></li><li><a href="#h6">Data Availability Statement</a></li><li><a href="#h7">Ethics Statement</a></li><li><a href="#h8">Author Contributions</a></li><li><a href="#h9">Funding</a></li><li><a href="#h10">Conflict of Interest</a></li><li><a href="#h11">Publisher&#x02019;s Note</a></li><li><a href="#h12">Acknowledgments</a></li><li><a href="#h13">Supplementary Material</a></li><li><a href="#h14">References</a></li></ul></div></div><span></span><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--typeOutline ActionsDropDown__button--iconQuote ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Export citation</span></button><div class="ActionsDropDown__menuWrapper"><!----><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/endNote" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-endNote">EndNote</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/reference" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-referenceManager">Reference Manager</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/text" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-simpleTextFile">Simple Text file</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/bibTex" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-bibTex">BibTex</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><div class="CheckForUpdates"><button data-target="crossmark" class="CheckForUpdates__link" data-event="checkForUpdates-btn-openModal"><img class="CheckForUpdates__link__img" src="/ap-2024/images/crossmark.svg" alt="Crossmark icon"><div class="CheckForUpdates__link__text">Check for updates</div></button></div><div class="AnnouncementCard"><p class="AnnouncementCard__title">Frontiers&#39; impact</p><article class="CardA"><div class="CardA__wrapper CardA__wrapper--vertical"><figure class="FrontiersImage CardA__img"><picture class="FrontiersImage"><!--[--><source srcset="https://images-provider.frontiersin.org/api/ipx/w=440&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 563px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=320x400&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1024px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=268x280&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media="(max-width: 1441px)"><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=webp/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><source srcset="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" media><!--]--><img src="https://images-provider.frontiersin.org/api/ipx/s=366x408&amp;fit=outside&amp;f=jpg/https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png" class="is-inside-mask" alt loading="eager"></picture><!----></figure><div class="CardA__info"><!--[--><h2 class="CardA__title">Articles published with Frontiers have received 12 million total citations</h2><p class="CardA__text">Your research is the real superpower - learn how we maximise its impact through our leading community journals</p><br><span class="Link__wrapper"><a class="Link Link--linkType Link--maincolor Link--small Link--icon Link--chevronRight Link--right" aria-label="Explore our impact metrics" href="https://www.frontiersin.org/about/impact" target="_self" data-event="customLink-linkType-a_exploreOurImpactMe"><span>Explore our impact metrics</span></a></span><!--]--></div></div></article></div><!----><!----></div><div><div class="Modal Modal--noFooter"><button aria-label="Close modal" class="Modal__overlay" data-event="modal-overlay-close"></button><div class="Modal__container"><div class="Modal__header"><p class="Modal__title">Supplementary Material</p><button aria-label="Close modal" class="Modal__close" data-event="modal-button-close"></button></div><div class="Modal__body"><!--[--><div class="SupplementalData"><ul class="SupplementalData__list"><!--[--><!--]--></ul></div><!--]--><!----></div><!----><!----></div></div></div><div><div class="FloatingButtons"><!----><div class="ActionsDropDown"><button aria-label="Open dropdown" class="ActionsDropDown__button--type ActionsDropDown__button--iconDownload ActionsDropDown__button--color ActionsDropDown__button" data-event="actionsDropDown-button-toggle"><span class="ActionsDropDown__button__label">Download article</span></button><div class="ActionsDropDown__menuWrapper"><div class="ActionsDropDown__mobileTitle">Download</div><ul class="ActionsDropDown__menu"><!--[--><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/pdf" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-pdf">Download PDF</a></li><li><a href="http://www.readcube.com/articles/10.3389/fphar.2022.872645" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-readCube">ReadCube</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/epub" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-epub">EPUB</a></li><li><a href="https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/xml" target="_blank" rel="noopener noreferrer" class="ActionsDropDown__option" data-event="actionsDropDown-a-nlmXml">XML</a></li><!--]--></ul><button class="ActionsDropDown__mobileClose" aria-label="Close modal" data-event="actionsDropDown-button-close"></button></div></div><!----></div></div></div></aside></div><div class=""><!----></div><!--]--></div><!----><footer class="Footer"><div class="Footer__wrapper"><div class="Footer__sections"><ul class="Accordion"><!--[--><!--[--><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Guidelines</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/guidelines/author-guidelines" target="_self" data-event="footer-block_0-a_authorGuidelines">Author guidelines</a></li><li><a href="https://www.frontiersin.org/for-authors/author-services" target="_self" data-event="footer-block_0-a_servicesForAuthors">Services for authors</a></li><li><a href="https://www.frontiersin.org/guidelines/policies-and-publication-ethics" target="_self" data-event="footer-block_0-a_policiesAndPublicationE">Policies and publication ethics</a></li><li><a href="https://www.frontiersin.org/guidelines/editor-guidelines" target="_self" data-event="footer-block_0-a_editorGuidelines">Editor guidelines</a></li><li><a href="https://www.frontiersin.org/about/fee-policy" target="_self" data-event="footer-block_0-a_feePolicy">Fee policy</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Explore</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://www.frontiersin.org/articles" target="_self" data-event="footer-block_1-a_articles">Articles</a></li><li><a href="https://www.frontiersin.org/research-topics" target="_self" data-event="footer-block_1-a_researchTopics">Research Topics </a></li><li><a href="https://www.frontiersin.org/journals" target="_self" data-event="footer-block_1-a_journals">Journals</a></li><li><a href="https://www.frontiersin.org/about/how-we-publish" target="_self" data-event="footer-block_1-a_howWePublish">How we publish</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Outreach</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://forum.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForum">Frontiers Forum </a></li><li><a href="https://policylabs.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersPolicyLabs">Frontiers Policy Labs </a></li><li><a href="https://kids.frontiersin.org/" target="_blank" data-event="footer-block_2-a_frontiersForYoungMinds">Frontiers for Young Minds</a></li><li><a href="https://www.frontiersin.org/about/frontiers-planet-prize" target="_self" data-event="footer-block_2-a_frontiersPlanetPrize">Frontiers Planet Prize</a></li><!--]--></ul><!--]--></div></li><li class="Accordion__item"><button class="Accordion__headline"><!----><!--[--><div class="Accordion__title">Connect</div><div class="Accordion__space"></div><!--]--><div class="Accordion__arrow"></div></button><div class="Accordion__content Accordion__content--fadeOut" style="height:0px;"><!--[--><ul><!--[--><li><a href="https://helpcenter.frontiersin.org" target="_blank" data-event="footer-block_3-a_helpCenter">Help center</a></li><li><a href="https://subscription-management.frontiersin.org/emails/preferences#block0" target="_blank" data-event="footer-block_3-a_emailsAndAlerts">Emails and alerts </a></li><li><a href="https://www.frontiersin.org/about/contact" target="_self" data-event="footer-block_3-a_contactUs">Contact us </a></li><li><a href="https://www.frontiersin.org/submission/submit" target="_self" data-event="footer-block_3-a_submit">Submit</a></li><li><a href="https://careers.frontiersin.org/" target="_blank" data-event="footer-block_3-a_careerOpportunities">Career opportunities</a></li><!--]--></ul><!--]--></div></li><!--]--><!--]--></ul><div class="Footer__socialLinks"><div class="Footer__socialLinks__title">Follow us</div><!--[--><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--facebook Link--right" aria-label="Frontiers Facebook" href="https://www.facebook.com/Frontiersin" target="_blank" data-event="footer-facebook-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--twitter Link--right" aria-label="Frontiers Twitter" href="https://twitter.com/frontiersin" target="_blank" data-event="footer-twitter-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--linkedin Link--right" aria-label="Frontiers LinkedIn" href="https://www.linkedin.com/company/frontiers" target="_blank" data-event="footer-linkedIn-a_true"><span></span></a></span><span class="Link__wrapper"><a class="Link Link--linkType Link--grey Link--medium Link--icon Link--instagram Link--right" aria-label="Frontiers Instagram" href="https://www.instagram.com/frontiersin_" target="_blank" data-event="footer-instagram-a_true"><span></span></a></span><!--]--></div></div><div class="Footer__copyright"><div><span>Â© 2025 Frontiers Media SA. All rights reserved.</span></div><div><a href="https://www.frontiersin.org/legal/privacy-policy" target="_blank">Privacy policy</a><span>Â |Â </span><a href="https://www.frontiersin.org/legal/terms-and-conditions" target="_blank">Terms and conditions</a></div></div></div></footer><div class="SnackbarWrapper"><div class="SnackbarManager"><!--[--><!--]--></div></div></div><noscript><iframe
            src="https://tag-manager.frontiersin.org/ns.html?id=GTM-M322FV2&gtm_auth=owVbWxfaJr21yQv1fe1cAQ&gtm_preview=env-1&gtm_cookies_win=x"
            height="0"
            width="0"
            style="display: none; visibility: hidden">
          </iframe></noscript><!--]--></div><div id="teleports"></div><script type="application/json" id="__NUXT_DATA__" data-ssr="true">[["ShallowReactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverRendered":13,"path":14,"pinia":15},["ShallowReactive",3],{},["Reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","Frontiers articles","https://article-pages-2024.frontiersin.org/",["Set"],["ShallowReactive",12],{},true,"/journals/pharmacology/articles/10.3389/fphar.2022.872645/full",["Reactive",16],{"main":17,"user":511,"article":512,"articleHub":878,"mainHeader":882},{"ibar":18,"footer":264,"newsletterComponent":-1,"snackbarItem":346,"toggleShowSnackbar":347,"contentfulJournal":348,"graphJournal":412,"settingsFeaturesSwitchers":416,"templateToggleBanner":417,"tenantConfig":476},{"tenantLogo":19,"journalLogo":19,"aboutUs":20,"submitUrl":113,"showSubmitButton":13,"journal":114,"sectionTerm":195,"aboutJournal":196,"mainLinks":245,"journalLinks":252,"helpCenterLink":261},"",[21,38,47,71,87],{"title":22,"links":23},"Who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"ariaLabel":28},"Mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"ariaLabel":28},"History","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"ariaLabel":28},"Leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"ariaLabel":28},"Awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"Impact and progress",[41,44],{"text":42,"url":43,"target":27,"ariaLabel":28},"Frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"ariaLabel":28},"Our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"Publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"ariaLabel":28},"How we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"ariaLabel":28},"Open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"ariaLabel":28},"Peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"ariaLabel":28},"Research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"ariaLabel":28},"Research Topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"ariaLabel":28},"FAIRÂ² Data Management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"ariaLabel":28},"Fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"Services",[74,78,81,84],{"text":75,"url":76,"target":77,"ariaLabel":28},"Societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"ariaLabel":28},"National consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"ariaLabel":28},"Institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"ariaLabel":28},"Collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"More from Frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"ariaLabel":93},"Frontiers Forum","https://forum.frontiersin.org/","this link will take you to the Frontiers Forum website",{"text":95,"url":96,"target":27,"ariaLabel":28},"Frontiers Planet Prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"ariaLabel":100},"Press office","https://pressoffice.frontiersin.org/","this link will take you to the Frontiers press office website",{"text":102,"url":103,"target":27,"ariaLabel":104},"Sustainability","https://www.frontiersin.org/about/sustainability","link to information about Frontiers' sustainability",{"text":106,"url":107,"target":77,"ariaLabel":108},"Career opportunities","https://careers.frontiersin.org/","this link will take you to the Frontiers careers website",{"text":110,"url":111,"target":27,"ariaLabel":112},"Contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=1&fieldid=62&specialtyid=0&entitytype=2&entityid=176",{"id":115,"name":116,"slug":117,"sections":118},176,"Frontiers in Pharmacology","pharmacology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191],{"id":120,"name":121,"slug":122},182,"Cardiovascular and Smooth Muscle Pharmacology","cardiovascular-and-smooth-muscle-pharmacology",{"id":124,"name":125,"slug":126},199,"Drug Metabolism and Transport","drug-metabolism-and-transport",{"id":128,"name":129,"slug":130},202,"Drugs Outcomes Research and Policies","drugs-outcomes-research-and-policies",{"id":132,"name":133,"slug":134},184,"Ethnopharmacology","ethnopharmacology",{"id":136,"name":137,"slug":138},183,"Experimental Pharmacology and Drug Discovery","experimental-pharmacology-and-drug-discovery",{"id":140,"name":141,"slug":142},186,"Gastrointestinal and Hepatic Pharmacology","gastrointestinal-and-hepatic-pharmacology",{"id":144,"name":145,"slug":146},188,"Inflammation Pharmacology","inflammation-pharmacology",{"id":148,"name":149,"slug":150},178,"Integrative and Regenerative Pharmacology","integrative-and-regenerative-pharmacology",{"id":152,"name":153,"slug":154},26,"Neuropharmacology","neuropharmacology",{"id":156,"name":157,"slug":158},196,"Obstetric and Pediatric Pharmacology","obstetric-and-pediatric-pharmacology",{"id":160,"name":161,"slug":162},2186,"Pharmacoepidemiology","pharmacoepidemiology",{"id":164,"name":165,"slug":166},198,"Pharmacogenetics and Pharmacogenomics","pharmacogenetics-and-pharmacogenomics",{"id":168,"name":169,"slug":170},192,"Pharmacology of Anti-Cancer Drugs","pharmacology-of-anti-cancer-drugs",{"id":172,"name":173,"slug":174},2216,"Pharmacology of Infectious Diseases","pharmacology-of-infectious-diseases",{"id":176,"name":177,"slug":178},179,"Pharmacology of Ion Channels and Channelopathies","pharmacology-of-ion-channels-and-channelopathies",{"id":180,"name":181,"slug":182},195,"Predictive Toxicology","predictive-toxicology",{"id":184,"name":185,"slug":186},1357,"Renal Pharmacology","renal-pharmacology",{"id":188,"name":189,"slug":190},190,"Respiratory Pharmacology","respiratory-pharmacology",{"id":192,"name":193,"slug":194},1251,"Translational Pharmacology","translational-pharmacology","Sections",[197,221],{"title":198,"links":199},"Scope",[200,203,206,209,212,215,218],{"text":201,"url":202,"target":27,"ariaLabel":28},"Field chief editors","https://www.frontiersin.org/journals/pharmacology/about#about-editors",{"text":204,"url":205,"target":27,"ariaLabel":28},"Mission & scope","https://www.frontiersin.org/journals/pharmacology/about#about-scope",{"text":207,"url":208,"target":27,"ariaLabel":28},"Facts","https://www.frontiersin.org/journals/pharmacology/about#about-facts",{"text":210,"url":211,"target":27,"ariaLabel":28},"Journal sections","https://www.frontiersin.org/journals/pharmacology/about#about-submission",{"text":213,"url":214,"target":27,"ariaLabel":28},"Open access statement","https://www.frontiersin.org/journals/pharmacology/about#about-open",{"text":216,"url":217,"target":27,"ariaLabel":28},"Copyright statement","https://www.frontiersin.org/journals/pharmacology/about#copyright-statement",{"text":219,"url":220,"target":27,"ariaLabel":28},"Quality","https://www.frontiersin.org/journals/pharmacology/about#about-quality",{"title":222,"links":223},"For authors",[224,227,230,233,236,239,242],{"text":225,"url":226,"target":27,"ariaLabel":28},"Why submit?","https://www.frontiersin.org/journals/pharmacology/for-authors/why-submit",{"text":228,"url":229,"target":27,"ariaLabel":28},"Article types","https://www.frontiersin.org/journals/pharmacology/for-authors/article-types",{"text":231,"url":232,"target":27,"ariaLabel":28},"Author guidelines","https://www.frontiersin.org/journals/pharmacology/for-authors/author-guidelines",{"text":234,"url":235,"target":27,"ariaLabel":28},"Editor guidelines","https://www.frontiersin.org/journals/pharmacology/for-authors/editor-guidelines",{"text":237,"url":238,"target":27,"ariaLabel":28},"Publishing fees","https://www.frontiersin.org/journals/pharmacology/for-authors/publishing-fees",{"text":240,"url":241,"target":27,"ariaLabel":28},"Submission checklist","https://www.frontiersin.org/journals/pharmacology/for-authors/submission-checklist",{"text":243,"url":244,"target":27,"ariaLabel":28},"Contact editorial office","https://www.frontiersin.org/journals/pharmacology/for-authors/contact-editorial-office",[246,249],{"text":247,"url":248,"target":27,"ariaLabel":28},"All journals","https://www.frontiersin.org/journals",{"text":250,"url":251,"target":27,"ariaLabel":28},"All articles","https://www.frontiersin.org/articles",[253,256,258],{"text":254,"url":255,"target":27,"ariaLabel":28},"Articles","articles",{"text":63,"url":257,"target":27,"ariaLabel":28},"research-topics",{"text":259,"url":260,"target":27,"ariaLabel":28},"Editorial board","editors",{"text":262,"url":263,"target":77,"ariaLabel":262},"Help center","https://helpcenter.frontiersin.org",{"blocks":265,"socialLinks":319,"copyright":343,"termsAndConditionsUrl":344,"privacyPolicyUrl":345},[266,280,290,304],{"title":267,"links":268},"Guidelines",[269,271,274,277,279],{"text":231,"url":270,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":272,"url":273,"target":27,"ariaLabel":28},"Services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":275,"url":276,"target":27,"ariaLabel":28},"Policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":234,"url":278,"target":27,"ariaLabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"ariaLabel":28},{"title":281,"links":282},"Explore",[283,284,287,289],{"text":254,"url":251,"target":27,"ariaLabel":28},{"text":285,"url":286,"target":27,"ariaLabel":28},"Research Topics ","https://www.frontiersin.org/research-topics",{"text":288,"url":248,"target":27,"ariaLabel":28},"Journals",{"text":51,"url":52,"target":27,"ariaLabel":28},{"title":291,"links":292},"Outreach",[293,296,299,303],{"text":294,"url":92,"target":77,"ariaLabel":295},"Frontiers Forum ","Frontiers Forum website",{"text":297,"url":298,"target":77,"ariaLabel":28},"Frontiers Policy Labs ","https://policylabs.frontiersin.org/",{"text":300,"url":301,"target":77,"ariaLabel":302},"Frontiers for Young Minds","https://kids.frontiersin.org/","Frontiers for Young Minds journal",{"text":95,"url":96,"target":27,"ariaLabel":28},{"title":305,"links":306},"Connect",[307,308,312,315,318],{"text":262,"url":263,"target":77,"ariaLabel":262},{"text":309,"url":310,"target":77,"ariaLabel":311},"Emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","Subscribe to Frontiers emails",{"text":313,"url":111,"target":27,"ariaLabel":314},"Contact us ","Subscribe to newsletter",{"text":316,"url":317,"target":27,"ariaLabel":28},"Submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"ariaLabel":28},[320,328,333,338],{"link":321,"type":324,"color":325,"icon":326,"size":327,"hiddenText":13},{"text":322,"url":323,"target":77,"ariaLabel":322},"Frontiers Facebook","https://www.facebook.com/Frontiersin","Link","Grey","Facebook","Medium",{"link":329,"type":324,"color":325,"icon":332,"size":327,"hiddenText":13},{"text":330,"url":331,"target":77,"ariaLabel":28},"Frontiers Twitter","https://twitter.com/frontiersin","Twitter",{"link":334,"type":324,"color":325,"icon":337,"size":327,"hiddenText":13},{"text":335,"url":336,"target":77,"ariaLabel":28},"Frontiers LinkedIn","https://www.linkedin.com/company/frontiers","LinkedIn",{"link":339,"type":324,"color":325,"icon":342,"size":327,"hiddenText":13},{"text":340,"url":341,"target":77,"ariaLabel":28},"Frontiers Instagram","https://www.instagram.com/frontiersin_","Instagram","Frontiers Media SA. All rights reserved.","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":349,"identifier":115,"name":116,"slug":117,"banner":350,"description":405,"mission":406,"palette":407,"impactFactor":408,"citeScore":409,"citations":410,"showTagline":28,"twitter":411},"Journal",[351],{"id":352,"src":353,"name":354,"tags":355,"type":363,"width":364,"height":365,"idHash":366,"archive":367,"brandId":368,"limited":367,"fileSize":369,"isPublic":370,"original":371,"copyright":372,"extension":373,"thumbnails":375,"dateCreated":383,"description":384,"orientation":385,"userCreated":386,"watermarked":367,"dateModified":383,"datePublished":387,"ecsArchiveFiles":388,"propertyOptions":389,"property_Channel":394,"property_Sub-Type":396,"property_Asset_Type":398,"activeOriginalFocusPoint":400,"property_Office_Department":403},"754E12A9-443F-4EA8-AB01E0811E45131D","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/754E12A9-443F-4EA8-AB01E0811E45131D/webimage-9D720582-24AD-4D2E-9205AB9D241919DA.jpg","FPHAR_Main Visual_Purple_Website",[356,357,358,359,360,361,362],"pain","medical","pharmaceutical","antibiotic","concept","capsule","treatment","image",5844,3896,"79b643019a2651e0",0,"22C10171-81B3-4DA6-99342F272A32E8BB",8675243,1,"https://brand.frontiersin.org/m/79b643019a2651e0/original/FPHAR_Main-Visual_Purple_Website.jpeg","Copyright (c) 2017 Marian Weyo/Shutterstock.  No use without permission.",[374],"jpeg",{"mini":376,"thul":377,"webimage":353,"Guidelines":378,"WebsiteJpg_XL":379,"WebsiteWebP_L":380,"WebsiteWebP_M":381,"WebsiteWebP_XL":382},"https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/754E12A9-443F-4EA8-AB01E0811E45131D/mini-97EEF455-249B-43BD-9D8F02FEE86046D3.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/754E12A9-443F-4EA8-AB01E0811E45131D/thul-B2DBD910-1DDF-4ED3-B1500DF973953144.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/754E12A9-443F-4EA8-AB01E0811E45131D/F3882BDE-513E-4D16-8DB695504865E7B8/Guidelines-FPHAR_Main Visual_Purple_Website.png","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/754E12A9-443F-4EA8-AB01E0811E45131D/F3882BDE-513E-4D16-8DB695504865E7B8/WebsiteJpg_XL-FPHAR_Main Visual_Purple_Website.jpg","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/754E12A9-443F-4EA8-AB01E0811E45131D/F3882BDE-513E-4D16-8DB695504865E7B8/WebsiteWebP_L-FPHAR_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/754E12A9-443F-4EA8-AB01E0811E45131D/F3882BDE-513E-4D16-8DB695504865E7B8/WebsiteWebP_M-FPHAR_Main Visual_Purple_Website.webp","https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/754E12A9-443F-4EA8-AB01E0811E45131D/F3882BDE-513E-4D16-8DB695504865E7B8/WebsiteWebP_XL-FPHAR_Main Visual_Purple_Website.webp","2022-06-27T10:00:45Z","Pills Tablets Capsule or Medicament freely laid on glass background.","landscape","Caroline Sutter","2022-06-27T09:27:09Z",[],[390,391,392,393],"414FB2D4-2283-43FD-BE14E534ECA67928","6C18119B-14BD-4951-B437696F4357BD33","7C692885-DB25-4858-B1FB4FF47B241E9B","D88C0047-EC30-4506-A7DF28A4D765E1CF",[395],"frontiersin_org",[397],"Main_Visual",[399],"Photography",{"x":401,"y":402},2922,1948,[404],"Publishing","The world's most cited pharmacology and pharmacy journal, advancing global pharmacological discoveries to prevent and treat human disease.","\u003Cp>Frontiers in Pharmacology is an interdisciplinary journal that publishes research on the interactions between drugs and living beings to prevent and cure human disease.\u003C/p>\n\n\u003Cp>Led by Field Chief Editor Heike Wulff (University of California, Davis, US), Frontiers in Pharmacology explores basic and clinical pharmacology, medicinal chemistry, pharmacy, and toxicology to clarify the fundamental processes of disease treatment and drug effects. Indexed in PubMed Central (PMC), Scopus, Web of Science (SCIE), and the DOAJ, the journal welcomes academic, industrial, and clinical work focused on pharmacology.\u003C/p>\n\n\u003Cp>Topics include, but are not limited to:\u003C/p>\n\u003Cul>\n  \u003Cli>cardiovascular and smooth muscle pharmacology\u003C/li>\n  \u003Cli>drug metabolism and transport\u003C/li>\n  \u003Cli>drugs outcomes research and policies\u003C/li>\n  \u003Cli>ELSI in science and genetics\u003C/li>\n  \u003Cli>ethnopharmacology\u003C/li>\n  \u003Cli>experimental pharmacology and drug discovery\u003C/li>\n  \u003Cli>gastrointestinal and hepatic pharmacology\u003C/li>\n  \u003Cli>inflammation pharmacology\u003C/li>\n  \u003Cli>integrative and regenerative pharmacology\u003C/li>\n  \u003Cli>neuropharmacology\u003C/li>\n  \u003Cli>obstetric and pediatric pharmacology\u003C/li>\n  \u003Cli>pharmacoepidemiology\u003C/li>\n  \u003Cli>pharmacogenetics and pharmacogenomics\u003C/li>\n  \u003Cli>pharmacology of anti-cancer drugs\u003C/li>\n  \u003Cli>pharmacology of infectious diseases\u003C/li>\n  \u003Cli>pharmacology of ion channels and channelopathies\u003C/li>\n  \u003Cli>predictive toxicology\u003C/li>\n  \u003Cli>renal pharmacology\u003C/li>\n  \u003Cli>respiratory pharmacology\u003C/li>\n  \u003Cli>translational pharmacology.\u003C/li>\n\u003C/ul>\n\n\u003Cp>All submissions to the journal involving natural products, including plant extracts or preparations, must adhere to \u003Ci>'The Four Pillars of Ethnopharmacology'\u003C/i> to be considered for peer review, regardless of the specialty section, as a baseline standard for sample characterization. These are a set of mandatory guidelines designed to maintain the scientific, cultural, and ethical integrity of the Journal, and describe what the leading journals in the field consider as the basic aspects of good research (full ConPhyMP statement available \u003Ca href=\"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.953205/full\" target=\"_blank\">here\u003C/a>, ConPhyMP statement overview \u003Ca href=\"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1338710/full\" target=\"_blank\">here\u003C/a>, and GA-tool \u003Ca href=\"https://ga-online.org/best-practice/\" target=\"_blank\">here\u003C/a>). Please refer to the \u003Ca href=\"https://assets.ctfassets.net/41vi7p4898pd/63DCrRxGncG4B1stfaYeh8/1b87b9a742b0610ace5b19fd11f62359/Four_pillars_ethnopharmacology_2025.pdf\" target=\"_blank\">FULL VERSION\u003C/a> of these guidelines before submitting a manuscript to the journal.\u003C/p> \n\u003Cp>To be considered for publication in Frontiers in Pharmacology, studies incorporating complementary or alternative medicine must be based on a set of data linked to local or traditional uses that can be evaluated pharmacologically. A clear and plausible set of pharmacological data must be generated in these studies. Similarly, the journal endorses protocols including a minimum of 2 cell-lines in vitro as an evidential basis to demonstrate proposed anti-cancer effects in all relevant studies submitted to all specialty sections in the journal.\u003C/p>\n\u003Cp>Isolated data mining studies using disproportionality analyses of databases containing spontaneously reported adverse events, frequently lead to misinterpretation due to various reporting biases, lack of structured control, and insufficient demographic details. Presenting such analyses in isolation typically does not yield clinically actionable safety findings without the broader context of a comprehensive signal evaluation. To ensure rigor and relevance, all submissions to the journal must be complemented by a proper systematic review and/or thorough analyses of reported cases, and adhere to the READUS-PV guidelines (\u003Ca href=\"https://www.equator-network.org/reporting-guidelines/the-reporting-of-a-disproportionality-analysis-for-drug-safety-signal-detection-using-individual-case-safety-reports-in-pharmacovigilance-readus-pv-development-and-statement/\" target=\"_blank\">The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance\u003C/a>). Authors are expected to ensure compliance with the corresponding \u003Ca href=\"https://readus-statement.org/wp-content/uploads/2024/03/readus-checklist.pdf\" target=\"_blank\">checklist\u003C/a> before proceeding with submission to the journal. Full publication of the READUS-PV guidelines is available \u003Ca href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11116242/pdf/40264_2024_Article_1421.pdf\" target=\"_blank\">here\u003C/a>.\u003C/p>\n\n\u003Cp>Frontiersâ€™ journals require that manuscripts primarily comprising computational studies of public data, such as NHANES or Mendelian Randomization studies, must include appropriate validation. Please refer to the \u003Ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,Standards%20for%20research%20methodology,-Experiments\">Frontiers Standards for research methodology policy\u003C/a>, for more information. Manuscripts not adhering to these standards will not be considered.\u003Cp>\n\n\u003Cp>Further unique criteria for the conception and review of submissions may apply, where appropriate, for individual specialty sections.\u003C/p>\n\n\u003Cp>The journal welcomes submissions that support and advance the \u003Ca href=\"https://www.globalgoals.org/goals/\" target=\"_blank\">UN Sustainable Development Goals\u003C/a> (SDGs), notably the \u003Ca href=\"https://www.globalgoals.org/goals/3-good-health-and-well-being/\" target=\"_blank\">SDG 3: Good Health and Well-being\u003C/a>.\u003C/p>\n\n\u003Cp>Manuscripts that focus solely on clinical trials, patient management, or conventional therapies without a focus on pharmacological research are not suitable for publication in this journal. Additionally, studies that are purely statistical or predictive in nature, without providing novel insights into pharmacological mechanisms or drug development, are not within the scope of this journal.\u003C/p>\n\n\u003Cp>Frontiers in Pharmacology is committed to advancing developments in the field of pharmacological discoveries by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.\u003C/p>\n\n\u003Cb>\u003Cp>Ethics Information\u003C/p>\u003C/b>\n\u003Cp>Research involving human subjects should comply with the ethical guidelines outlined in the \u003Ca href= https://www.wma.net/policies-post/wma-declaration-of-helsinki/â€ target=â€_blankâ€>World Medical Associationâ€™s Declaration of Helsinki\u003C/a>.\u003C/p>\n\u003Cp>Similarly, authors are required to specify the institutional and national standards adhered to for the care and use of laboratory animals. Transparent and accurate reporting of animal studies is required, with references to guidelines such as \u003Ca href=\"https://arriveguidelines.org/arrive-guidelines\" target=\"_blank\">ARRIVE\u003C/a> and \u003Ca href=\"https://nc3rs.org.uk/sites/default/files/2022-01/The%20IMPROVE%20Guidelines%20%28poster%29.pdf\" target=\"_blank\"> IMPROVE\u003C/a>.\u003C/p>\n\u003Cp>Extended information on research ethics can be found under the Frontiers Policies and Publication Ethics page.\u003C/p>","purple","5.6","6.3","531663","@FrontPharmacol",{"id":115,"name":116,"slug":117,"abbreviation":413,"isOnline":13,"isOpenForSubmissions":13,"citeScore":414,"impactFactor":415},"fphar",8.9,4.8,{"displayTitlePillLabels":13,"displayRelatedArticlesBox":13,"showEditors":13,"showReviewers":13,"showLoopImpactLink":13,"enableFigshare":347},{"isPublic":13,"allowCompanyUsers":347,"whiteListEmails":418,"enableAllJournals":13,"whiteListJournals":440},[419,420,421,422,423,424,425,426,427,424,428,429,430,431,432,433,434,435,436,437,438,439],"Y2FybG9zLmxvcmNhQGZyb250aWVyc2luLm9yZw==","ZGFuaWVsLmx1ekBmcm9udGllcnNpbi5vcmc=","bGF1cmEudGVuYUBmcm9udGllcnNpbi5vcmc=","cmFmYWVsLnJpYW5jaG9AZnJvbnRpZXJzaW4ub3Jn","amFtZXMuc21hbGxib25lQGZyb250aWVyc2luLm9yZw==","ZnJhbi5tb3Jlbm9AZnJvbnRpZXJzaW4ub3Jn","c2FtdWVsLmZlcm5hbmRlekBmcm9udGllcnNpbi5vcmc=","YmFyYmFyYS5jYXJjYW5naXVAZnJvbnRpZXJzaW4ub3Jn","aXZhbi5zYW50YW1hcmlhQGZyb250aWVyc2luLm9yZw==","aHVlLnRyYW5AZnJvbnRpZXJzaW4ub3Jn","Z29uY2Fsby52YXJnYXNAZnJvbnRpZXJzaW4ub3Jn","bHVjaWUuc2VubkBmcm9udGllcnNpbi5vcmc=","bG9ybi5mcmFzZXJAZnJvbnRpZXJzaW4ub3Jn","ZWxzYS5jYXJyb25AZnJvbnRpZXJzaW4ub3Jn","bWFhcnRlbi52YW5kaWpja0Bmcm9udGllcnNpbi5vcmc=","YmluZGh1LmtyaXNobmFuQGZyb250aWVyc2luLm9yZw==","bWF0dGhldy5hdHR3YXRlcnNAZnJvbnRpZXJzaW4ub3Jn","Z2l1bGlhLnZhbHNlY2NoaUBmcm9udGllcnNpbi5vcmc=","ZmFiaWFuLmRlbGxhbW9ydGVAZnJvbnRpZXJzaW4ub3Jn","dmlqYXlhbi5wcEBwaXRzb2x1dGlvbnMuY29t","Z3VpbGxhdW1lLnNldXJhdEBmcm9udGllcnNpbi5vcmc=",[441,442,443,444,445,446,370,447,448,449,450,451,452,453,454,455,456,457,458,459,460,461,462,463,464,465,466,467,468,115,469,470,471,472,473,474,475],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,141,1335,2655,1238,604,698,1547,1440,403,1239,755,2136,609,1534,{"spaceId":370,"name":370,"availableJournalPages":477,"announcement":481},[255,260,257,478,479,480],"volumes","about","community-reviewers",{"__typename":482,"sys":483,"preHeader":42,"title":485,"description":486,"image":487,"link":509},"Announcement",{"id":484},"5ITtnTtQgAzPPGH6rX0AlM","Articles published with Frontiers have received 12 million total citations","Your research is the real superpower - learn how we maximise its impact through our leading community journals",[488],{"archive":367,"brandId":368,"copyright":28,"dateCreated":489,"dateModified":490,"datePublished":491,"description":28,"extension":492,"fileSize":494,"height":495,"id":496,"isPublic":367,"limited":367,"name":497,"orientation":385,"original":28,"thumbnails":498,"type":363,"watermarked":367,"width":505,"videoPreviewURLs":506,"tags":507,"textMetaproperties":508,"src":499},"2025-06-18T12:58:01Z","2025-06-18T14:15:34Z","2025-06-18T12:57:32Z",[493],"png",1365026,920,"7C5269C4-3C83-4591-951A74D15B95DAEA","Impact metrics banner for article pages",{"webimage":499,"thul":500,"mini":501,"WebsiteWebP_L":502,"WebsiteWebP_M":503,"Guidelines":504},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-Impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_L/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/WebsiteWebP_M/Impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/Guidelines/Impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":510,"url":43,"target":27,"ariaLabel":28},"Explore our impact metrics",{"loggedUserInfo":-1},{"currentArticle":513,"isPreviewPage":347,"hasSupplementalData":347,"showCrossmarkWidget":13,"articleTemplate":709,"currentArticlePageMetaInfo":710,"xmlParsedArticleContent":-1,"xmlParsingError":-1},{"id":514,"doi":515,"title":516,"acceptanceDate":517,"receptionDate":518,"publicationDate":519,"lastModifiedDate":520,"isPublished":13,"abstract":521,"researchTopic":522,"articleType":528,"stage":531,"keywords":533,"authors":539,"editors":634,"reviewers":645,"journal":663,"section":670,"impactMetrics":672,"volume":676,"articleVolume":677,"relatedArticles":678,"isPublishedV2":347,"contents":679,"files":683},872645,"10.3389/fphar.2022.872645","Functional Characterization of Two Variants at the Intron 6â€”Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes",["Date","2022-05-10T07:03:50.000Z"],["Date","2022-02-09T17:40:20.000Z"],["Date","2022-06-13T00:00:00.000Z"],["Date","2025-11-26T04:06:15.996Z"],"Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE) to severe Developmental and Epileptic Encephalopathy (DEE). Thus, understanding the pathogenic molecular mechanisms of Kv7.2 variants and their correlation with clinical phenotypes has a relevant impact on the clinical management of these patients. \nIn the present study, the genetic, biochemical, and functional effects prompted by two variants, each found in a non-familial SLNE or a DEE patient but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in these patients. \nAnalysis of KCNQ2 mRNA splicing in patient-derived lymphoblasts revealed that the SLNE-causing intronic variant (c.928-1G>C) impeded the use of the natural splice site, thus leading to a 10-aa Kv7.2 in frame deletion (Kv7.2 p.G310delta10); by contrast, the DEE-causing exonic variant (c.928G>A) only had subtle effects on the splicing process at this site, thus leading to the synthesis of a full-length subunit carrying the G310S missense variant (Kv7.2 p.G310S). \nPatch-clamp recordings in transiently-transfected CHO cells and primary neurons revealed that both variants fully impeded Kv7.2 channel function, and exerted strong dominant-negative effects when co-expressed with Kv7.2 and/or Kv7.3 subunits. Notably, Kv7.2 p.G310S, but not Kv7.2 p.G310delta10, currents were recovered upon overexpression of the PIP2-synthesizing enzyme PIP5K, and/or CaM; moreover, currents from heteromeric Kv7.2/Kv7.3 channels incorporating either Kv7.2 mutant subunits were differentially regulated by changes in PIP2 availability, with Kv7.2/Kv7.2 G310S/Kv7.3 currents showing  a greater sensitivity to PIP2 depletion when compared to those from Kv7.2/Kv7.2 G310delta10/Kv7.3 channels. \nAltogether, these results suggest that the two variants investigated differentially affected the splicing process at the intron 6-exon 7 boundary, and led to the synthesis of Kv7.2 subunits showing a differential sensitivity to PIP2 and CaM regulation; more studies are needed to clarify how such different functional properties contribute to the widely-divergent clinical phenotypes.",{"id":523,"title":524,"articlesCount":525,"isMagazinePage":13,"slug":526,"isOpenForSubmission":347,"views":527},26272,"â€‹Ion Channels in Health and Disease",7,"ion-channels-in-health-and-disease",23209,{"id":529,"name":530},24,"Original Research",{"id":532,"name":19},18,[534,535,536,537,538],"Alternative Splicing","Kv7.2 channels","epileptic encephalopathy","PIP2","Calmodulin",[540,548,554,562,569,576,582,590,597,603,610,619,626],{"id":367,"firstName":541,"middleName":19,"lastName":542,"givenNames":543,"isCorresponding":347,"isProfilePublic":347,"userId":367,"email":-1,"affiliations":544},"Ilaria","Mosca","Ilaria ",[545],{"organizationName":546,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},"Department of Medicine and Health Science â€œV. Tiberioâ€","Italy",{"id":549,"firstName":541,"middleName":19,"lastName":550,"givenNames":543,"isCorresponding":347,"isProfilePublic":13,"userId":549,"email":-1,"affiliations":551},381848,"Rivolta",[552],{"organizationName":553,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},"School of Medicine and Surgery",{"id":367,"firstName":555,"middleName":19,"lastName":556,"givenNames":557,"isCorresponding":347,"isProfilePublic":347,"userId":367,"email":-1,"affiliations":558},"Audrey","Labalme","Audrey ",[559],{"organizationName":560,"countryName":561,"cityName":19,"stateName":19,"zipCode":19},"Department of Medical Genetics","France",{"id":367,"firstName":563,"middleName":19,"lastName":564,"givenNames":565,"isCorresponding":347,"isProfilePublic":347,"userId":367,"email":-1,"affiliations":566},"Paolo","Ambrosino","Paolo ",[567],{"organizationName":568,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},"Department of Science and Technology (DST)",{"id":367,"firstName":570,"middleName":19,"lastName":571,"givenNames":572,"isCorresponding":347,"isProfilePublic":347,"userId":367,"email":-1,"affiliations":573},"Barbara","Castellotti","Barbara ",[574],{"organizationName":575,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},"Unit of Medical Genetics and Neurogenetics",{"id":367,"firstName":577,"middleName":19,"lastName":578,"givenNames":579,"isCorresponding":347,"isProfilePublic":347,"userId":367,"email":-1,"affiliations":580},"Cinzia","Gellera","Cinzia ",[581],{"organizationName":575,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},{"id":583,"firstName":584,"middleName":19,"lastName":585,"givenNames":586,"isCorresponding":347,"isProfilePublic":13,"userId":583,"email":-1,"affiliations":587},594028,"Tiziana","Granata","Tiziana ",[588],{"organizationName":589,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},"Department of Pediatric Neuroscience",{"id":591,"firstName":592,"middleName":19,"lastName":593,"givenNames":594,"isCorresponding":347,"isProfilePublic":13,"userId":591,"email":-1,"affiliations":595},592870,"Elena","Freri","Elena ",[596],{"organizationName":589,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},{"id":367,"firstName":598,"middleName":19,"lastName":599,"givenNames":600,"isCorresponding":347,"isProfilePublic":347,"userId":367,"email":-1,"affiliations":601},"Anna","Binda","Anna ",[602],{"organizationName":553,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},{"id":604,"firstName":605,"middleName":19,"lastName":606,"givenNames":607,"isCorresponding":347,"isProfilePublic":13,"userId":604,"email":-1,"affiliations":608},195337,"Gaetan","Lesca","Gaetan ",[609],{"organizationName":560,"countryName":561,"cityName":19,"stateName":19,"zipCode":19},{"id":611,"firstName":612,"middleName":19,"lastName":613,"givenNames":614,"isCorresponding":347,"isProfilePublic":13,"userId":611,"email":-1,"affiliations":615},257119,"Jacopo C.","DiFrancesco","Jacopo C. ",[616,617],{"organizationName":589,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},{"organizationName":618,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},"Department of Neurology",{"id":620,"firstName":621,"middleName":19,"lastName":622,"givenNames":623,"isCorresponding":347,"isProfilePublic":13,"userId":620,"email":-1,"affiliations":624},25389,"Maria Virginia","Soldovieri","Maria Virginia ",[625],{"organizationName":546,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},{"id":627,"firstName":628,"middleName":19,"lastName":629,"givenNames":630,"isCorresponding":347,"isProfilePublic":13,"userId":627,"email":-1,"affiliations":631},432607,"Maurizio","Taglialatela","Maurizio ",[632],{"organizationName":633,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},"Department of Neuroscience",[635],{"id":636,"firstName":637,"middleName":638,"lastName":639,"givenNames":640,"isCorresponding":347,"isProfilePublic":13,"userId":636,"email":-1,"affiliations":641},945653,"Tarek","Mohamed","Abd El-Aziz","Tarek  Mohamed",[642],{"organizationName":643,"countryName":644,"cityName":19,"stateName":19,"zipCode":19},"The University of Texas Health Science Center at San Antonio","United States",[646,654],{"id":647,"firstName":648,"middleName":19,"lastName":649,"givenNames":650,"isCorresponding":347,"isProfilePublic":13,"userId":647,"email":-1,"affiliations":651},808359,"Marina","Trivisano","Marina ",[652],{"organizationName":653,"countryName":547,"cityName":19,"stateName":19,"zipCode":19},"Bambino GesÃ¹ Children's Hospital (IRCCS)",{"id":655,"firstName":656,"middleName":19,"lastName":657,"givenNames":658,"isCorresponding":347,"isProfilePublic":13,"userId":655,"email":-1,"affiliations":659},639939,"Peter","Sparber","Peter ",[660],{"organizationName":661,"countryName":662,"cityName":19,"stateName":19,"zipCode":19},"Research Centre for Medical Genetics","Russia",{"id":115,"slug":117,"name":116,"shortName":664,"electronicISSN":665,"field":666,"specialtyId":28,"journalSectionPaths":668},"Front. Pharmacol.","1663-9812",{"id":667,"domainId":370},62,[669],{"section":670},{"id":176,"name":177,"slug":178,"specialtyId":671},862,{"views":673,"downloads":674,"citations":675},2059,1119,5,13,"Volume 13 - 2022",[],{"titleHtml":680,"fullTextHtml":681,"menuHtml":682},"Functional Characterization of Two Variants at the Intron 6&#x02014;Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes","\u003Cdiv class=\"JournalAbstract\">\u003Ca id=\"h1\" name=\"h1\">\u003C/a>\u003Cdiv class=\"authors\">\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Ilaria Mosca&#x;\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Ilaria Mosca\u003Csup>1\u003C/sup>\u003Csup>&#x02020;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/381848\" class=\"user-id-381848\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/381848/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Ilaria Rivolta&#x;\">Ilaria Rivolta\u003C/a>\u003Csup>2\u003C/sup>\u003Csup>&#x02020;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Audrey Labalme&#x;\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Audrey Labalme\u003Csup>3\u003C/sup>\u003Csup>&#x02020;\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Paolo Ambrosino\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Paolo Ambrosino\u003Csup>4\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Barbara Castellotti\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Barbara Castellotti\u003Csup>5\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Cinzia Gellera\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Cinzia Gellera\u003Csup>5\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/594028\" class=\"user-id-594028\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/594028/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Tiziana Granata\">Tiziana Granata\u003C/a>\u003Csup>6\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/592870\" class=\"user-id-592870\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/592870/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Elena Freri\">Elena Freri\u003C/a>\u003Csup>6\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"Anna Binda\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">Anna Binda\u003Csup>2\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/195337\" class=\"user-id-195337\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/195337/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Gaetan Lesca\">Gaetan Lesca\u003C/a>\u003Csup>3\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/257119\" class=\"user-id-257119\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/257119/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Jacopo C. DiFrancesco,\">Jacopo C. DiFrancesco\u003C/a>\u003Csup>6,7\u003C/sup>\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/25389\" class=\"user-id-25389\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/25389/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Maria Virginia Soldovieri&#xa;\">Maria Virginia Soldovieri\u003C/a>\u003Csup>1\u003C/sup>&#x0002a;\u003C/span>\u003Cspan class=\"author-wrapper notranslate\">\u003Ca href=\"https://loop.frontiersin.org/people/432607\" class=\"user-id-432607\">\u003Cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/432607/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"Maurizio Taglialatela&#xa;\">Maurizio Taglialatela\u003C/a>\u003Csup>8\u003C/sup>&#x0002a;\u003C/span>\u003C/div>\u003Cul class=\"notes\">\u003Cli>\u003Cspan>\u003Csup>1\u003C/sup>\u003C/span>Department of Medicine and Health Science &#x0201c;V. Tiberio&#x0201d;, University of Molise, Campobasso, Italy\u003C/li>\u003Cli>\u003Cspan>\u003Csup>2\u003C/sup>\u003C/span>School of Medicine and Surgery, University of Milano-Bicocca, Monza-Center for Neuroscience (NeuroMI), Milan, Italy\u003C/li>\u003Cli>\u003Cspan>\u003Csup>3\u003C/sup>\u003C/span>Department of Medical Genetics, Hospices Civils de Lyon, Universit&#x000e9; Claude Bernard Lyon 1, Lyon, France\u003C/li>\u003Cli>\u003Cspan>\u003Csup>4\u003C/sup>\u003C/span>Department of Science and Technology (DST), University of Sannio, Benevento, Italy\u003C/li>\u003Cli>\u003Cspan>\u003Csup>5\u003C/sup>\u003C/span>Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy\u003C/li>\u003Cli>\u003Cspan>\u003Csup>6\u003C/sup>\u003C/span>Department of Pediatric Neuroscience, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy\u003C/li>\u003Cli>\u003Cspan>\u003Csup>7\u003C/sup>\u003C/span>Department of Neurology, ASST &#x0201c;San Gerardo&#x0201d; Hospital, University of Milano-Bicocca, Monza, Italy\u003C/li>\u003Cli>\u003Cspan>\u003Csup>8\u003C/sup>\u003C/span>Department of Neuroscience, University of Naples &#x0201c;Federico II&#x0201d;, Naples, Italy\u003C/li>\u003C/ul>\u003Cp class=\"mb15\">Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE) to severe Developmental and Epileptic Encephalopathy (DEE). Thus, understanding the pathogenic molecular mechanisms of KCNQ2 variants and their correlation with clinical phenotypes has a relevant impact on the clinical management of these patients. In the present study, the genetic, biochemical, and functional effects prompted by two variants, each found in a non-familial SLNE or a DEE patient but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in these patients. Analysis of KCNQ2 mRNA splicing in patient-derived lymphoblasts revealed that the SLNE-causing intronic variant (c.928-1G &#x0003e; C) impeded the use of the natural splice site, but lead to a 10-aa Kv7.2 in frame deletion (Kv7.2 p.G310&#x00394;10); by contrast, the DEE-causing exonic variant (c.928G &#x0003e; A) only had subtle effects on the splicing process at this site, thus leading to the synthesis of a full-length subunit carrying the G310S missense variant (Kv7.2 p.G310S). Patch-clamp recordings in transiently-transfected CHO cells and primary neurons revealed that both variants fully impeded Kv7.2 channel function, and exerted strong dominant-negative effects when co-expressed with Kv7.2 and/or Kv7.3 subunits. Notably, Kv7.2 p.G310S, but not Kv7.2 p.G310&#x00394;10, currents were recovered upon overexpression of the PIP\u003Csub>2\u003C/sub>-synthesizing enzyme PIP5K, and/or CaM; moreover, currents from heteromeric Kv7.2/Kv7.3 channels incorporating either Kv7.2 mutant subunits were differentially regulated by changes in PIP\u003Csub>2\u003C/sub> availability, with Kv7.2/Kv7.2 G310S/Kv7.3 currents showing a greater sensitivity to PIP\u003Csub>2\u003C/sub> depletion when compared to those from Kv7.2/Kv7.2 G310&#x00394;10/Kv7.3 channels. Altogether, these results suggest that the two variants investigated differentially affected the splicing process at the intron 6-exon 7 boundary, and led to the synthesis of Kv7.2 subunits showing a differential sensitivity to PIP\u003Csub>2\u003C/sub> and CaM regulation; more studies are needed to clarify how such different functional properties contribute to the widely-divergent clinical phenotypes.\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>\u003Cdiv class=\"JournalFullText\">\u003Ca id=\"h2\" name=\"h2\">\u003C/a>\u003Ch2>Introduction\u003C/h2>\u003Cp class=\"mb15\">KCNQ2 and KCNQ3 genes encode for Kv7.2 and Kv7.3 voltage-gated K\u003Csup>&#x0002b;\u003C/sup> channel subunits each showing six transmembrane segments (S\u003Csub>1\u003C/sub>-S\u003Csub>6\u003C/sub>) and cytoplasmic N- and C-termini of variable length; the pore domain is encompassed by the S\u003Csub>5\u003C/sub>-S\u003Csub>6\u003C/sub> segments and the intervening linker of each subunit, whereas the transmembrane segments between S\u003Csub>1\u003C/sub> and S\u003Csub>4\u003C/sub> form the voltage-sensing domain (VSD). The C-terminal region of Kv7 subunits contains domains (called from A to D) required for homo- or heteromeric subunit assembly and for a complex network of mutually interacting molecules, such as phosphatidylinositol 4,5-bisphosphate (PIP\u003Csub>2\u003C/sub>), calmodulin, syntaxyn, A-kinase-anchoring proteins, which allow Kv7 channel regulation by pKC, and ankyrin-G (\u003Ca href=\"#B26\">Soldovieri et al., 2011\u003C/a>). Kv7.2/Kv7.3 channels are mainly expressed in neuronal cells, where they contribute to a slowly activating and deactivating K\u003Csup>&#x0002b;\u003C/sup> current called I\u003Csub>KM\u003C/sub> (or M-current) as it is inhibited by the activation of M\u003Csub>1\u003C/sub> receptors (\u003Ca href=\"#B21\">Selyanko et al., 2000\u003C/a>). The molecular pathways leading to M-current inhibition include pKC phosphorylation of the Kv7.2 subunits, dissociation of CaM from the channel and a consequent reduced affinity towards PIP\u003Csub>2\u003C/sub> (\u003Ca href=\"#B10\">Kosenko et al., 2012\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">I\u003Csub>KM\u003C/sub> controls neuronal excitability in the sub-threshold range for action potential generation (\u003Ca href=\"#B13\">Marrion, 1997\u003C/a>; \u003Ca href=\"#B28\">Wang et al., 1998\u003C/a>); thus, it is not surprising that pathogenic variants in KCNQ2 and KCNQ3 genes have been identified in epileptic disorders, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE), characterized by seizures occurring in the first days of life and disappearing after few months, without significant effects on the subsequent neuropsychomotor development, to developmental and epileptic encephalopathies (DEEs), most often characterized by severe epileptic conditions, associated to variable degrees of social, cognitive, motor, language, and behavioral impairments, and pharmacoresistance (\u003Ca href=\"#B30\">Weckhuysen et al., 2012\u003C/a>; \u003Ca href=\"#B29\">Weckhuysen et al., 2013\u003C/a>). Although the causes for this differential developmental trajectories are still largely unknown, some genotype-phenotype correlations have emerged; in fact, while most variants causing SLFNE are nonsense, splice, or frameshifts randomly distributed throughout the gene, those causing DEE are almost invariably missense and cluster in four hot-spots channel domains exerting critical functional roles (\u003Ca href=\"#B18\">Millichap et al., 2016\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">Characterization of the specific effects prompted by each KCNQ2 variant on channel function could allow to identify distinct pathogenetic mechanisms, thus corroborating genotype-phenotype correlations between novel KCNQ2 variants and disease severity, with a potentially-relevant impact on the clinical management of these patients. Functional studies, mainly performed with missense variants, have revealed that, when compared with SLFNE-causing variants, associated with haploinsufficiency, most of the DEE-causing substitutions prompt strong loss-of-function (LoF) (\u003Ca href=\"#B14\">Miceli et al., 2013\u003C/a>), dominant-negative (\u003Ca href=\"#B19\">Orhan et al., 2014\u003C/a>) or gain-of-function (GoF) (\u003Ca href=\"#B15\">Miceli et al., 2015\u003C/a>; \u003Ca href=\"#B17\">Millichap et al., 2017\u003C/a>) effects. No study has yet been performed in KCNQ2 splice-site variants. Therefore, the genetic, biochemical, and functional effects prompted by two variants, each found in a SLNE (\u003Ca href=\"#B23\">Soldovieri et al., 2014\u003C/a>) or a DEE patient (\u003Ca href=\"#B25\">Soldovieri et al., 2020\u003C/a>) but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated in the present study to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in the probands carrying these two variants.\u003C/p>\u003Ca id=\"h3\" name=\"h3\">\u003C/a>\u003Ch2>Materials and Methods\u003C/h2>\u003Ch3 class=\"pt0\">Patients\u003C/h3>\u003Cp class=\"mb0\">Parents of each patient signed an informed consent for the participation, according to the French bioethics law. The clinical features of the two patients herein investigated have been previously described (\u003Ca href=\"#B23\">Soldovieri et al., 2014\u003C/a>; \u003Ca href=\"#B25\">Soldovieri et al., 2020\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">Briefly, the girl with early-onset DEE caused by the heterozygous NM_172107.4:c.928 G &#x0003e; A mutation described in \u003Ca href=\"#B25\">Soldovieri et al. (2020)\u003C/a> showed burst-suppression pattern at the EEG, recurrent seizures with multifocal onset occurring during the first days of life, and was refractory to different therapeutic trials with phenobarbital, phenytoin, levetiracetam, vigabatrin and pyridoxine. The neurologic evolution was characterized by severe psychomotor delay, absent speech, apostural tetraparesis, and strabismus. A significant decrease of the epileptiform activity was observed following introduction of gabapentin, a newly-identified Kv7 activator (\u003Ca href=\"#B12\">Manville and Abbott, 2018\u003C/a>) able to counteract \u003Cem>in vitro\u003C/em> mutation-induced LoF effects (\u003Ca href=\"#B25\">Soldovieri et al., 2020\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">The male patient carrying a heterozygous NM_172107.4:c.928-1G &#x0003e; C mutation described in Soldovieri et al. (2014; Individual II-I in family 9) had seizures in the neonatal period but no recurrence thereafter, normal EEG and normal neurodevelopment; the variant was not detected in either parent, and occurred \u003Cem>de novo\u003C/em>, thus confirming the diagnosis of non-familial Self-Limiting Neonatal Epilepsy (SLNE; \u003Ca href=\"#B23\">Soldovieri et al., 2014\u003C/a>).\u003C/p>\u003Ch3 class=\"pt0\">Genetic Analysis on Immortalized Lymphoblasts\u003C/h3>\u003Cp class=\"mb0\">For the c.928-1G &#x0003e; C variant, the validation of the effects on Kv7.2 mRNAs splicing was performed as previously described (\u003Ca href=\"#B23\">Soldovieri et al., 2014\u003C/a>). Briefly, mRNA was extracted from Epstein-Barr Virus-immortalized lymphoblastoid cells with the RNeasy minikit (Qiagen, Courtaboeuf, France). Retrotranscription was performed using the Expand RT kit (Invitrogen, Saint Aubin, France). PCR was performed with primers in exon 5 (forward: 5&#x02032;-TAC&#x0200b;GCG&#x0200b;GAT&#x0200b;GCA&#x0200b;CTC&#x0200b;TGG-3&#x02032;) and exon 8 (reverse: 5&#x02032;-GTG&#x0200b;GAG&#x0200b;TGC&#x0200b;AGG&#x0200b;TCT&#x0200b;GTG&#x0200b;C-3&#x02032;); PCR products were subsequently sequenced.\u003C/p>\u003Cp class=\"mb0\">For the c.928G &#x0003e; A variant, RNA was extracted from Blood samples collected on PAXgene Blood Tube using the PAXgene Blood RNA Kit (Qiagen). cDNA was synthesized from RNA using the SuperScriptTM II RT (ThermoFisher Scientific) according to the manufacturer instructions with primers in exon 6 (forward: 5&#x02032;-CCT&#x0200b;TGC&#x0200b;GGC&#x0200b;AAC&#x0200b;CTT&#x0200b;CAC-3&#x02032;) and exon 8 (reverse: 5&#x02032;- GCT&#x0200b;CGT&#x0200b;AGT&#x0200b;ACT&#x0200b;GCC&#x0200b;ACG-3&#x02032;). cDNA amplicons were separated on a gel electrophoresis using a Labchip GX (Perkin Elmer). Both variants were submitted to ClinVar database (SCV001423824.1 and SCV000484597.1).\u003C/p>\u003Ch3 class=\"pt0\">Mutagenesis and Heterologous Expression of Channel Subunits\u003C/h3>\u003Cp class=\"mb0\">As reported (\u003Ca href=\"#B25\">Soldovieri et al., 2020\u003C/a>), c.928G &#x0003e; A/p.G310S variant was engineered in a pcDNA3.1-Kv7.2 plasmid for electrophysiological and western-blot experiments, as well as in a dual-tagged Enhanced Green Fluorescent Protein-Kv7.2-hemagglutinin (EGFP-Kv7.2-HA) plasmid used for experiments in neurons, by Quick-change mutagenesis (Agilent Technologies), accordingly to previously described procedure (\u003Ca href=\"#B16\">Miceli et al., 2012\u003C/a>). In the EGFP-Kv7.2-HA chimeric construct, in addition to an EGFP at the cytoplasmic N-terminus, an HA epitope was inserted in the extracellular loop that connects transmembrane domains S\u003Csub>1\u003C/sub> and S\u003Csub>2\u003C/sub> of Kv7.2 subunits (\u003Ca href=\"#B20\">Schwake et al., 2000\u003C/a>; \u003Ca href=\"#B24\">Soldovieri et al., 2006\u003C/a>). By contrast, the cDNA for the Kv7.2 p.G310&#x00394;10 variant was engineered by Eurofins service (Eurofins Genomics, Germany); then, a BspeEI/BstXI restriction cassette encompassing variant position was extracted and inserted into the dual-tagged EGFP-Kv7.2-HA plasmid, previously reacted with the same enzymes. Successful cloning was checked by direct sequencing.\u003C/p>\u003Cp class=\"mb0\">Methods for CHO cell growth and primary cortical neurons isolation, as well as protocols for wild-type and mutant cDNAs expression by transient transfection have been previously described (\u003Ca href=\"#B22\">Soldovieri et al., 2016\u003C/a>; \u003Ca href=\"#B25\">Soldovieri et al., 2020\u003C/a>). Total cDNA in the transfection mixture was kept constant at 4&#x000a0;&#x003bc;g (for electrophysiological recordings in CHO cells), 2&#x000a0;&#x003bc;g (for electrophysiological recordings in neurons), or 6&#x000a0;&#x003bc;g (for Western-blotting experiments).\u003C/p>\u003Ch3 class=\"pt0\">Cell Surface Biotinylation and Western-Blot\u003C/h3>\u003Cp class=\"mb0\">Expression of wild-type or variant Kv7.2 subunits in CHO cells in total lysate or plasma membrane-enriched fractions was investigated by surface biotinylation and western-blotting analysis, as described (\u003Ca href=\"#B23\">Soldovieri et al., 2014\u003C/a>). Channel subunits were identified using mouse monoclonal anti-Kv7.2 primary antibodies (clone N26A/23, dilution 1:1,000; Antibodies Inc., Davis, CA), followed by horseradish peroxidase (HRP)-conjugated anti-mouse secondary antibodies (clone NA931V; dilution 1:5,000; GE Healthcare, Little Chalfont, United Kingdom).\u003C/p>\u003Ch3 class=\"pt0\">Patch-Clamp Recordings\u003C/h3>\u003Cp class=\"mb0\">Macroscopic current recordings were performed in CHO cells (24&#x000a0;h after transfection) or in neurons (48&#x000a0;h after transfection), as previously reported (\u003Ca href=\"#B14\">Miceli et al., 2013\u003C/a>; \u003Ca href=\"#B3\">Binda et al., 2018\u003C/a>). Current densities were obtained dividing the current amplitude measured at each test voltage by the cell capacitance (pA/pF). The conductance was calculated by normalizing the currents measured at the end of each pulse to the driving force. Experimental data were fitted to a Boltzmann equation of the following form: \u003Cem>y\u003C/em>&#x0003d;max/[1&#x0002b;exp(\u003Cem>V\u003C/em>\u003Csub>1/2\u003C/sub>&#x02212;\u003Cem>V\u003C/em>)/\u003Cem>k\u003C/em>] to obtain the voltage of half activation (V\u003Csub>&#x000bd;\u003C/sub>) and the slope factor (\u003Cem>k\u003C/em>).\u003C/p>\u003Cp class=\"mb0\">Experiments on primary cortical neurons were performed either in voltage-clamp mode, using protocols similar to those applied on CHO cells, or in current-clamp mode, to record membrane resting potential. Data were acquired with a Multiclamp 700B amplifier and Digidata 1440A (Axon Instruments, Molecular Device) and pClamp 10.3 software (Molecular Devices) and analyzed with Clampfit 10.3 software (Molecular Devices).\u003C/p>\u003Cp class=\"mb0\">Experiments with the Danio rerio voltage-sensing phosphatase (DrVSP) were performed as previously reported (\u003Ca href=\"#B2\">Ambrosino et al., 2018\u003C/a>). Briefly, a 0&#x000a0;mV step lasting 1.5&#x000a0;s was used to activate Kv7 currents, followed by a &#x0002b;100&#x000a0;mV step of variable length (from 0.1 to 1&#x000a0;s, with increments of 0.1&#x000a0;s) to activate DrVSP, and by a second 0&#x000a0;mV step, causing DrVSP switch off and Kv7 current recovery (25&#x000a0;s). Time-dependent current decline following DrVSP activation was quantified as the ratio between the current size measured at the beginning of the second 0&#x000a0;mV step (after DrVSP activation) versus that measured at the end of the first 0&#x000a0;mV step (before DrVSP activation), expressed as a function of the duration of the &#x0002b;100&#x000a0;mV step; these values were then fitted to a Boltzmann function of the following form: y &#x0003d; 1/[1&#x0002b;(x/t\u003Csub>&#x000bd;\u003C/sub>)-Hill slope], where t\u003Csub>&#x000bd;\u003C/sub> was the duration of the &#x0002b;100&#x000a0;mV step required to inhibit 50% of maximal currents. Kv7 current recovery was instead quantified by normalizing current values recorded during the entire second step at 0&#x000a0;mV to the currents measured at the end of the first 0&#x000a0;mV step. The kinetics of DrVSP-induced Kv7 current inhibition and of Kv7 current recovery after DrVSP switch off were measured by fitting the current traces to a single exponential function of the following form: y &#x0003d; amp&#x000d7;e(&#x02212;t/&#x003c4;)&#x0002b;c, where &#x003c4; was the time constant of the function.\u003C/p>\u003Ch3 class=\"pt0\">Statistics\u003C/h3>\u003Cp class=\"mb0\">Each data point shown in figures or in the text is the Mean &#x000b1; SEM of at least 4 determinations, each performed in a single cell or in a separate experiment. Statistically significant differences were evaluated with the Student&#x02019;s t-test or with the ANOVA followed by the Student-Newman-Keuls test, with the threshold set at \u003Cem>p\u003C/em> &#x0003c; 0.05.\u003C/p>\u003Ca id=\"h4\" name=\"h4\">\u003C/a>\u003Ch2>Results\u003C/h2>\u003Ch3 class=\"pt0\">Analysis of Kv7.2 mRNAs Expressed in Patient-Derived Lymphoblasts\u003C/h3>\u003Cp class=\"mb0\">Both variants herein reported fall at the intron 6-exon 7 boundary of the KCNQ2 gene (\u003Ca href=\"#F1\">Figure 1A\u003C/a>). Four in silico tools provided by Alamut software (SpliceSiteFinder-like, MaxEntScan, NNSPLICE, and Gene Splicer; Suppl. \u003Ca href=\"#F1\">Figure 1A\u003C/a>) revealed that the SLNE-causing c.Kv7.2 c.928-1G &#x0003e; C intronic variant (affecting the g of the ag acceptor site located at the end of intron 6; \u003Ca href=\"#F1\">Figure 1A\u003C/a>) drastically reduced the strength of the affected splice site (\u003Ca href=\"#SM1\">Supplementary Figure S1A\u003C/a>; \u003Ca href=\"#B23\">Soldovieri et al., 2014\u003C/a>); similar results were obtained with the software spliceAI (acceptor loss score: 0.96). In keeping with this prediction, while Kv7.2 mRNAs analysis in lymphoblasts from the unaffected, non-carrier father revealed the presence of only wild-type fragments (295 bp), transcript analysis in lymphoblasts from the proband carrying the c.928-1G &#x0003e; C variant revealed the presence of both wild-type (295 bp) and shorter (265 bp) fragments (\u003Ca href=\"#F1\">Figure 1B\u003C/a>), the latter corresponding to the variant-induced use of a cryptic ag site located 30 bp downstream in exon 7, thus causing the removal of encompassed nucleotides (\u003Ca href=\"#F1\">Figure 1A\u003C/a>). The intensity of this low molecular weight band was much stronger than that corresponding to the full-length band of the wild-type allele, leading to an intensity ratio higher than the 1:1 expected from the heterozygous state of the patient; this result, possibly explained by the more efficient amplification of shorter amplicons, suggests that the effect of the variant on the splicing is complete. Expression of shorter mRNAs causes a 10 aminoacid in-frame deletion (Kv7.2 p.G310_K319del10, herein referred as Kv7.2 p.G310&#x00394;10), affecting the end of S6 domain and the beginning of the C-terminus of Kv7.2 subunits (\u003Ca href=\"#F1\">Figure 1D\u003C/a>).\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 1\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg\" name=\"Figure1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg\" alt=\"www.frontiersin.org\" id=\"F1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 1\u003C/strong>. Localization of KCNQ2 variants herein investigated and effects on KCNQ2 mRNAs expression. \u003Cstrong>(A)\u003C/strong> Localization of the two variants herein investigated in the KCNQ2 gene, falling at the last nucleotide of intron 6 (KCNQ2 \u003Cstrong>(C)\u003C/strong>928-1G &#x0003e; C; blue circle; already reported in \u003Ca href=\"#B23\">Soldovieri et al., 2014\u003C/a>) or at the first nucleotide of exon 7 (KCNQ2 \u003Cstrong>(C)\u003C/strong>928G &#x0003e; \u003Cstrong>(A)\u003C/strong>; already reported in \u003Ca href=\"#B25\">Soldovieri et al., 2020\u003C/a>). \u003Cstrong>(B)\u003C/strong> Representative agarose gel run and \u003Cstrong>(C)\u003C/strong> electrophoresis profiles of major bands obtained from RT-PCR experiments performed on Kv7.2 mRNAs expressed in father- or probands-deriving lymphoblasts, as indicated; the mRNA fragment of 295 bp \u003Cstrong>(B)\u003C/strong> or 218&#x000a0;bp \u003Cstrong>(C)\u003C/strong> are expected when the ag acceptor site at the end of intron 6 is used, while those of 265&#x000a0;bp \u003Cstrong>(B)\u003C/strong> or 188&#x000a0;bp \u003Cstrong>(C)\u003C/strong> bands are obtained using the alternative splice site in the exon 7. Panels in C have been obtained cropping the regions of interest from the complete electrophoresis profiles, reported in \u003Ca href=\"#SM1\">Supplementary Figure S2\u003C/a> Topology of a Kv7.2 subunit showing the 6 transmembrane segments (called from S1 to S6) and four intracellular domains at the C-terminus (called from A to D), binding many regulatory molecules. Middle and left panels show the structural alterations prompted by the Kv7.2 G310&#x00394;10 in-frame deletion or by the missense Kv7.2 G310S variant, respectively.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cp class=\"mb0\">By contrast, in the case of the DEE-causing exonic c.928G &#x0003e; A variant, affecting the first nucleotide of exon 7 (\u003Ca href=\"#F1\">Figure 1A\u003C/a>), prediction tools provided by Alamut (SpliceSiteFinder-like, MaxEntScan, NNSPLICE, and Gene Splicer) were in favor of only a slight reduction of the strength of the splice site (\u003Ca href=\"#SM1\">Supplementary Figure S1A\u003C/a>); similar results were obtained with the software spliceAI (acceptor loss score: 0.06). Accordingly, PCR analysis performed in lymphoblasts from the patient carrying this variant revealed that, while only the expected 218 bp-long fragments were detected in samples from the father (used as a control), a shorter (188&#x000a0;bp) Kv7.2 mRNA fragment was also detected in the patient carrying the c.928G &#x0003e; A variant (\u003Ca href=\"#F1\">Figure 1C\u003C/a>), with the first being much more abundant than the latter (90:10, respectively) (\u003Ca href=\"#F1\">Figure 1C\u003C/a>). The most abundant mRNA incorporates the c.928G &#x0003e; A substitution in exon 7, causing the missense substitution p.G310S (\u003Ca href=\"#F1\">Figures 1A&#x02013;D\u003C/a>).\u003C/p>\u003Ch3 class=\"pt0\">Functional Characterization of Kv7.2 Channels Carrying p.G310S or p.G310&#x00394;10 Variants in CHO Cells\u003C/h3>\u003Cp class=\"mb0\">The functional consequences of p.G310&#x00394;10 or p.G310S Kv7.2 subunits were investigated by electrophysiological recordings upon their expression in CHO cells by transient transfection. Expression of Kv7.2 channels in these cells elicited robust voltage-gated outward K\u003Csup>&#x0002b;\u003C/sup> currents with slow activation and deactivation kinetics, lack of inactivation and activating at about &#x02212;40&#x000a0;mV, with a current density of about 30&#x000a0;pA/pF (\u003Ca href=\"#F2\">Figure 2A\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>). By contrast, K\u003Csup>&#x0002b;\u003C/sup> current densities recorded from CHO cells transfected with either mutant plasmids were identical to those of non-transfected cells (\u003Ca href=\"#F2\">Figure 2A\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>).\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 2\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg\" name=\"Figure2\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g002.jpg\" alt=\"www.frontiersin.org\" id=\"F2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 2\u003C/strong>. Functional and biochemical characterization of Kv7.2 G310S and Kv7.2 G310&#x00394;10 subunits. \u003Cstrong>(A)\u003C/strong> Maximal current densities measured in non transfected cells (NT) or in cells expressing wild-type or mutant Kv7.2 subunits, as indicated. &#x0002a; &#x0003d; \u003Cem>p\u003C/em> &#x0003c; 0.05 versus NT cells. \u003Cstrong>(B)\u003C/strong> Western blot analysis of proteins from total lysates (upper panels) or biotinylated plasma membrane fractions (lower panels) from CHO cells transfected with the indicated constructs. Higher and lower blots were probed with anti-Kv7.2 or anti-&#x003b1;-tubulin antibodies, as indicated. Numbers on the left correspond to the molecular masses of the protein markers. ODKv7.2 TOT/ODTUB ratios were 1.00 &#x000b1; 0.20, 1.54 &#x000b1; 0.19, or 0.66 &#x000b1; 0.25; n &#x0003d; 4; \u003Cem>p\u003C/em> &#x0003e; 0.05 among each other; ODKv7.2 BIOT/ODTUB ratios were 1.00 &#x000b1; 0.50, 5.2 &#x000b1; 1.50, or 3.33 &#x000b1; 0.45 in Kv7.2-, Kv7.2 p.G310S-, or Kv7.2 p.G310&#x00394;10-transfected cells, respectively; n &#x0003d; 4; \u003Cem>p\u003C/em> &#x0003c; 0.05 versus Kv7.2. \u003Cstrong>(C,D)\u003C/strong> Quantification of maximal currents measured in CHO cells expressing either Kv7.2 variant with Kv7.2 \u003Cstrong>(C)\u003C/strong> and/or Kv7.3 \u003Cstrong>(D)\u003C/strong> subunits, as indicated. &#x0002a; &#x0003d; \u003Cem>p\u003C/em> &#x0003c; 0.05 versus the black bar in each panel; &#x0002a;&#x0002a; &#x0003d; \u003Cem>p\u003C/em> &#x0003c; 0.05 versus Kv7.3; &#x0002a;&#x0002a;&#x0002a; &#x0003d; \u003Cem>p\u003C/em> &#x0003c; 0.05 Kv7.2 &#x0002b; Kv7.3 (0.5:1). \u003Cstrong>(E)\u003C/strong> Representative current traces recorded upon application of the ramp protocol (shown below the first traces) on CHO cells expressing the indicated constructs in control solution \u003Cstrong>(C)\u003C/strong>, after 2-min 3&#x000a0;mM TEA perfusion, or upon drug washout (W). Current scale: 100&#x000a0;pA; time scale: 1&#x000a0;s.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">TABLE 1\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg\" name=\"Table1\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t001.jpg\" alt=\"www.frontiersin.org\" id=\"T1\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>TABLE 1\u003C/strong>. Functional properties of currents of wild-type or mutant Kv7.2 subunits when expressed in CHO cells or cortical neurons.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cp class=\"mb0\">To investigate possible variant-induced changes in Kv7.2 subunits trafficking to the plasma membrane, Western-blot experiments were performed in both total lysates and plasma membrane-enriched fractions from CHO cells expressing Kv7.2, Kv7.2&#x000a0;G310S, or Kv7.2 G310&#x00394;10 subunits. The results obtained showed that either substitutions did not interfere with whole-cell expression of Kv7.2 subunits (\u003Ca href=\"#F2\">Figure 2B\u003C/a>; \u003Cem>p\u003C/em> &#x0003e; 0.05 among each other), whilst both significantly increased Kv7.2 subunit expression at the plasma membrane (\u003Ca href=\"#F2\">Figure 2B\u003C/a>; \u003Cem>p\u003C/em> &#x0003c; 0.05 versus Kv7.2). Although this increase in plasma membrane abundance, quantitatively similar for both variants, was not further investigated, these results suggested that the functional impairment observed in electrophysiological experiments upon transfection with plasmids carrying either variant was not due to the inability of Kv7.2 mutant subunits to efficiently traffic to the plasma membrane.\u003C/p>\u003Cp class=\"mb0\">Having detected non-functional mutant subunits at the plasma membrane, we also investigated whether they interfered with the function of wild-type Kv7.2 and/or Kv7.2 subunits, as Kv7.2/3 heteromers underlie most of the M-current in adult neurons (\u003Ca href=\"#B28\">Wang et al., 1998\u003C/a>). Notably, co-expression of Kv7.2 subunits carrying either variant with Kv7.2 or Kv7.3 &#x0002b; Kv7.3 subunits significantly reduced maximal currents, thus indicating mutation-induced dominant-negative effects on Kv7.2 (\u003Ca href=\"#F2\">Figure 2C\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>) or Kv7.2/Kv7.3 (\u003Ca href=\"#F2\">Figure 2D\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>) currents. By contrast, significant dominant-negative effects on Kv7.3 currents only occurred upon co-expression of Kv7.2 p.G310&#x00394;10, but not Kv7.2 p.G310S subunits, whereas currents levels in Kv7.3- or Kv7.2 G310S/Kv7.3-expressing cells were identical (\u003Ca href=\"#F2\">Figure 2D\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>). To discern whether currents measured in Kv7.2 G310S/Kv7.3-expressing cells were carried by homomeric Kv7.3 or Kv7.2 G310S/Kv7.3 heteromeric channels, pharmacological experiments using tetraethylammonium (TEA, 3&#x000a0;mM) were performed; in fact, TEA is widely used to discriminate among Kv7 channel of distinct subunit composition since it blocks homomeric Kv7.2, homomeric Kv7.3 or heteromeric Kv7.2/Kv7.3 channels with a high, low, or intermediate potency, respectively (\u003Ca href=\"#B8\">Hadley et al., 2000\u003C/a>). In these experiments, currents from cells expressing Kv7.2 G310S/Kv7.3 channels were blocked by TEA to a similar extent as Kv7.2/Kv7.3 channels (\u003Ca href=\"#F2\">Figure 2E\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>), thus suggesting that Kv7.2 p.G310S subunits form functional heteromeric channels with Kv7.3 subunits.\u003C/p>\u003Ch3 class=\"pt0\">Functional Characterization of Kv7.2 Channels Carrying p.G310S or p.G310&#x00394;10 Variants in Cortical Neurons\u003C/h3>\u003Cp class=\"mb0\">Co-expression of Kv7.2 &#x0002b; Kv7.3 subunits in cortical neurons yielded robust outward currents with gating properties very similar to those measured in CHO cells (\u003Ca href=\"#F3\">Figure 3A\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>). Notably, the co-expression of Kv7.2 p.G310S or Kv7.2 p.G310&#x00394;10 subunits with wild-type Kv7.3 subunits reduced current densities to background (non-transfected) levels (\u003Ca href=\"#T1\">Table 1\u003C/a>). Moreover, cells co-expressing either Kv7.2 variant subunits with Kv7.2 &#x0002b; Kv7.3 subunits channels carried currents whose size was roughly intermediate between that of non-transfected neurons and those expressing Kv7.2 &#x0002b; Kv7.3 channels (\u003Ca href=\"#F3\">Figures 3B,C\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>). When compared to non-transfected neurons, neuronal resting membrane potential was hyperpolarized upon Kv7.2 &#x0002b; Kv7.3 co-expression; by contrast, co-expression of either variant failed to cause membrane hyperpolarization (\u003Ca href=\"#T1\">Table 1\u003C/a>). Altogether, these results validate the results obtained in CHO cells and suggest that both p.G310&#x00394;10 and p.G310S Kv7.2 variants strongly suppress Kv7.2 and/or Kv7.3 channel function.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 3\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg\" name=\"Figure3\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g003.jpg\" alt=\"www.frontiersin.org\" id=\"F3\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 3\u003C/strong>. Functional characterization of heteromeric Kv7.2 &#x0002b; Kv7.3 channels incorporating Kv7.2 G310S or Kv7.2 G310&#x00394;10 subunits expressed in neurons. \u003Cstrong>(A)\u003C/strong> Macroscopic currents from neurons expressing wild-type or mutant Kv7.2 &#x0002b; Kv7.3 subunits, as indicated. \u003Cstrong>(B,C)\u003C/strong> Current density/voltage curves measured in non transfected neurons (NT) or expressing the indicated channels incorporating Kv7.2 G310&#x00394;10 \u003Cstrong>(B)\u003C/strong> or Kv7.2 G310S \u003Cstrong>(C)\u003C/strong> subunits, as indicated.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Ch3 class=\"pt0\">p.G310S and p.G310&#x00394;10 Kv7.2 Subunits Show Distinct Changes in PIP\u003Csub>2\u003C/sub>/CaM Regulation\u003C/h3>\u003Cp class=\"mb0\">Both Kv7.2 variants herein investigated affect bottom end of the S\u003Csub>6\u003C/sub> segment in the pore of Kv7.2 subunits (\u003Ca href=\"#F1\">Figure 1C\u003C/a>); this region is critical for PIP\u003Csub>2\u003C/sub>-dependent regulation of Kv7.2 subunit function (\u003Ca href=\"#B34\">Zhang et al., 2003\u003C/a>; \u003Ca href=\"#B27\">Telezhkin et al., 2013\u003C/a>; \u003Ca href=\"#B35\">Zhang et al., 2013\u003C/a>; \u003Ca href=\"#B22\">Soldovieri et al., 2016\u003C/a>), and is located just prior helix A in the C-terminus (\u003Ca href=\"#F1\">Figure 1C\u003C/a>), a major anchoring site for CaM (\u003Ca href=\"#B33\">Yus-Najera et al., 2002\u003C/a>; \u003Ca href=\"#B5\">Gamper and Shapiro, 2003\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">Both PIP\u003Csub>2\u003C/sub> and CaM positively affect Kv7.2 subunit function (\u003Ca href=\"#B27\">Telezhkin et al., 2013\u003C/a>; \u003Ca href=\"#B1\">Ambrosino et al., 2015\u003C/a>). To investigate whether the loss-of-function effects caused by either Kv7.2 variant were dependent on changes in PIP\u003Csub>2\u003C/sub>- and/or CaM-dependent modulation, patch-clamp recordings were performed in CHO cells in which PIP\u003Csub>2\u003C/sub> levels were either increased by the co-expression of the PIP\u003Csub>2\u003C/sub>-synthesizing enzyme PIP5K (\u003Ca href=\"#B31\">Wenk et al., 2001\u003C/a>; \u003Ca href=\"#B32\">Winks et al., 2005\u003C/a>), or decreased by a voltage-dependent phosphatase (DrVSP) (\u003Ca href=\"#B4\">Falkenburger et al., 2010\u003C/a>); in addition, CaM regulation was tested by measuring the functional consequences of an enhanced CaM availability, achieved by co-expressing wild-type CaM or CaM\u003Csub>1234\u003C/sub>, a CaM variant unable to bind Ca2&#x0002b; (\u003Ca href=\"#B7\">Geiser et al., 1991\u003C/a>).\u003C/p>\u003Cp class=\"mb0\">The results obtained suggest that Kv7.2 currents were significantly increased upon co-expression of PIP5K, CaM, or CaM\u003Csub>1234\u003C/sub> (\u003Ca href=\"#F4\">Figure 4A\u003C/a>; \u003Ca href=\"#T2\">Table 2\u003C/a>); notably, potentiation by PIP5K, CaM, or CaM\u003Csub>1234\u003C/sub> was non-additive in the present experimental conditions. Instead, Kv7.2 p.G310S channels showed strong functional recovery in the presence of PIP5K and CaM\u003Csub>1234\u003C/sub>, but not wild-type CaM (\u003Ca href=\"#F4\">Figure 4A\u003C/a>; \u003Ca href=\"#T2\">Table 2\u003C/a>); notably, the effects of PIP5K and CaM\u003Csub>1234\u003C/sub> were synergistic (\u003Ca href=\"#F4\">Figure 4B\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>). By contrast, none of the previously mentioned experimental condition (alone or in combination) was able to recover Kv7.2 p.G310&#x00394;10 function (\u003Ca href=\"#F4\">Figures 4A,B\u003C/a>; \u003Ca href=\"#T1\">Table 1\u003C/a>), possibly suggesting that the G310-K319 region deleted by the mutation is critically involved in Kv7.2 currents functional modulation by PIP\u003Csub>2\u003C/sub> and/or CaM.\u003C/p>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">FIGURE 4\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg\" name=\"Figure4\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g004.jpg\" alt=\"www.frontiersin.org\" id=\"F4\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>FIGURE 4\u003C/strong>. Functional study of the modulation of Kv7.2 G310S or Kv7.2 G310&#x00394;10 subunits by PIP\u003Csub>2\u003C/sub> and calmodulin. \u003Cstrong>(A,B)\u003C/strong> Representative traces \u003Cstrong>(A)\u003C/strong> and quantification \u003Cstrong>(B)\u003C/strong> of currents measured in CHO cells co-expressing homomeric wild-type or mutant Kv7.2 subunits with PIP5K, CaM, and/or CaM\u003Csub>1234\u003C/sub>, as indicated. &#x0002a; &#x0003d; \u003Cem>p\u003C/em> &#x0003c; 0.05 versus Kv7.2. \u003Cstrong>(C)\u003C/strong> Time-dependence of current decrease (left panel) and recovery (right panel) of currents measured in CHO cells co-expressing the indicated channels with DrVSP.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cdiv class=\"Imageheaders\">TABLE 2\u003C/div>\u003Cdiv class=\"FigureDesc\">\u003Ca href=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg\" name=\"Table2\" target=\"_blank\">\n  \u003Cpicture>\n    \u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg\" media=\"(max-width: 563px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg\" media=\"(max-width: 1024px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg\" media=\"(max-width: 1441px)\">\u003Csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg\" media=\"\">\u003Csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg\" media=\"\"> \u003Cimg src=\"https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-t002.jpg\" alt=\"www.frontiersin.org\" id=\"T2\" loading=\"lazy\">\n  \u003C/picture>\n\u003C/a>\u003Cp>\u003Cstrong>TABLE 2\u003C/strong>. Functional properties of currents measured in CHO cells expressing wild-type or mutant Kv7.2 subunits upon modulation of PIP\u003Csub>2\u003C/sub> or CaM levels.\u003C/p>\u003C/div>\u003Cdiv class=\"clear\">\u003C/div>\u003Cdiv class=\"DottedLine\">\u003C/div>\u003Cp class=\"mb0\">To further investigate variant-induced changes in PIP\u003Csub>2\u003C/sub>-dependent Kv7.2 currents modulation, PIP\u003Csub>2\u003C/sub> levels were decreased upon co-expression of the voltage-dependent phosphatase DrVSP. As reported in \u003Ca href=\"#F4\">Figure 4C\u003C/a>, Kv7.2 &#x0002b; Kv7.3 currents were time-dependently inhibited when &#x0002b;100&#x000a0;mV depolarizing pulses lasting &#x0003e;0.2&#x000a0;s were used to activate DrVSP (t\u003Csub>&#x000bd;\u003C/sub> was 0.298 &#x000b1; 0.003 s, n &#x0003d; 16), with a time constant of current inhibition (\u003Cem>&#x003c4;\u003C/em>) of 0.24 &#x000b1; 0.03&#x000a0;s (n &#x0003d; 13). Membrane repolarization at 0&#x000a0;mV, a membrane potential value at which the DrVSP is switched off, led to a complete time-dependent recovery of Kv7.2 &#x0002b; Kv7.3 currents with a time constant of 26.8 &#x000b1; 3.27&#x000a0;s (n &#x0003d; 15). Notably, currents expressed by Kv7.2 &#x0002b; Kv7.2 G310S &#x0002b; Kv7.3 or Kv7.2 &#x0002b; Kv7.2 G310&#x00394;10 &#x0002b; Kv7.3 channels were more easily inhibited upon DrVSP activation: in fact, t\u003Csub>&#x000bd;\u003C/sub> were 0.185 &#x000b1; 0.008 or 0.214 &#x000b1; 0.003 s, respectively (n &#x0003d; 12&#x02013;15; \u003Cem>p\u003C/em> &#x0003c; 0.05 versus control and among each other; \u003Ca href=\"#F4\">Figure 4C\u003C/a>); in addition, a faster time constant was measured in cells expressing Kv7.2 &#x0002b; Kv7.2 G310S &#x0002b; Kv7.3 (&#x003c4; &#x0003d; 0.15 &#x000b1; 0.02 s; n &#x0003d; 9; \u003Cem>p\u003C/em> &#x0003c; 0.05 versus wild-type channels), but not Kv7.2 &#x0002b; Kv7.2 G310&#x00394;10 &#x0002b; Kv7.3 subunits (&#x003c4; &#x0003d; 0.24 &#x000b1; 0.02 s; n &#x0003d; 10; \u003Cem>p\u003C/em> &#x0003e; 0.05 versus wild-type channels). No difference in time constant of current recovery was measured for Kv7.2 &#x0002b; Kv7.2 G310S &#x0002b; Kv7.3 or Kv7.2 &#x0002b; Kv7.2 G310&#x00394;10 &#x0002b; Kv7.3 channels when compared to wild-type channels (&#x003c4; &#x0003d; 26.5 &#x000b1; 3.85 or 33.1 &#x000b1; 4.77 s, respectively; n &#x0003d; 9&#x02013;10; \u003Cem>p\u003C/em> &#x0003e; 0.05 versus wild-type channels).\u003C/p>\u003Cp class=\"mb0\">Altogether, these results suggest that both variants herein studied prompted significant alterations in CaM- and PIP\u003Csub>2\u003C/sub>-dependent Kv7.2 current modulation, with a greater functional derangement in the presence of the DEE-causing p.G310S variant when compared to the SLNE-causing p.G310&#x00394;10 variant.\u003C/p>\u003Ca id=\"h5\" name=\"h5\">\u003C/a>\u003Ch2>Discussion\u003C/h2>\u003Cp class=\"mb15\">Pathogenic variants in Kv7.2 potassium channels have been found in patients affected by widely diverging epileptic phenotypes, ranging from self-limiting (SLFNE) to very severe DEEs (\u003Ca href=\"#B30\">Weckhuysen et al., 2012\u003C/a>; \u003Ca href=\"#B29\">Weckhuysen et al., 2013\u003C/a>). Given the rarity of KCNQ2-related disorders, genotype-phenotype correlations are difficult to establish; in general, haploinsufficiency caused by the loss of function of a single KCNQ2 allele (by nonsense, splice, or frameshift variants) is the most common cause of familial KCNQ2-SLFNE, while pathogenic variants so far identified in KCNQ2-DEE are all \u003Cem>de novo\u003C/em> missense variants, and are thought to exert more severe functional defects on potassium current function (\u003Ca href=\"#B14\">Miceli et al., 2013\u003C/a>; \u003Ca href=\"#B19\">Orhan et al., 2014\u003C/a>). No studies have yet been performed on KCNQ2 variants affecting splice sites (\u003Ca href=\"http://www.rikee.org\">www.rikee.org\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">In the present study, we have characterized the genetic, biochemical, and functional consequences prompted by two known variants in the KCNQ2 gene falling at the intron 6-exon 7 boundary: the SLNE-causing c.Kv7.2 c.928-1G &#x0003e; C intronic variant, and the DEE-causing exonic c.928G &#x0003e; A variant, to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in the probands carrying these two variants.\u003C/p>\u003Cp class=\"mb15\">Kv7.2 mRNAs analysis from patient-derived immortalized lymphoblasts revealed that the SLNE-causing Kv7.2 c.928-1G &#x0003e; C substitution abolished the physiological &#x0201c;ag&#x0201d; acceptor site, and promoted the use of a cryptic site located 30 bp downstream, thus leading to a 10 aminoacid in-frame deletion (p.G310_K319&#x00394;10); in the proband samples, comparison of the intensity of the new, mutation-induced, lower molecular weight band with that corresponding to the wild-type full-length band suggested that the mutation-induced effect of the variant on the splicing process is complete. By contrast, in the case of the c.928G &#x0003e; A substitution, mRNAs analysis revealed more complex effects, with most of the mRNAs (&#x0003e;90%) resulting from the use of the natural &#x0201c;ag&#x0201d; acceptor site localized at the end of intron 6, and leading to Kv7.2 mRNAs of the same length as wild-type, but encoding for the missense substitution p.G310S; in addition, the same splicing alteration described above and leading to the 10 aminoacid in-frame deletion (p.Gly310_Lys319&#x00394;10) was also detected in this patient, although this component only accounted for &#x0003c;10% of total Kv7.2 mRNAs. Although splicing in lymphoblasts might not fully recapitulate that occurring at neuronal level, based on these results we have investigated the functional consequences of Kv7.2 p.G310&#x00394;10 subunits produced by the intronic Kv7.2 c.928-1G &#x0003e; C variant, and those of Kv7.2 p.G310S subunits occurring as a result of the Kv7.2 c.928G &#x0003e; A exonic mutation.\u003C/p>\u003Cp class=\"mb15\">Both Kv7.2 p.G310S and Kv7.2 p.G310&#x00394;10 mutant subunits failed to elicit measurable currents and prompted dominant-negative effects in heteromeric configuration with Kv7.2 and/or Kv7.3 subunits when transiently-transfected in CHO cells. A similar lack of function was also observed when these subunits were co-expressed with Kv7.2/Kv7.3 subunits in primary culture of neonatal rat cortical neurons, a more physiological cellular context.\u003C/p>\u003Cp class=\"mb15\">Kv7.2 currents are regulated by a complex network of mutually-interacting intracellular molecules (\u003Ca href=\"#B9\">Hernandez et al., 2008\u003C/a>); mutations herein investigated are located slightly upstream of the C-terminal helix A, a critical anchoring site for CaM (\u003Ca href=\"#B33\">Yus-Najera et al., 2002\u003C/a>; \u003Ca href=\"#B5\">Gamper and Shapiro, 2003\u003C/a>), and of one of the binding sites for the Kv7 activator PIP\u003Csub>2\u003C/sub> (\u003Ca href=\"#B34\">Zhang et al., 2003\u003C/a>; \u003Ca href=\"#B11\">Li et al., 2005\u003C/a>; \u003Ca href=\"#B6\">Gamper and Shapiro, 2007\u003C/a>; \u003Ca href=\"#B27\">Telezhkin et al., 2013\u003C/a>; \u003Ca href=\"#B35\">Zhang et al., 2013\u003C/a>; \u003Ca href=\"#B22\">Soldovieri et al., 2016\u003C/a>). Both CaM and PIP\u003Csub>2\u003C/sub> potentiate Kv7.2 currents; thus, the possibility existed that the observed mutation-induced LoF effects were dependent on alterations in the PIP\u003Csub>2\u003C/sub>/CaM-dependent Kv7.2 current regulation. To test this hypothesis, the intracellular levels of these mediators were modified by overexpressing CaM (either in a wild-type or unable to bind Ca\u003Csup>2&#x0002b;\u003C/sup> isoform; \u003Ca href=\"#B7\">Geiser et al., 1991\u003C/a>), the PIP\u003Csub>2\u003C/sub>-synthesizing enzyme PIP5K (thus increasing PIP\u003Csub>2\u003C/sub> levels; \u003Ca href=\"#B31\">Wenk et al., 2001\u003C/a>) or the PIP\u003Csub>2\u003C/sub>-degrading voltage-dependent phosphatase from Danio rerio (\u003Ca href=\"#B4\">Falkenburger et al., 2010\u003C/a>).\u003C/p>\u003Cp class=\"mb15\">In most of these experimental conditions (overexpression of PIP5K and/or CaM\u003Csub>1234\u003C/sub>), currents carried by Kv7.2 subunits carrying the DEE-causing variant p.G310S were recovered to levels identical to those of wild-type Kv7.2 channels, suggesting that the LoF effects prompted by this variant on Kv7.2 currents are dependent to an alteration in the affinity of both mediators. By contrast, none of these experimental conditions (alone or in combination) were able to recover channel function in the case of Kv7.2 subunits incorporating the SLNE-causing variant p.G310&#x00394;10, possibly because of a complete inability of CaM and/or PIP\u003Csub>2\u003C/sub> to bind Kv7.2 channels as a consequence of the variant-induced in-frame deletion. This could lead to a reduced incorporation of Kv7.2 subunits carrying the SLNE-causing variant in functional heterotetrameric channels and therefore in a reduction of dominant-negative effects prompted on Kv7.2/Kv7.3 currents at high CaM and/or PIP\u003Csub>2\u003C/sub> levels, thus providing a plausible molecular explanation for the more benign clinical phenotypes observed in the individual carrying this variant. Moreover, both Kv7.2/Kv7.2 G310S/Kv7.3 and Kv7.2/Kv7.2 G310&#x00394;10/Kv7.3 currents were more sensitive than wild-type Kv7.2/Kv7.3 channels to PIP\u003Csub>2\u003C/sub> depletion; notably, the p.G310S variant prompted slightly stronger functional derangement when compared to the p.G310&#x00394;10 variant, which could further contribute to the divergent clinical phenotypes observed in the two probands.\u003C/p>\u003Cp class=\"mb15\">These results also suggest that a quantitative threshold level exists in terms of tolerance of Kv7.2 to variant-dependent changes in PIP\u003Csub>2\u003C/sub>-dependent current regulation, with smaller effects (such those of the Kv7.2 p.G310&#x00394;10 variant) leading to more benign forms of the clinical spectrum, and stronger derangements (as those caused by the Kv7.2 p.G310S variant) to more severe phenotypes. A similar hypothesis seems to provide a reasonable explanation for the results obtained in a DEE-affected patient carrying two variants in compound heterozygosity in KCNQ3, each inherited by a healthy parent; in this case, Kv7.2/Kv7.3 channels incorporating either KCNQ3 variant showed a smaller alteration in PIP\u003Csub>2\u003C/sub>-dependent current regulation when compared to channels incorporating both KCNQ3 variants (\u003Ca href=\"#B2\">Ambrosino et al., 2018\u003C/a>). The fact that, in this latter case, parents were asymptomatic could be explained by the fact that, when compared to KCNQ2, KCNQ3 shows a greater &#x0201c;mutation tolerance,&#x0201d; as also suggested by the higher incidence of KCNQ2-DEE when compared to KCNQ3-DEE cases.\u003C/p>\u003Cp class=\"mb15\">Altogether, the present results suggest that differences in both the alternative splicing process and in PIP\u003Csub>2\u003C/sub>/CaM-dependent Kv7.2 current regulation may contribute to the divergent clinical phenotypes caused by the two KCNQ2 variants herein studied.\u003C/p>\u003Ca id=\"h6\" name=\"h6\">\u003C/a>\u003Ch2>Data Availability Statement\u003C/h2>\u003Cp class=\"mb15\">The original contributions presented in the study are included in the article/\u003Ca href=\"#SM1\">Supplementary Material\u003C/a>, further inquiries can be directed to the corresponding authors.\u003C/p>\u003Ca id=\"h7\" name=\"h7\">\u003C/a>\u003Ch2>Ethics Statement\u003C/h2>\u003Cp class=\"mb0\">The procedures involving animals were conducted according to European (EEC Council Directive 86/609, OJ L 358, 1, December 12 1987) and Italian (D.L. n. 26/2014) laws and policies and approved by the University of Milano-Bicocca Animal Care and Use Ethic Commitee (n.02/2019) and by the Italian Ministry of Health (DGSAF 0017710-P-26/07/2017).\u003C/p>\u003Ca id=\"h8\" name=\"h8\">\u003C/a>\u003Ch2>Author Contributions\u003C/h2>\u003Cp class=\"mb0\">MVS, TG, EF, GL, JCD, and MT designed research; MVS, PA, IM, IR, AL, BC, CG, AB, and MT performed research and analysed data; MVS and MT wrote the paper.\u003C/p>\u003Ca id=\"h9\" name=\"h9\">\u003C/a>\u003Ch2>Funding\u003C/h2>\u003Cp class=\"mb0\">The present study was supported by grants, from the Department of Medicine and Health Science of the University of Molise to MVS, from the Italian Ministry for University and Research (PRIN 2017ALCR7C) to MT and MVS, from the Italian Ministry of Health (Project RF-2019-12370491) to MT and BC, the European Commission H2020 (UNICOM &#x02013; 875299), and the European Joint Programme on Rare Disease JTC 2020 to MT, and from the Italian Ministry of Health Ricerca Finalizzata Giovani Ricercatori 2016 (Project GR-2016-02363337) to JCD and MVS.\u003C/p>\u003Ca id=\"h10\" name=\"h10\">\u003C/a>\u003Ch2>Conflict of Interest\u003C/h2>\u003Cp class=\"mb0\">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003C/p>\u003Ca id=\"h11\" name=\"h11\">\u003C/a>\u003Ch2>Publisher&#x02019;s Note\u003C/h2>\u003Cp class=\"mb15\">All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003C/p>\u003Ca id=\"h12\" name=\"h12\">\u003C/a>\u003Ch2>Acknowledgments\u003C/h2>\u003Cp class=\"mb03\">We are deeply grateful to: Dr. Thomas J. Jentsch, Leibniz-Institut f&#x000fc;r Molekulare Pharmakologie (FMP), Berlin (Germany) for Kv7.2 and Kv7.3 cDNAs; Dr. Mark S. Shapiro for pcDNA3.1-CaM and pcDNA3.1-CaM\u003Csub>1234\u003C/sub> plasmids; Dr. Alvaro Villarroel, UPV-CSIC, Leioa (ES) for PIP(4)5Kly; Dr. Yasushi Okamura, Osaka University, Suita, Osaka (JP) for Dr. VSP-IRES-GFP cDNA\u003C/p>\u003Ca id=\"h13\" name=\"h13\">\u003C/a>\u003Ch2>Supplementary Material\u003C/h2>\u003Cp class=\"mb15\" id=\"SM1\">The Supplementary Material for this article can be found online at: \u003Ca href=\"https://www.frontiersin.org/articles/10.3389/fphar.2022.872645/full#supplementary-material\">https://www.frontiersin.org/articles/10.3389/fphar.2022.872645/full&#x00023;supplementary-material\u003C/a>\u003C/p>\u003Ca id=\"h14\" name=\"h14\">\u003C/a>\u003Ch2>References\u003C/h2>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B1\" id=\"B1\">\u003C/a>Ambrosino, P., Alaimo, A., Bartollino, S., Manocchio, L., De Maria, M., Mosca, I., et al. (2015). Epilepsy-Causing Mutations in Kv7.2 C-Terminus Affect Binding and Functional Modulation by Calmodulin. \u003Cem>Biochim. Biophys. Acta\u003C/em> 1852 (9), 1856&#x02013;1866. doi:10.1016/j.bbadis.2015.06.012\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/26073431/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.bbadis.2015.06.012\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Epilepsy-Causing+Mutations+in+Kv7.2+C-Terminus+Affect+Binding+and+Functional+Modulation+by+Calmodulin&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B2\" id=\"B2\">\u003C/a>Ambrosino, P., Freri, E., Castellotti, B., Soldovieri, M. V., Mosca, I., Manocchio, L., et al. (2018). Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP\u003Csub>2\u003C/sub>-Dependent K\u003Csup>&#x0002b;\u003C/sup> Channel Gating. \u003Cem>Mol. Neurobiol.\u003C/em> 55 (8), 7009&#x02013;7024. doi:10.1007/s12035-018-0883-5\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29383681/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s12035-018-0883-5\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Kv7.3+Compound+Heterozygous+Variants+in+Early+Onset+Encephalopathy+Reveal+Additive+Contribution+of+C-Terminal+Residues+to+PIP2-Dependent+K++Channel+Gating&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B3\" id=\"B3\">\u003C/a>Binda, A., Panariti, A., Barbuti, A., Murano, C., Dal Magro, R., Masserini, M., et al. (2018). Modulation of the Intrinsic Neuronal Excitability by Multifunctional Liposomes Tailored for the Treatment of Alzheimer&#x00027;s Disease. \u003Cem>Int. J. Nanomedicine\u003C/em> 13, 4059&#x02013;4071. doi:10.2147/IJN.S161563\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30034232/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.2147/IJN.S161563\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Modulation+of+the+Intrinsic+Neuronal+Excitability+by+Multifunctional+Liposomes+Tailored+for+the+Treatment+of+Alzheimer's+Disease&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B4\" id=\"B4\">\u003C/a>Falkenburger, B. H., Jensen, J. B., and Hille, B. (2010). Kinetics of PIP\u003Csub>2\u003C/sub> Metabolism and KCNQ2/3 Channel Regulation Studied with a Voltage-Sensitive Phosphatase in Living Cells. \u003Cem>J. Gen. Physiol.\u003C/em> 135, 99&#x02013;114. doi:10.1085/jgp.200910345\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/20100891/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1085/jgp.200910345\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Kinetics+of+PIP2+Metabolism+and+KCNQ2/3+Channel+Regulation+Studied+with+a+Voltage-Sensitive+Phosphatase+in+Living+Cells&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B5\" id=\"B5\">\u003C/a>Gamper, N., and Shapiro, M. S. (2003). Calmodulin Mediates Ca2&#x0002b;-Dependent Modulation of M-Type K\u003Csup>&#x0002b;\u003C/sup> Channels. \u003Cem>J. Gen. Physiol.\u003C/em> 122, 17&#x02013;31. doi:10.1085/jgp.200208783\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12810850/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1085/jgp.200208783\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Calmodulin+Mediates+Ca2+-Dependent+Modulation+of+M-Type+K++Channels&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B6\" id=\"B6\">\u003C/a>Gamper, N., and Shapiro, M. S. (2007). Regulation of Ion Transport Proteins by Membrane Phosphoinositides. \u003Cem>Nat. Rev. Neurosci.\u003C/em> 8, 921&#x02013;934. doi:10.1038/nrn2257\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/17971783/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/nrn2257\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Regulation+of+Ion+Transport+Proteins+by+Membrane+Phosphoinositides&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B7\" id=\"B7\">\u003C/a>Geiser, J. R., van Tuinen, D., Brockerhoff, S. E., Neff, M. M., and Davis, T. N. (1991). Can Calmodulin Function Without Binding Calcium? \u003Cem>Cell\u003C/em> 65, 949&#x02013;959. doi:10.1016/0092-8674(91)90547-c\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/2044154/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/0092-8674(91)90547-c\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Can+Calmodulin+Function+Without+Binding+Calcium?&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B8\" id=\"B8\">\u003C/a>Hadley, J. K., Noda, M., Selyanko, A. A., Wood, I. C., Abogadie, F. C., and Brown, D. A. (2000). Differential Tetraethylammonium Sensitivity of KCNQ1-4 Potassium Channels. \u003Cem>Br. J. Pharmacol.\u003C/em> 129, 413&#x02013;415. doi:10.1038/sj.bjp.0703086\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/10711337/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/sj.bjp.0703086\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Differential+Tetraethylammonium+Sensitivity+of+KCNQ1-4+Potassium+Channels&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B9\" id=\"B9\">\u003C/a>Hernandez, C. C., Zaika, O., Tolstykh, G. P., and Shapiro, M. S. (2008). Regulation of Neural KCNQ Channels: Signalling Pathways, Structural Motifs and Functional Implications. \u003Cem>J. Physiol.\u003C/em> 586 (7), 1811&#x02013;1821. doi:10.1113/jphysiol.2007.14830410.1113/jphysiol.2007.148304\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/18238808/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1113/jphysiol.2007.14830410.1113/jphysiol.2007.148304\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Regulation+of+Neural+KCNQ+Channels:+Signalling+Pathways,+Structural+Motifs+and+Functional+Implications&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B10\" id=\"B10\">\u003C/a>Kosenko, A., Kang, S., Smith, I. M., Greene, D. L., Langeberg, L. K., Scott, J. D., et al. (2012). Coordinated Signal Integration at the M-Type Potassium Channel Upon Muscarinic Stimulation. \u003Cem>EMBO J.\u003C/em> 31 (14), 3147&#x02013;3156. doi:10.1038/emboj.2012.156\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22643219/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/emboj.2012.156\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Coordinated+Signal+Integration+at+the+M-Type+Potassium+Channel+Upon+Muscarinic+Stimulation&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B11\" id=\"B11\">\u003C/a>Li, Y., Gamper, N., Hilgemann, D. W., and Shapiro, M. S. (2005). Regulation of Kv7 (KCNQ) K\u003Csup>&#x0002b;\u003C/sup> Channel Open Probability by Phosphatidylinositol 4,5-Bisphosphate. \u003Cem>J. Neurosci.\u003C/em> 25, 9825&#x02013;9835. doi:10.1523/JNEUROSCI.2597-05.2005\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16251430/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1523/JNEUROSCI.2597-05.2005\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Regulation+of+Kv7+(KCNQ)+K++Channel+Open+Probability+by+Phosphatidylinositol+4,5-Bisphosphate&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B12\" id=\"B12\">\u003C/a>Manville, R. W., and Abbott, G. W. (2018). Gabapentin is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels. \u003Cem>Mol. Pharmacol.\u003C/em> 94 (4), 1155&#x02013;1163. doi:10.1124/mol.118.112953\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30021858/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1124/mol.118.112953\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Gabapentin+is+a+Potent+Activator+of+KCNQ3+and+KCNQ5+Potassium+Channels&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B13\" id=\"B13\">\u003C/a>Marrion, N. V. (1997). Control of M-Current. \u003Cem>Annu. Rev. Physiol.\u003C/em> 59, 483&#x02013;504. doi:10.1146/annurev.physiol.59.1.483\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/9074774/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1146/annurev.physiol.59.1.483\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Control+of+M-Current&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B14\" id=\"B14\">\u003C/a>Miceli, F., Soldovieri, M. V., Ambrosino, P., Barrese, V., Migliore, M., Cilio, M. R., et al. (2013). Genotype-Phenotype Correlations in Neonatal Epilepsies Caused by Mutations in the Voltage Sensor of K(v)7.2 Potassium Channel Subunits. \u003Cem>Proc. Natl. Acad. Sci. U. S. A.\u003C/em> 110 (11), 4386&#x02013;4391. doi:10.1073/pnas.1216867110\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23440208/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1073/pnas.1216867110\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Genotype-Phenotype+Correlations+in+Neonatal+Epilepsies+Caused+by+Mutations+in+the+Voltage+Sensor+of+K(v)7.2+Potassium+Channel+Subunits&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B15\" id=\"B15\">\u003C/a>Miceli, F., Soldovieri, M. V., Ambrosino, P., De Maria, M., Migliore, M., Migliore, R., et al. (2015). Early-Onset Epileptic Encephalopathy Caused by Gain-Of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. \u003Cem>J. Neurosci.\u003C/em> 35 (9), 3782&#x02013;3793. doi:10.1523/JNEUROSCI.4423-14.2015\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/25740509/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1523/JNEUROSCI.4423-14.2015\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Early-Onset+Epileptic+Encephalopathy+Caused+by+Gain-Of-Function+Mutations+in+the+Voltage+Sensor+of+Kv7.2+and+Kv7.3+Potassium+Channel+Subunits&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B16\" id=\"B16\">\u003C/a>Miceli, F., Vargas, E., Bezanilla, F., and Taglialatela, M. (2012). Gating Currents From Kv7 Channels Carrying Neuronal Hyperexcitability Mutations in the Voltage-Sensing Domain. \u003Cem>Biophys. J.\u003C/em> 102 (6), 1372&#x02013;1382. doi:10.1016/j.bpj.2012.02.004\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22455920/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.bpj.2012.02.004\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Gating+Currents+From+Kv7+Channels+Carrying+Neuronal+Hyperexcitability+Mutations+in+the+Voltage-Sensing+Domain&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B17\" id=\"B17\">\u003C/a>Millichap, J. J., Miceli, F., De Maria, M., Keator, C., Joshi, N., Tran, B., et al. (2017). Infantile Spasms and Encephalopathy Without Preceding Neonatal Seizures Caused by KCNQ2 R198Q, a Gain-Of-Function Variant. \u003Cem>Epilepsia\u003C/em> 58 (1), e10&#x02013;e15. doi:10.1111/epi.13601\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27861786/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1111/epi.13601\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Infantile+Spasms+and+Encephalopathy+Without+Preceding+Neonatal+Seizures+Caused+by+KCNQ2+R198Q,+a+Gain-Of-Function+Variant&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B18\" id=\"B18\">\u003C/a>Millichap, J. J., Park, K. L., Tsuchida, T., Ben-Zeev, B., Carmant, L., Flamini, R., et al. (2016). KCNQ2 Encephalopathy: Features, Mutational Hot Spots, and Ezogabine Treatment of 11 Patients. \u003Cem>Neurol. Genet.\u003C/em> 2 (5), e96. doi:10.1212/NXG.0000000000000096\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27602407/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1212/NXG.0000000000000096\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=KCNQ2+Encephalopathy:+Features,+Mutational+Hot+Spots,+and+Ezogabine+Treatment+of+11+Patients&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B19\" id=\"B19\">\u003C/a>Orhan, G., Bock, M., Schepers, D., Ilina, E. I., Reichel, S. N., L&#x000f6;ffler, H., et al. (2014). Dominant-Negative Effects of KCNQ2 Mutations are Associated with Epileptic Encephalopathy. \u003Cem>Ann. Neurol.\u003C/em> 75, 382&#x02013;394. doi:10.1002/ana.24080\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24318194/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/ana.24080\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Dominant-Negative+Effects+of+KCNQ2+Mutations+are+Associated+with+Epileptic+Encephalopathy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B20\" id=\"B20\">\u003C/a>Schwake, M., Pusch, M., Kharkovets, T., and Jentsch, T. J. (2000). Surface Expression and Single Channel Properties of KCNQ2/KCNQ3, M-Type K\u003Csup>&#x0002b;\u003C/sup> Channels Involved in Epilepsy. \u003Cem>J. Biol. Chem.\u003C/em> 275 (18), 13343&#x02013;13348. doi:10.1074/jbc.275.18.13343\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/10788442/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1074/jbc.275.18.13343\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Surface+Expression+and+Single+Channel+Properties+of+KCNQ2/KCNQ3,+M-Type+K++Channels+Involved+in+Epilepsy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B21\" id=\"B21\">\u003C/a>Selyanko, A. A., Hadley, J. K., Wood, I. C., Abogadie, F. C., Jentsch, T. J., and Brown, D. A. (2000). Inhibition of KCNQ1-4 Potassium Channels Expressed in Mammalian Cells via M1 Muscarinic Acetylcholine Receptors. \u003Cem>J. Physiol.\u003C/em> 522 (Pt 3), 349&#x02013;355. doi:10.1111/j.1469-7793.2000.t01-2-00349.x\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/10713961/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1111/j.1469-7793.2000.t01-2-00349.x\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Inhibition+of+KCNQ1-4+Potassium+Channels+Expressed+in+Mammalian+Cells+via+M1+Muscarinic+Acetylcholine+Receptors&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B22\" id=\"B22\">\u003C/a>Soldovieri, M. V., Ambrosino, P., Mosca, I., De Maria, M., Moretto, E., Miceli, F., et al. (2016). Early-Onset Epileptic Encephalopathy Caused by a Reduced Sensitivity of Kv7.2 Potassium Channels to Phosphatidylinositol 4,5-Bisphosphate. \u003Cem>Sci. Rep.\u003C/em> 6, 38167. doi:10.1038/srep38167\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/27905566/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1038/srep38167\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Early-Onset+Epileptic+Encephalopathy+Caused+by+a+Reduced+Sensitivity+of+Kv7.2+Potassium+Channels+to+Phosphatidylinositol+4,5-Bisphosphate&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B23\" id=\"B23\">\u003C/a>Soldovieri, M. V., Boutry-Kryza, N., Milh, M., Doummar, D., Heron, B., Bourel, E., et al. (2014). Novel KCNQ2 and KCNQ3 Mutations in a Large Cohort of Families with Benign Neonatal Epilepsy: First Evidence for an Altered Channel Regulation by Syntaxin-1A. \u003Cem>Hum. Mutat.\u003C/em> 35, 356&#x02013;367. doi:10.1002/humu.22500\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24375629/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/humu.22500\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Novel+KCNQ2+and+KCNQ3+Mutations+in+a+Large+Cohort+of+Families+with+Benign+Neonatal+Epilepsy:+First+Evidence+for+an+Altered+Channel+Regulation+by+Syntaxin-1A&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B24\" id=\"B24\">\u003C/a>Soldovieri, M. V., Castaldo, P., Iodice, L., Miceli, F., Barrese, V., Bellini, G., et al. (2006). Decreased Subunit Stability as a Novel Mechanism for Potassium Current Impairment by a KCNQ2 C Terminus Mutation Causing Benign Familial Neonatal Convulsions. \u003Cem>J. Biol. Chem.\u003C/em> 281 (1), 418&#x02013;428. doi:10.1074/jbc.M510980200\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/16260777/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1074/jbc.M510980200\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Decreased+Subunit+Stability+as+a+Novel+Mechanism+for+Potassium+Current+Impairment+by+a+KCNQ2+C+Terminus+Mutation+Causing+Benign+Familial+Neonatal+Convulsions&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B25\" id=\"B25\">\u003C/a>Soldovieri, M. V., Freri, E., Ambrosino, P., Rivolta, I., Mosca, I., Binda, A., et al. (2020). Gabapentin Treatment in a Patient with KCNQ2 Developmental Epileptic Encephalopathy. \u003Cem>Pharmacol. Res.\u003C/em> 160, 105200. doi:10.1016/j.phrs.2020.105200\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32942014/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/j.phrs.2020.105200\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Gabapentin+Treatment+in+a+Patient+with+KCNQ2+Developmental+Epileptic+Encephalopathy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B26\" id=\"B26\">\u003C/a>Soldovieri, M. V., Miceli, F., and Taglialatela, M. (2011). Driving with No Brakes: Molecular Pathophysiology of Kv7 Potassium Channels. \u003Cem>Physiology (Bethesda)\u003C/em> 26 (5), 365&#x02013;376. doi:10.1152/physiol.00009.2011\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22013194/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1152/physiol.00009.2011\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Driving+with+No+Brakes:+Molecular+Pathophysiology+of+Kv7+Potassium+Channels&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B27\" id=\"B27\">\u003C/a>Telezhkin, V., Thomas, A. M., Harmer, S. C., Tinker, A., and Brown, D. A. (2013). A Basic Residue in the Proximal C-Terminus Is Necessary for Efficient Activation of the M-Channel Subunit Kv7.2 by PI(4,5)P&#x02082;. \u003Cem>Pflugers Arch.\u003C/em> 465 (7), 945&#x02013;953. doi:10.1007/s00424-012-1199-3\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/23291709/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1007/s00424-012-1199-3\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=A+Basic+Residue+in+the+Proximal+C-Terminus+Is+Necessary+for+Efficient+Activation+of+the+M-Channel+Subunit+Kv7.2+by+PI(4,5)PÃ¢Â‚Â‚&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B28\" id=\"B28\">\u003C/a>Wang, H. S., Pan, Z., Shi, W., Brown, B. S., Wymore, R. S., Cohen, I. S., et al. (1998). KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel. \u003Cem>Science\u003C/em> 282 (5395), 1890&#x02013;1893. doi:10.1126/science.282.5395.1890\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/9836639/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1126/science.282.5395.1890\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=KCNQ2+and+KCNQ3+Potassium+Channel+Subunits:+Molecular+Correlates+of+the+M-Channel&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B29\" id=\"B29\">\u003C/a>Weckhuysen, S., Ivanovic, V., Hendrickx, R., Van Coster, R., Hjalgrim, H., M&#x000f8;ller, R. S., et al. (2013). Extending the KCNQ2 Encephalopathy Spectrum: Clinical and Neuroimaging Findings in 17 Patients. \u003Cem>Neurology\u003C/em> 81 (19), 1697&#x02013;1703. doi:10.1212/01.wnl.0000435296.72400.a1\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24107868/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1212/01.wnl.0000435296.72400.a1\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Extending+the+KCNQ2+Encephalopathy+Spectrum:+Clinical+and+Neuroimaging+Findings+in+17+Patients&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B30\" id=\"B30\">\u003C/a>Weckhuysen, S., Mandelstam, S., Suls, A., Audenaert, D., Deconinck, T., Claes, L. R., et al. (2012). KCNQ2 Encephalopathy: Emerging Phenotype of a Neonatal Epileptic Encephalopathy. \u003Cem>Ann. Neurol.\u003C/em> 71 (1), 15&#x02013;25. doi:10.1002/ana.22644\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/22275249/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1002/ana.22644\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=KCNQ2+Encephalopathy:+Emerging+Phenotype+of+a+Neonatal+Epileptic+Encephalopathy&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B31\" id=\"B31\">\u003C/a>Wenk, M. R., Pellegrini, L., Klenchin, V. A., Di Paolo, G., Chang, S., Daniell, L., et al. (2001). PIP Kinase Igamma is the Major PI(4,5)P(2) Synthesizing Enzyme at the Synapse. \u003Cem>Neuron\u003C/em> 32, 79&#x02013;88. doi:10.1016/s0896-6273(01)00456-1\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/11604140/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/s0896-6273(01)00456-1\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=PIP+Kinase+Igamma+is+the+Major+PI(4,5)P(2)+Synthesizing+Enzyme+at+the+Synapse&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B32\" id=\"B32\">\u003C/a>Winks, J. S., Hughes, S., Filippov, A. K., Tatulian, L., Abogadie, F. C., Brown, D. A., et al. (2005). Relationship Between Membrane Phosphatidylinositol-4,5-Bisphosphate and Receptor-Mediated Inhibition of Native Neuronal M Channels. \u003Cem>J. Neurosci.\u003C/em> 25, 3400&#x02013;3413. doi:10.1523/JNEUROSCI.3231-04.2005\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/15800195/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1523/JNEUROSCI.3231-04.2005\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Relationship+Between+Membrane+Phosphatidylinositol-4,5-Bisphosphate+and+Receptor-Mediated+Inhibition+of+Native+Neuronal+M+Channels&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B33\" id=\"B33\">\u003C/a>Yus-Najera, E., Santana-Castro, I., and Villarroel, A. (2002). The Identification and Characterization of a Noncontinuous Calmodulin-Binding Site in Noninactivating Voltage-Dependent KCNQ Potassium Channels. \u003Cem>J. Biol. Chem.\u003C/em> 277 (32), 28545&#x02013;28553. doi:10.1074/jbc.M204130200\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12032157/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1074/jbc.M204130200\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=The+Identification+and+Characterization+of+a+Noncontinuous+Calmodulin-Binding+Site+in+Noninactivating+Voltage-Dependent+KCNQ+Potassium+Channels&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B34\" id=\"B34\">\u003C/a>Zhang, H., Craciun, L. C., Mirshahi, T., Roh&#x000e1;cs, T., Lopes, C. M., Jin, T., et al. (2003). PIP(2) Activates KCNQ Channels, and its Hydrolysis Underlies Receptor-Mediated Inhibition of M Currents. \u003Cem>Neuron\u003C/em> 37 (6), 963&#x02013;975. doi:10.1016/s0896-6273(03)00125-9\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/12670425/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1016/s0896-6273(03)00125-9\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=PIP(2)+Activates+KCNQ+Channels,+and+its+Hydrolysis+Underlies+Receptor-Mediated+Inhibition+of+M+Currents&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003Cdiv class=\"References\">\u003Cp class=\"ReferencesCopy1\">\u003Ca name=\"B35\" id=\"B35\">\u003C/a>Zhang, Q., Zhou, P., Chen, Z., Li, M., Jiang, H., Gao, Z., et al. (2013). Dynamic PIP\u003Csub>2\u003C/sub> Interactions with Voltage Sensor Elements Contribute to KCNQ2 Channel Gating. \u003Cem>Proc. Natl. Acad. Sci. U. S. A.\u003C/em> 110 (50), 20093&#x02013;20098. doi:10.1073/pnas.1312483110\u003C/p>\u003Cp class=\"ReferencesCopy2\">\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/24277843/\">PubMed Abstract\u003C/a> &#x0007c; \u003Ca href=\"https://doi.org/10.1073/pnas.1312483110\">CrossRef Full Text\u003C/a> &#x0007c; \u003Ca href=\"https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Dynamic+PIP2+Interactions+with+Voltage+Sensor+Elements+Contribute+to+KCNQ2+Channel+Gating&amp;btnG=\">Google Scholar\u003C/a>\u003C/p>\u003C/div>\u003C/div>\u003Cdiv class=\"thinLineM20\">\u003C/div>\u003Cdiv class=\"AbstractSummary\">\u003Cp>\u003Cspan>Keywords:\u003C/span> alternative splicing, Kv7.2 subunits, epileptic encephalopathy, PIP\u003Csub>2\u003C/sub>, calmodulin, KCNQ2\u003C/p>\u003Cp>\u003Cspan>Citation:\u003C/span> Mosca I, Rivolta I, Labalme A, Ambrosino P, Castellotti B, Gellera C, Granata T, Freri E, Binda A, Lesca G, DiFrancesco JC, Soldovieri MV and Taglialatela M (2022) Functional Characterization of Two Variants at the Intron 6&#x02014;Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes. \u003Cem>Front. Pharmacol.\u003C/em> 13:872645. doi: 10.3389/fphar.2022.872645\u003C/p>\u003Cp id=\"timestamps\">\u003Cspan>Received:\u003C/span> 09 February 2022; \u003Cspan>Accepted:\u003C/span> 10 May 2022;\u003Cbr>\u003Cspan>Published:\u003C/span> 13 June 2022.\u003C/p>\u003Cdiv>\u003Cp>Edited by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/945653/overview\">Tarek Mohamed Abd El-Aziz\u003C/a>, The University of Texas Health Science Center at San Antonio, United States\u003C/div>\u003Cdiv>\u003Cp>Reviewed by:\u003C/p> \u003Ca href=\"https://loop.frontiersin.org/people/808359/overview\">Marina Trivisano\u003C/a>, Bambino Ges&#x000f9; Children&#x02019;s Hospital (IRCCS), Italy\u003Cbr>\u003Ca href=\"https://loop.frontiersin.org/people/639939/overview\">Peter Sparber\u003C/a>, Federal State Budgetary Scientific Institution Research Centre for Medical Genetics (RCMG), Russia\u003C/div>\u003Cp>\u003Cspan>Copyright\u003C/span> &#x000a9; 2022 Mosca, Rivolta, Labalme, Ambrosino, Castellotti, Gellera, Granata, Freri, Binda, Lesca, DiFrancesco, Soldovieri and Taglialatela. This is an open-access article distributed under the terms of the \u003Ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">Creative Commons Attribution License (CC BY).\u003C/a> The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\u003C/p>\u003Cp>\u003Cspan>&#x0002a;Correspondence:\u003C/span> Maria Virginia Soldovieri, \u003Ca id=\"encmail\">bWFyaWF2aXJnaW5pYS5zb2xkb3ZpZXJpQHVuaW1vbC5pdA==\u003C/a>; Maurizio Taglialatela, \u003Ca id=\"encmail\">bXRhZ2xpYWxAdW5pbmEuaXQ=\u003C/a>\u003C/p>\u003Cp>\u003Cspan>\u003Csup>&#x02020;\u003C/sup>\u003C/span>These authors share first authorship\u003C/p>\u003Cdiv class=\"clear\">\u003C/div>\u003C/div>","\u003Cul class=\"flyoutJournal\">\u003Cli>\u003Ca href=\"#h1\">Abstract\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h2\">Introduction\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h3\">Materials and Methods\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h4\">Results\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h5\">Discussion\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h6\">Data Availability Statement\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h7\">Ethics Statement\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h8\">Author Contributions\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h9\">Funding\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h10\">Conflict of Interest\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h11\">Publisher&#x02019;s Note\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h12\">Acknowledgments\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h13\">Supplementary Material\u003C/a>\u003C/li>\u003Cli>\u003Ca href=\"#h14\">References\u003C/a>\u003C/li>\u003C/ul>",[684,690,696,699,705],{"name":685,"fileServerPackageEntryId":19,"fileServerId":686,"fileServerVersionNumber":687,"type":688},"EPUB.epub","872645/epub",2,{"code":689,"name":689},"EPUB",{"name":691,"fileServerPackageEntryId":692,"fileServerId":693,"fileServerVersionNumber":687,"type":694},"fphar-13-872645.pdf","fphar-13-872645-r1/fphar-13-872645.pdf","872645/pubmed-zip",{"code":695,"name":695},"PDF",{"name":691,"fileServerPackageEntryId":19,"fileServerId":697,"fileServerVersionNumber":687,"type":698},"872645/publishers-proof/pdf",{"code":695,"name":695},{"name":700,"fileServerPackageEntryId":701,"fileServerId":693,"fileServerVersionNumber":687,"type":702},"fphar-13-872645.xml","fphar-13-872645-r1/fphar-13-872645.xml",{"code":703,"name":704},"NLM_XML","XML",{"name":706,"fileServerPackageEntryId":19,"fileServerId":707,"fileServerVersionNumber":370,"type":708},"Provisional PDF.pdf","872645/provisional-pdf",{"code":695,"name":695},"v3",{"title":711,"link":712,"meta":716,"script":866},"Frontiers | Functional Characterization of Two Variants at the Intron 6â€”Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes",[713],{"rel":714,"href":715},"canonical","https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/full",[717,720,723,725,728,732,735,739,742,745,748,750,752,754,756,758,761,764,766,769,772,774,777,780,783,786,789,793,797,800,803,806,809,812,815,818,821,824,826,829,832,835,837,840,842,845,847,850,852,855,857,860,863],{"hid":718,"property":718,"name":718,"content":719},"description","Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ran...",{"hid":721,"property":721,"name":722,"content":711},"og:title","title",{"hid":724,"property":724,"name":718,"content":719},"og:description",{"hid":726,"name":726,"content":727},"keywords","Alternative Splicing,Kv7.2 channels,epileptic encephalopathy,PIP2,Calmodulin",{"hid":729,"property":729,"name":730,"content":731},"og:site_name","site_name","Frontiers",{"hid":733,"property":733,"name":363,"content":734},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/872645/fphar-13-872645-HTML-r1/image_m/fphar-13-872645-g001.jpg",{"hid":736,"property":736,"name":737,"content":738},"og:type","type","article",{"hid":740,"property":740,"name":741,"content":715},"og:url","url",{"hid":743,"name":743,"content":744},"twitter:card","summary_large_image",{"hid":746,"name":746,"content":747},"citation_volume","13",{"hid":749,"name":749,"content":116},"citation_journal_title",{"hid":751,"name":751,"content":731},"citation_publisher",{"hid":753,"name":753,"content":664},"citation_journal_abbrev",{"hid":755,"name":755,"content":665},"citation_issn",{"hid":757,"name":757,"content":515},"citation_doi",{"hid":759,"name":759,"content":760},"citation_firstpage","872645",{"hid":762,"name":762,"content":763},"citation_language","English",{"hid":765,"name":765,"content":516},"citation_title",{"hid":767,"name":767,"content":768},"citation_keywords","Alternative Splicing; Kv7.2 channels; epileptic encephalopathy; PIP2; Calmodulin",{"hid":770,"name":770,"content":771},"citation_abstract","Pathogenic variants in KCNQ2 encoding for Kv7.2 potassium channel subunits have been found in patients affected by widely diverging epileptic phenotypes, ranging from Self-Limiting Familial Neonatal Epilepsy (SLFNE) to severe Developmental and Epileptic Encephalopathy (DEE). Thus, understanding the pathogenic molecular mechanisms of Kv7.2 variants and their correlation with clinical phenotypes has a relevant impact on the clinical management of these patients. In the present study, the genetic, biochemical, and functional effects prompted by two variants, each found in a non-familial SLNE or a DEE patient but both affecting nucleotides at the KCNQ2 intron 6-exon 7 boundary, have been investigated to test whether and how they affected the splicing process and to clarify whether such mechanism might play a pathogenetic role in these patients. Analysis of KCNQ2 mRNA splicing in patient-derived lymphoblasts revealed that the SLNE-causing intronic variant (c.928-1G>C) impeded the use of the natural splice site, thus leading to a 10-aa Kv7.2 in frame deletion (Kv7.2 p.G310delta10); by contrast, the DEE-causing exonic variant (c.928G>A) only had subtle effects on the splicing process at this site, thus leading to the synthesis of a full-length subunit carrying the G310S missense variant (Kv7.2 p.G310S). Patch-clamp recordings in transiently-transfected CHO cells and primary neurons revealed that both variants fully impeded Kv7.2 channel function, and exerted strong dominant-negative effects when co-expressed with Kv7.2 and/or Kv7.3 subunits. Notably, Kv7.2 p.G310S, but not Kv7.2 p.G310delta10, currents were recovered upon overexpression of the PIP2-synthesizing enzyme PIP5K, and/or CaM; moreover, currents from heteromeric Kv7.2/Kv7.3 channels incorporating either Kv7.2 mutant subunits were differentially regulated by changes in PIP2 availability, with Kv7.2/Kv7.2 G310S/Kv7.3 currents showing  a greater sensitivity to PIP2 depletion when compared to those from Kv7.2/Kv7.2 G310delta10/Kv7.3 channels. Altogether, these results suggest that the two variants investigated differentially affected the splicing process at the intron 6-exon 7 boundary, and led to the synthesis of Kv7.2 subunits showing a differential sensitivity to PIP2 and CaM regulation; more studies are needed to clarify how such different functional properties contribute to the widely-divergent clinical phenotypes.",{"hid":773,"name":773,"content":530},"citation_article_type",{"hid":775,"name":775,"content":776},"citation_pdf_url","https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/pdf",{"hid":778,"name":778,"content":779},"citation_xml_url","https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.872645/xml",{"hid":781,"name":781,"content":782},"citation_fulltext_world_readable","yes",{"hid":784,"name":784,"content":785},"citation_online_date","2022/05/10",{"hid":787,"name":787,"content":788},"citation_publication_date","2022/06/13",{"hid":790,"name":791,"content":792},"citation_author_0","citation_author","Mosca, Ilaria ",{"hid":794,"name":795,"content":796},"citation_author_institution_0","citation_author_institution","Department of Medicine and Health Science â€œV. Tiberioâ€, Italy",{"hid":798,"name":791,"content":799},"citation_author_1","Rivolta, Ilaria ",{"hid":801,"name":795,"content":802},"citation_author_institution_1","School of Medicine and Surgery, Italy",{"hid":804,"name":791,"content":805},"citation_author_2","Labalme, Audrey ",{"hid":807,"name":795,"content":808},"citation_author_institution_2","Department of Medical Genetics, France",{"hid":810,"name":791,"content":811},"citation_author_3","Ambrosino, Paolo ",{"hid":813,"name":795,"content":814},"citation_author_institution_3","Department of Science and Technology (DST), Italy",{"hid":816,"name":791,"content":817},"citation_author_4","Castellotti, Barbara ",{"hid":819,"name":795,"content":820},"citation_author_institution_4","Unit of Medical Genetics and Neurogenetics, Italy",{"hid":822,"name":791,"content":823},"citation_author_5","Gellera, Cinzia ",{"hid":825,"name":795,"content":820},"citation_author_institution_5",{"hid":827,"name":791,"content":828},"citation_author_6","Granata, Tiziana ",{"hid":830,"name":795,"content":831},"citation_author_institution_6","Department of Pediatric Neuroscience, Italy",{"hid":833,"name":791,"content":834},"citation_author_7","Freri, Elena ",{"hid":836,"name":795,"content":831},"citation_author_institution_7",{"hid":838,"name":791,"content":839},"citation_author_8","Binda, Anna ",{"hid":841,"name":795,"content":802},"citation_author_institution_8",{"hid":843,"name":791,"content":844},"citation_author_9","Lesca, Gaetan ",{"hid":846,"name":795,"content":808},"citation_author_institution_9",{"hid":848,"name":791,"content":849},"citation_author_10","DiFrancesco, Jacopo C. ",{"hid":851,"name":795,"content":831},"citation_author_institution_10",{"hid":853,"name":791,"content":854},"citation_author_11","Soldovieri, Maria Virginia ",{"hid":856,"name":795,"content":796},"citation_author_institution_11",{"hid":858,"name":791,"content":859},"citation_author_12","Taglialatela, Maurizio ",{"hid":861,"name":795,"content":862},"citation_author_institution_12","Department of Neuroscience, Italy",{"hid":864,"name":864,"content":865},"dc.identifier","doi:10.3389/fphar.2022.872645",[867,870,872,874,876],{"src":868,"body":13,"type":869,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":871,"body":13,"type":869,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML",{"src":873,"body":13,"type":869,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":875,"body":13,"type":869,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fphar.2022.872645?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":877,"body":13,"type":869,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articleHubSlug":19,"articleHubPage":879,"articleHubArticlesList":880,"canJournalHasArticleHub":347,"articleDoiList":881},{},[],[],{"title":19,"image":-1,"breadcrumbs":883,"linksCollection":884,"metricsCollection":886},[],{"total":367,"items":885},[],{"total":367,"items":887},[]]</script>
<script>window.__NUXT__={};window.__NUXT__.config={public:{isDevMode:false,appName:"article-pages-2024",baseUrl:"https://www.frontiersin.org",domain:"frontiersin.org",loopUrl:"https://loop.frontiersin.org",ssMainDomain:"frontiersin.org",contentfulUrl:"https://graphql.contentful.com/content/v1/spaces",spaceId:1,spaceName:"Frontiers",liveSpaceId:1,tenantLogoUrl:"",frontiersGraphUrl:"https://apollo-federation-gateway.frontiersin.org",registrationApiUrl:"https://onboarding-ui.frontiersin.org",emailDigestApiUrl:"https://api-email-digest.frontiersin.org",journalFilesApiUrl:"https://files-journal-api.frontiersin.org",publicPagesFilesUrl:"https://public-pages-files-2025.frontiersin.org",searchApiUrl:"https://search-api.frontiersin.org",productionForumApiUrl:"https://production-forum-api-v2.frontiersin.org",gtmServerUrl:"https://tag-manager.frontiersin.org",gtmId:"GTM-M322FV2",gtmAuth:"owVbWxfaJr21yQv1fe1cAQ",gtmPreview:"env-1",figsharePluginUrl:"https://widgets.figshare.com/static/figshare.js",figshareApiUrl:"https://api.figshare.com/v2/collections/search",figshareTimeout:3000,crossmarkPublishedDate:"2015/08/24",googleRecaptchaSiteKey:"6LdG3i0UAAAAAOC4qUh35ubHgJotEHp_STXHgr_v",googleRecaptchaKeyName:"FrontiersRecaptchaV2",faviconSize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantFavicon-Frontiers.png",faviconSize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantFavicon-Frontiers.png",faviconSize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantFavicon-Frontiers.png",faviconSize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantFavicon-Frontiers.png",faviconSize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantFavicon-Frontiers.png",socialMediaImg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/Guidelines-Frontiers_Logo_1200x628_1-91to1.png",linkedArticleCopyText:"'{\"articleTypeCopyText\":[{\"articleTypeId\":0,\"originalArticleCopyText\":\"Part of this article's content has been mentioned in:\",\"linkedArticleCopyText\":\"This article mentions parts of:\"},{\"articleTypeId\":122,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an erratum on:\"},{\"articleTypeId\":129,\"originalArticleCopyText\":\"Parts of this article's content have been modified or rectified in:\",\"linkedArticleCopyText\":\"This article is an addendum to:\"},{\"articleTypeId\":128,\"originalArticleCopyText\":\"A correction has been applied to this article in:\",\"linkedArticleCopyText\":\"This article is a correction to:\"},{\"articleTypeId\":134,\"originalArticleCopyText\":\"A retraction of this article was approved in:\",\"linkedArticleCopyText\":\"This article is a retraction of:\"},{\"articleTypeId\":29,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"},{\"articleTypeId\":30,\"originalArticleCopyText\":\"A commentary has been posted on this article:\",\"linkedArticleCopyText\":\"This article is a commentary on:\"}],\"articleIdCopyText\":[]}'\n",acceptedArticleExcludedJournalIds:"'[2766,979]'\n",articleTypeConfigurableLabel:"\u003C\u003Carticle-type:uppercase>> article",settingsFeaturesSwitchers:"'{\"displayTitlePillLabels\":true,\"displayRelatedArticlesBox\":true,\"showEditors\":true,\"showReviewers\":true,\"showLoopImpactLink\":true,\"enableFigshare\":false}'\n",journalsWithArticleHub:"'{\"strings\":[\"science\"]}'\n",terminologySettings:"'{\"terms\":[{\"sequenceNumber\":1,\"key\":\"frontiers\",\"tenantTerm\":\"Frontiers\",\"frontiersDefaultTerm\":\"Frontiers\",\"category\":\"Customer\"},{\"sequenceNumber\":2,\"key\":\"submission_system\",\"tenantTerm\":\"submission system\",\"frontiersDefaultTerm\":\"submission system\",\"category\":\"Product\"},{\"sequenceNumber\":3,\"key\":\"public_pages\",\"tenantTerm\":\"public pages\",\"frontiersDefaultTerm\":\"public pages\",\"category\":\"Product\"},{\"sequenceNumber\":4,\"key\":\"my_frontiers\",\"tenantTerm\":\"my frontiers\",\"frontiersDefaultTerm\":\"my frontiers\",\"category\":\"Product\"},{\"sequenceNumber\":5,\"key\":\"digital_editorial_office\",\"tenantTerm\":\"digital editorial office\",\"frontiersDefaultTerm\":\"digital editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":6,\"key\":\"deo\",\"tenantTerm\":\"DEO\",\"frontiersDefaultTerm\":\"DEO\",\"category\":\"Product\"},{\"sequenceNumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantTerm\":\"digital editorial office for chiefs\",\"frontiersDefaultTerm\":\"digital editorial office for chiefs\",\"category\":\"Product\"},{\"sequenceNumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantTerm\":\"digital editorial office for eof\",\"frontiersDefaultTerm\":\"digital editorial office for eof\",\"category\":\"Product\"},{\"sequenceNumber\":9,\"key\":\"editorial_office\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"Product\"},{\"sequenceNumber\":10,\"key\":\"eof\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"Product\"},{\"sequenceNumber\":11,\"key\":\"research_topic_management\",\"tenantTerm\":\"research topic management\",\"frontiersDefaultTerm\":\"research topic management\",\"category\":\"Product\"},{\"sequenceNumber\":12,\"key\":\"review_forum\",\"tenantTerm\":\"review forum\",\"frontiersDefaultTerm\":\"review forum\",\"category\":\"Product\"},{\"sequenceNumber\":13,\"key\":\"accounting_office\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"Product\"},{\"sequenceNumber\":14,\"key\":\"aof\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"Product\"},{\"sequenceNumber\":15,\"key\":\"publishing_office\",\"tenantTerm\":\"publishing office\",\"frontiersDefaultTerm\":\"publishing office\",\"category\":\"Product\"},{\"sequenceNumber\":16,\"key\":\"production_office\",\"tenantTerm\":\"production office forum\",\"frontiersDefaultTerm\":\"production office forum\",\"category\":\"Product\"},{\"sequenceNumber\":17,\"key\":\"pof\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"Product\"},{\"sequenceNumber\":18,\"key\":\"book_office_forum\",\"tenantTerm\":\"book office forum\",\"frontiersDefaultTerm\":\"book office forum\",\"category\":\"Product\"},{\"sequenceNumber\":19,\"key\":\"bof\",\"tenantTerm\":\"BOF\",\"frontiersDefaultTerm\":\"BOF\",\"category\":\"Product\"},{\"sequenceNumber\":20,\"key\":\"aira\",\"tenantTerm\":\"AIRA\",\"frontiersDefaultTerm\":\"AIRA\",\"category\":\"Product\"},{\"sequenceNumber\":21,\"key\":\"editorial_board_management\",\"tenantTerm\":\"editorial board management\",\"frontiersDefaultTerm\":\"editorial board management\",\"category\":\"Product\"},{\"sequenceNumber\":22,\"key\":\"ebm\",\"tenantTerm\":\"EBM\",\"frontiersDefaultTerm\":\"EBM\",\"category\":\"Product\"},{\"sequenceNumber\":23,\"key\":\"domain\",\"tenantTerm\":\"domain\",\"frontiersDefaultTerm\":\"domain\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":24,\"key\":\"journal\",\"tenantTerm\":\"journal\",\"frontiersDefaultTerm\":\"journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":25,\"key\":\"section\",\"tenantTerm\":\"section\",\"frontiersDefaultTerm\":\"section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":26,\"key\":\"domains\",\"tenantTerm\":\"domains\",\"frontiersDefaultTerm\":\"domains\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":27,\"key\":\"specialty_section\",\"tenantTerm\":\"specialty section\",\"frontiersDefaultTerm\":\"specialty section\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":28,\"key\":\"specialty_journal\",\"tenantTerm\":\"specialty journal\",\"frontiersDefaultTerm\":\"specialty journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":29,\"key\":\"journals\",\"tenantTerm\":\"journals\",\"frontiersDefaultTerm\":\"journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":30,\"key\":\"sections\",\"tenantTerm\":\"sections\",\"frontiersDefaultTerm\":\"sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":31,\"key\":\"specialty_sections\",\"tenantTerm\":\"specialty sections\",\"frontiersDefaultTerm\":\"specialty sections\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":32,\"key\":\"specialty_journals\",\"tenantTerm\":\"specialty journals\",\"frontiersDefaultTerm\":\"specialty journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":33,\"key\":\"manuscript\",\"tenantTerm\":\"manuscript\",\"frontiersDefaultTerm\":\"manuscript\",\"category\":\"Core\"},{\"sequenceNumber\":34,\"key\":\"manuscripts\",\"tenantTerm\":\"manuscripts\",\"frontiersDefaultTerm\":\"manuscripts\",\"category\":\"Core\"},{\"sequenceNumber\":35,\"key\":\"article\",\"tenantTerm\":\"article\",\"frontiersDefaultTerm\":\"article\",\"category\":\"Core\"},{\"sequenceNumber\":36,\"key\":\"articles\",\"tenantTerm\":\"articles\",\"frontiersDefaultTerm\":\"articles\",\"category\":\"Core\"},{\"sequenceNumber\":37,\"key\":\"article_type\",\"tenantTerm\":\"article type\",\"frontiersDefaultTerm\":\"article type\",\"category\":\"Core\"},{\"sequenceNumber\":38,\"key\":\"article_types\",\"tenantTerm\":\"article types\",\"frontiersDefaultTerm\":\"article types\",\"category\":\"Core\"},{\"sequenceNumber\":39,\"key\":\"author\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":40,\"key\":\"authors\",\"tenantTerm\":\"authors\",\"frontiersDefaultTerm\":\"authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":41,\"key\":\"authoring\",\"tenantTerm\":\"authoring\",\"frontiersDefaultTerm\":\"authoring\",\"category\":\"Core\"},{\"sequenceNumber\":42,\"key\":\"authored\",\"tenantTerm\":\"authored\",\"frontiersDefaultTerm\":\"authored\",\"category\":\"Core\"},{\"sequenceNumber\":43,\"key\":\"accept\",\"tenantTerm\":\"accept\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":44,\"key\":\"accepted\",\"tenantTerm\":\"accepted\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantTerm\":\"Assistant Field Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editor\",\"description\":\"An editorial role on a Field Journal that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantTerm\":\"Assistant Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantTerm\":\"Assistant Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":48,\"key\":\"associate_editor\",\"tenantTerm\":\"Associate Editor\",\"frontiersDefaultTerm\":\"Associate Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":49,\"key\":\"specialty_chief_editor\",\"tenantTerm\":\"Specialty Chief Editor\",\"frontiersDefaultTerm\":\"Specialty Chief Editor\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":50,\"key\":\"specialty_chief_editors\",\"tenantTerm\":\"Specialty Chief Editors\",\"frontiersDefaultTerm\":\"Specialty Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":51,\"key\":\"chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":52,\"key\":\"chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":53,\"key\":\"call_for_participation\",\"tenantTerm\":\"call for participation\",\"frontiersDefaultTerm\":\"call for participation\",\"category\":\"Process\"},{\"sequenceNumber\":54,\"key\":\"citation\",\"tenantTerm\":\"citation\",\"frontiersDefaultTerm\":\"citation\",\"category\":\"Misc.\"},{\"sequenceNumber\":55,\"key\":\"citations\",\"tenantTerm\":\"citations\",\"frontiersDefaultTerm\":\"citations\",\"category\":\"Misc.\"},{\"sequenceNumber\":56,\"key\":\"contributor\",\"tenantTerm\":\"contributor\",\"frontiersDefaultTerm\":\"contributor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":57,\"key\":\"contributors\",\"tenantTerm\":\"contributors\",\"frontiersDefaultTerm\":\"contributors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":58,\"key\":\"corresponding_author\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":59,\"key\":\"corresponding_authors\",\"tenantTerm\":\"corresponding authors\",\"frontiersDefaultTerm\":\"corresponding authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":60,\"key\":\"decline\",\"tenantTerm\":\"decline\",\"frontiersDefaultTerm\":\"decline\",\"category\":\"Process\"},{\"sequenceNumber\":61,\"key\":\"declined\",\"tenantTerm\":\"declined\",\"frontiersDefaultTerm\":\"declined\",\"category\":\"Process\"},{\"sequenceNumber\":62,\"key\":\"reject\",\"tenantTerm\":\"reject\",\"frontiersDefaultTerm\":\"reject\",\"category\":\"Process\"},{\"sequenceNumber\":63,\"key\":\"rejected\",\"tenantTerm\":\"rejected\",\"frontiersDefaultTerm\":\"rejected\",\"category\":\"Process\"},{\"sequenceNumber\":64,\"key\":\"publish\",\"tenantTerm\":\"publish\",\"frontiersDefaultTerm\":\"publish\",\"category\":\"Core\"},{\"sequenceNumber\":65,\"key\":\"published\",\"tenantTerm\":\"published\",\"frontiersDefaultTerm\":\"published\",\"category\":\"Core\"},{\"sequenceNumber\":66,\"key\":\"publication\",\"tenantTerm\":\"publication\",\"frontiersDefaultTerm\":\"publication\",\"category\":\"Core\"},{\"sequenceNumber\":67,\"key\":\"peer_review\",\"tenantTerm\":\"peer review\",\"frontiersDefaultTerm\":\"peer review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":68,\"key\":\"peer_reviewed\",\"tenantTerm\":\"peer reviewed\",\"frontiersDefaultTerm\":\"peer reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":69,\"key\":\"initial_validation\",\"tenantTerm\":\"initial validation\",\"frontiersDefaultTerm\":\"initial validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":70,\"key\":\"editorial_assignment\",\"tenantTerm\":\"editorial assignment\",\"frontiersDefaultTerm\":\"editorial assignment\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":71,\"key\":\"independent_review\",\"tenantTerm\":\"independent review\",\"frontiersDefaultTerm\":\"independent review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":72,\"key\":\"interactive_review\",\"tenantTerm\":\"interactive review\",\"frontiersDefaultTerm\":\"interactive review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":73,\"key\":\"review\",\"tenantTerm\":\"review\",\"frontiersDefaultTerm\":\"review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":74,\"key\":\"reviewing\",\"tenantTerm\":\"reviewing\",\"frontiersDefaultTerm\":\"reviewing\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":75,\"key\":\"reviewer\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":76,\"key\":\"reviewers\",\"tenantTerm\":\"reviewers\",\"frontiersDefaultTerm\":\"reviewers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":77,\"key\":\"review_finalized\",\"tenantTerm\":\"review finalized\",\"frontiersDefaultTerm\":\"review finalized\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":78,\"key\":\"final_decision\",\"tenantTerm\":\"final decision\",\"frontiersDefaultTerm\":\"final decision\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":79,\"key\":\"final_validation\",\"tenantTerm\":\"final validation\",\"frontiersDefaultTerm\":\"final validation\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantTerm\":\"recommend to accept manuscript\",\"frontiersDefaultTerm\":\"accept manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":81,\"key\":\"fee\",\"tenantTerm\":\"fee\",\"frontiersDefaultTerm\":\"fee\",\"category\":\"Accounting\"},{\"sequenceNumber\":82,\"key\":\"fees\",\"tenantTerm\":\"fees\",\"frontiersDefaultTerm\":\"fees\",\"category\":\"Accounting\"},{\"sequenceNumber\":83,\"key\":\"guest_associate_editor\",\"tenantTerm\":\"Guest Associate Editor\",\"frontiersDefaultTerm\":\"Guest Associate Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":84,\"key\":\"guest_associate_editors\",\"tenantTerm\":\"Guest Associate Editors\",\"frontiersDefaultTerm\":\"Guest Associate Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":85,\"key\":\"in_review\",\"tenantTerm\":\"in review\",\"frontiersDefaultTerm\":\"in review\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":86,\"key\":\"institutional_member\",\"tenantTerm\":\"institutional partner\",\"frontiersDefaultTerm\":\"institutional partner\",\"category\":\"Accounting\"},{\"sequenceNumber\":87,\"key\":\"institutional_membership\",\"tenantTerm\":\"institutional partnership\",\"frontiersDefaultTerm\":\"institutional partnership\",\"category\":\"Accounting\"},{\"sequenceNumber\":88,\"key\":\"article_processing_charge\",\"tenantTerm\":\"article processing charge\",\"frontiersDefaultTerm\":\"article processing charge\",\"category\":\"Accounting\"},{\"sequenceNumber\":89,\"key\":\"article_processing_charges\",\"tenantTerm\":\"article processing charges\",\"frontiersDefaultTerm\":\"article processing charges\",\"category\":\"Accounting\"},{\"sequenceNumber\":90,\"key\":\"apcs\",\"tenantTerm\":\"APCs\",\"frontiersDefaultTerm\":\"APCs\",\"category\":\"Accounting\"},{\"sequenceNumber\":91,\"key\":\"apc\",\"tenantTerm\":\"APC\",\"frontiersDefaultTerm\":\"APC\",\"category\":\"Accounting\"},{\"sequenceNumber\":92,\"key\":\"received\",\"tenantTerm\":\"received\",\"frontiersDefaultTerm\":\"received\",\"description\":\"Date manuscript was received on.\",\"category\":\"Core\"},{\"sequenceNumber\":93,\"key\":\"transferred\",\"tenantTerm\":\"transferred\",\"frontiersDefaultTerm\":\"transferred\",\"category\":\"Core\"},{\"sequenceNumber\":94,\"key\":\"transfer\",\"tenantTerm\":\"transfer\",\"frontiersDefaultTerm\":\"transfer\",\"category\":\"Core\"},{\"sequenceNumber\":95,\"key\":\"research_topic\",\"tenantTerm\":\"research topic\",\"frontiersDefaultTerm\":\"research topic\",\"category\":\"Core\"},{\"sequenceNumber\":96,\"key\":\"research_topics\",\"tenantTerm\":\"research topics\",\"frontiersDefaultTerm\":\"research topics\",\"category\":\"Core\"},{\"sequenceNumber\":97,\"key\":\"topic_editor\",\"tenantTerm\":\"Topic Editor\",\"frontiersDefaultTerm\":\"Topic Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":98,\"key\":\"review_editor\",\"tenantTerm\":\"Community Reviewer\",\"frontiersDefaultTerm\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":99,\"key\":\"title\",\"tenantTerm\":\"title\",\"frontiersDefaultTerm\":\"title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":100,\"key\":\"running_title\",\"tenantTerm\":\"running title\",\"frontiersDefaultTerm\":\"running title\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":101,\"key\":\"submit\",\"tenantTerm\":\"submit\",\"frontiersDefaultTerm\":\"submit\",\"category\":\"Process\"},{\"sequenceNumber\":102,\"key\":\"submitted\",\"tenantTerm\":\"submitted\",\"frontiersDefaultTerm\":\"submitted\",\"category\":\"Process\"},{\"sequenceNumber\":103,\"key\":\"submitting\",\"tenantTerm\":\"submitting\",\"frontiersDefaultTerm\":\"submitting\",\"category\":\"Process\"},{\"sequenceNumber\":104,\"key\":\"t_e\",\"tenantTerm\":\"TE\",\"frontiersDefaultTerm\":\"TE\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":105,\"key\":\"topic\",\"tenantTerm\":\"topic\",\"frontiersDefaultTerm\":\"topic\",\"category\":\"Process\"},{\"sequenceNumber\":106,\"key\":\"topic_summary\",\"tenantTerm\":\"topic summary\",\"frontiersDefaultTerm\":\"topic summary\",\"category\":\"Process\"},{\"sequenceNumber\":107,\"key\":\"figure\",\"tenantTerm\":\"figure\",\"frontiersDefaultTerm\":\"figure\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":108,\"key\":\"figures\",\"tenantTerm\":\"figures\",\"frontiersDefaultTerm\":\"figures\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":109,\"key\":\"editorial_file\",\"tenantTerm\":\"editorial file\",\"frontiersDefaultTerm\":\"editorial file\",\"category\":\"Core\"},{\"sequenceNumber\":110,\"key\":\"editorial_files\",\"tenantTerm\":\"editorial files\",\"frontiersDefaultTerm\":\"editorial files\",\"category\":\"Core\"},{\"sequenceNumber\":111,\"key\":\"e_book\",\"tenantTerm\":\"e-book\",\"frontiersDefaultTerm\":\"e-book\",\"category\":\"Core\"},{\"sequenceNumber\":112,\"key\":\"organization\",\"tenantTerm\":\"organization\",\"frontiersDefaultTerm\":\"organization\",\"category\":\"Core\"},{\"sequenceNumber\":113,\"key\":\"institution\",\"tenantTerm\":\"institution\",\"frontiersDefaultTerm\":\"institution\",\"category\":\"Core\"},{\"sequenceNumber\":114,\"key\":\"reference\",\"tenantTerm\":\"reference\",\"frontiersDefaultTerm\":\"reference\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":115,\"key\":\"references\",\"tenantTerm\":\"references\",\"frontiersDefaultTerm\":\"references\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":116,\"key\":\"sce\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"description\":\"Abbreviation for Specialty Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":117,\"key\":\"submission\",\"tenantTerm\":\"submission\",\"frontiersDefaultTerm\":\"submission\",\"category\":\"Process\"},{\"sequenceNumber\":118,\"key\":\"submissions\",\"tenantTerm\":\"submissions\",\"frontiersDefaultTerm\":\"submissions\",\"category\":\"Process\"},{\"sequenceNumber\":119,\"key\":\"editing\",\"tenantTerm\":\"editing\",\"frontiersDefaultTerm\":\"editing\",\"category\":\"Process\"},{\"sequenceNumber\":120,\"key\":\"in_preparation\",\"tenantTerm\":\"in preparation\",\"frontiersDefaultTerm\":\"in preparation\",\"category\":\"Process\"},{\"sequenceNumber\":121,\"key\":\"country_region\",\"tenantTerm\":\"country/region\",\"frontiersDefaultTerm\":\"country/region\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":122,\"key\":\"countries_regions\",\"tenantTerm\":\"countries/regions\",\"frontiersDefaultTerm\":\"countries/regions\",\"description\":\"Because of political issues, some of the country listings are actually classified as `regions` and we need to include this. However other clients may not want to do this.\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":123,\"key\":\"specialty\",\"tenantTerm\":\"specialty\",\"frontiersDefaultTerm\":\"specialty\",\"category\":\"Core\"},{\"sequenceNumber\":124,\"key\":\"specialties\",\"tenantTerm\":\"specialties\",\"frontiersDefaultTerm\":\"specialties\",\"category\":\"Core\"},{\"sequenceNumber\":125,\"key\":\"associate_editors\",\"tenantTerm\":\"Associate Editors\",\"frontiersDefaultTerm\":\"Associate Editors\",\"description\":\"An editorial role on a specialty that a Registered User may hold. This gives them rights to different functionality and parts of the platform\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":126,\"key\":\"reviewed\",\"tenantTerm\":\"reviewed\",\"frontiersDefaultTerm\":\"reviewed\",\"category\":\"Peer Review Process\"},{\"sequenceNumber\":127,\"key\":\"institutional_members\",\"tenantTerm\":\"institutional partners\",\"frontiersDefaultTerm\":\"institutional partners\",\"category\":\"Accounting\"},{\"sequenceNumber\":128,\"key\":\"institutional_memberships\",\"tenantTerm\":\"institutional partnerships\",\"frontiersDefaultTerm\":\"institutional partnerships\",\"category\":\"Accounting\"},{\"sequenceNumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantTerm\":\"Assistant Field Chief Editors\",\"frontiersDefaultTerm\":\"Assistant Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":130,\"key\":\"publications\",\"tenantTerm\":\"publications\",\"frontiersDefaultTerm\":\"publications\",\"category\":\"Process\"},{\"sequenceNumber\":131,\"key\":\"ae_accepted\",\"tenantTerm\":\"recommended acceptance\",\"frontiersDefaultTerm\":\"accepted\",\"category\":\"Process\"},{\"sequenceNumber\":132,\"key\":\"field_journal\",\"tenantTerm\":\"field journal\",\"frontiersDefaultTerm\":\"field journal\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":133,\"key\":\"field_journals\",\"tenantTerm\":\"field journals\",\"frontiersDefaultTerm\":\"field journals\",\"category\":\"Taxonomy\"},{\"sequenceNumber\":134,\"key\":\"program_manager\",\"tenantTerm\":\"program manager\",\"frontiersDefaultTerm\":\"program manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":135,\"key\":\"journal_manager\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":136,\"key\":\"journal_specialist\",\"tenantTerm\":\"journal specialist\",\"frontiersDefaultTerm\":\"journal specialist\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":137,\"key\":\"program_managers\",\"tenantTerm\":\"program managers\",\"frontiersDefaultTerm\":\"program managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":138,\"key\":\"journal_managers\",\"tenantTerm\":\"journal managers\",\"frontiersDefaultTerm\":\"journal managers\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":139,\"key\":\"journal_specialists\",\"tenantTerm\":\"journal specialists\",\"frontiersDefaultTerm\":\"journal specialists\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":140,\"key\":\"cover_letter\",\"tenantTerm\":\"manuscript contribution to the field\",\"frontiersDefaultTerm\":\"manuscript contribution to the field\",\"category\":\"Process\"},{\"sequenceNumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantTerm\":\"recommended to accept manuscript\",\"frontiersDefaultTerm\":\"accepted manuscript\",\"category\":\"Process\"},{\"sequenceNumber\":142,\"key\":\"recommend_for_rejection\",\"tenantTerm\":\"recommend for rejection\",\"frontiersDefaultTerm\":\"recommend for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":143,\"key\":\"recommended_for_rejection\",\"tenantTerm\":\"recommended for rejection\",\"frontiersDefaultTerm\":\"recommended for rejection\",\"category\":\"Process\"},{\"sequenceNumber\":144,\"key\":\"ae\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"description\":\"Associate Editor - board member\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":145,\"key\":\"re\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"description\":\"Review Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":146,\"key\":\"rev\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"description\":\"Reviewer\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":147,\"key\":\"aut\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"description\":\"Author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":148,\"key\":\"coraut\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"description\":\"Corresponding author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":149,\"key\":\"saut\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"description\":\"Submitting author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":150,\"key\":\"coaut\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"description\":\"co-author\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":151,\"key\":\"tsof\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"description\":\"Typesetter\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":152,\"key\":\"typesetting_office\",\"tenantTerm\":\"typesetting office\",\"frontiersDefaultTerm\":\"typesetting office\",\"category\":\"Product\"},{\"sequenceNumber\":153,\"key\":\"config\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"description\":\"Configuration office role\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":154,\"key\":\"jm\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"description\":\"Journal Manager\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":155,\"key\":\"rte\",\"tenantTerm\":\"RTE\",\"frontiersDefaultTerm\":\"RTE\",\"description\":\"Research topic editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":156,\"key\":\"organizations\",\"tenantTerm\":\"organizations\",\"frontiersDefaultTerm\":\"organizations\",\"category\":\"Core\"},{\"sequenceNumber\":157,\"key\":\"publishing\",\"tenantTerm\":\"publishing\",\"frontiersDefaultTerm\":\"publishing\",\"category\":\"Core\"},{\"sequenceNumber\":158,\"key\":\"acceptance\",\"tenantTerm\":\"acceptance\",\"frontiersDefaultTerm\":\"acceptance\",\"category\":\"Process\"},{\"sequenceNumber\":159,\"key\":\"preferred_associate_editor\",\"tenantTerm\":\"preferred associate editor\",\"frontiersDefaultTerm\":\"preferred associate editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":160,\"key\":\"topic_editors\",\"tenantTerm\":\"Topic Editors\",\"frontiersDefaultTerm\":\"Topic Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":161,\"key\":\"institutions\",\"tenantTerm\":\"institutions\",\"frontiersDefaultTerm\":\"institutions\",\"category\":\"Core\"},{\"sequenceNumber\":162,\"key\":\"author(s)\",\"tenantTerm\":\"author(s)\",\"frontiersDefaultTerm\":\"author(s)\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":163,\"key\":\"figure(s)\",\"tenantTerm\":\"figure(s)\",\"frontiersDefaultTerm\":\"figure(s)\",\"category\":\"Manuscript Metadata\"},{\"sequenceNumber\":164,\"key\":\"co-authors\",\"tenantTerm\":\"co-authors\",\"frontiersDefaultTerm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":165,\"key\":\"editorial_board_members\",\"tenantTerm\":\"editorial board members\",\"frontiersDefaultTerm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":166,\"key\":\"editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"Product\"},{\"sequenceNumber\":167,\"key\":\"co-authorship\",\"tenantTerm\":\"co-authorship\",\"frontiersDefaultTerm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"Misc.\"},{\"sequenceNumber\":168,\"key\":\"role_id_1\",\"tenantTerm\":\"registration office\",\"frontiersDefaultTerm\":\"registration office\",\"category\":\"User Role\"},{\"sequenceNumber\":169,\"key\":\"role_id_2\",\"tenantTerm\":\"editorial office\",\"frontiersDefaultTerm\":\"editorial office\",\"category\":\"User Role\"},{\"sequenceNumber\":170,\"key\":\"role_id_7\",\"tenantTerm\":\"field chief editor\",\"frontiersDefaultTerm\":\"field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":171,\"key\":\"role_id_8\",\"tenantTerm\":\"assistant field chief editor\",\"frontiersDefaultTerm\":\"assistant field chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":172,\"key\":\"role_id_9\",\"tenantTerm\":\"specialty chief editor\",\"frontiersDefaultTerm\":\"specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":173,\"key\":\"role_id_10\",\"tenantTerm\":\"assistant specialty chief editor\",\"frontiersDefaultTerm\":\"assistant specialty chief editor\",\"category\":\"User Role\"},{\"sequenceNumber\":174,\"key\":\"role_id_11\",\"tenantTerm\":\"associate editor\",\"frontiersDefaultTerm\":\"associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":175,\"key\":\"role_id_12\",\"tenantTerm\":\"guest associate editor\",\"frontiersDefaultTerm\":\"guest associate editor\",\"category\":\"User Role\"},{\"sequenceNumber\":176,\"key\":\"role_id_13\",\"tenantTerm\":\"review editor\",\"frontiersDefaultTerm\":\"review editor\",\"category\":\"User Role\"},{\"sequenceNumber\":177,\"key\":\"role_id_14\",\"tenantTerm\":\"reviewer\",\"frontiersDefaultTerm\":\"reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":178,\"key\":\"role_id_15\",\"tenantTerm\":\"author\",\"frontiersDefaultTerm\":\"author\",\"category\":\"User Role\"},{\"sequenceNumber\":179,\"key\":\"role_id_16\",\"tenantTerm\":\"corresponding author\",\"frontiersDefaultTerm\":\"corresponding author\",\"category\":\"User Role\"},{\"sequenceNumber\":180,\"key\":\"role_id_17\",\"tenantTerm\":\"submitting author\",\"frontiersDefaultTerm\":\"submitting author\",\"category\":\"User Role\"},{\"sequenceNumber\":181,\"key\":\"role_id_18\",\"tenantTerm\":\"co-author\",\"frontiersDefaultTerm\":\"co-author\",\"category\":\"User Role\"},{\"sequenceNumber\":182,\"key\":\"role_id_20\",\"tenantTerm\":\"production office\",\"frontiersDefaultTerm\":\"production office\",\"category\":\"User Role\"},{\"sequenceNumber\":183,\"key\":\"role_id_22\",\"tenantTerm\":\"typesetting office (typesetter)\",\"frontiersDefaultTerm\":\"typesetting office (typesetter)\",\"category\":\"User Role\"},{\"sequenceNumber\":184,\"key\":\"role_id_24\",\"tenantTerm\":\"registered user\",\"frontiersDefaultTerm\":\"registered user\",\"category\":\"User Role\"},{\"sequenceNumber\":185,\"key\":\"role_id_35\",\"tenantTerm\":\"job office\",\"frontiersDefaultTerm\":\"job office\",\"category\":\"User Role\"},{\"sequenceNumber\":186,\"key\":\"role_id_41\",\"tenantTerm\":\"special event administrator\",\"frontiersDefaultTerm\":\"special event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":187,\"key\":\"role_id_42\",\"tenantTerm\":\"special event reviewer\",\"frontiersDefaultTerm\":\"special event reviewer\",\"category\":\"User Role\"},{\"sequenceNumber\":188,\"key\":\"role_id_43\",\"tenantTerm\":\"submit abstract\",\"frontiersDefaultTerm\":\"submit abstract\",\"category\":\"User Role\"},{\"sequenceNumber\":189,\"key\":\"role_id_52\",\"tenantTerm\":\"events office\",\"frontiersDefaultTerm\":\"events office\",\"category\":\"User Role\"},{\"sequenceNumber\":190,\"key\":\"role_id_53\",\"tenantTerm\":\"event administrator\",\"frontiersDefaultTerm\":\"event administrator\",\"category\":\"User Role\"},{\"sequenceNumber\":191,\"key\":\"role_id_89\",\"tenantTerm\":\"content management office\",\"frontiersDefaultTerm\":\"content management office\",\"category\":\"User Role\"},{\"sequenceNumber\":192,\"key\":\"role_id_98\",\"tenantTerm\":\"accounting office\",\"frontiersDefaultTerm\":\"accounting office\",\"category\":\"User Role\"},{\"sequenceNumber\":193,\"key\":\"role_id_99\",\"tenantTerm\":\"projects\",\"frontiersDefaultTerm\":\"projects\",\"category\":\"User Role\"},{\"sequenceNumber\":194,\"key\":\"role_id_103\",\"tenantTerm\":\"configuration office\",\"frontiersDefaultTerm\":\"configuration office\",\"category\":\"User Role\"},{\"sequenceNumber\":195,\"key\":\"role_id_104\",\"tenantTerm\":\"beta user\",\"frontiersDefaultTerm\":\"beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":196,\"key\":\"role_id_106\",\"tenantTerm\":\"wfconf\",\"frontiersDefaultTerm\":\"wfconf\",\"category\":\"User Role\"},{\"sequenceNumber\":197,\"key\":\"role_id_107\",\"tenantTerm\":\"rt management beta user\",\"frontiersDefaultTerm\":\"rt management beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":198,\"key\":\"role_id_108\",\"tenantTerm\":\"deo beta user\",\"frontiersDefaultTerm\":\"deo beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":199,\"key\":\"role_id_109\",\"tenantTerm\":\"search beta user\",\"frontiersDefaultTerm\":\"search beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":200,\"key\":\"role_id_110\",\"tenantTerm\":\"journal manager\",\"frontiersDefaultTerm\":\"journal manager\",\"category\":\"User Role\"},{\"sequenceNumber\":201,\"key\":\"role_id_111\",\"tenantTerm\":\"myfrontiers beta user\",\"frontiersDefaultTerm\":\"myfrontiers beta user\",\"category\":\"User Role\"},{\"sequenceNumber\":202,\"key\":\"role_id_21\",\"tenantTerm\":\"copy editor\",\"frontiersDefaultTerm\":\"copy editor\",\"category\":\"User Role\"},{\"sequenceNumber\":203,\"key\":\"role_id_1_abr\",\"tenantTerm\":\"ROF\",\"frontiersDefaultTerm\":\"ROF\",\"category\":\"User Role\"},{\"sequenceNumber\":204,\"key\":\"role_id_2_abr\",\"tenantTerm\":\"EOF\",\"frontiersDefaultTerm\":\"EOF\",\"category\":\"User Role\"},{\"sequenceNumber\":205,\"key\":\"role_id_7_abr\",\"tenantTerm\":\"FCE\",\"frontiersDefaultTerm\":\"FCE\",\"category\":\"User Role\"},{\"sequenceNumber\":206,\"key\":\"role_id_8_abr\",\"tenantTerm\":\"AFCE\",\"frontiersDefaultTerm\":\"AFCE\",\"category\":\"User Role\"},{\"sequenceNumber\":207,\"key\":\"role_id_9_abr\",\"tenantTerm\":\"SCE\",\"frontiersDefaultTerm\":\"SCE\",\"category\":\"User Role\"},{\"sequenceNumber\":208,\"key\":\"role_id_10_abr\",\"tenantTerm\":\"ASCE\",\"frontiersDefaultTerm\":\"ASCE\",\"category\":\"User Role\"},{\"sequenceNumber\":209,\"key\":\"role_id_11_abr\",\"tenantTerm\":\"AE\",\"frontiersDefaultTerm\":\"AE\",\"category\":\"User Role\"},{\"sequenceNumber\":210,\"key\":\"role_id_12_abr\",\"tenantTerm\":\"GAE\",\"frontiersDefaultTerm\":\"GAE\",\"category\":\"User Role\"},{\"sequenceNumber\":211,\"key\":\"role_id_13_abr\",\"tenantTerm\":\"RE\",\"frontiersDefaultTerm\":\"RE\",\"category\":\"User Role\"},{\"sequenceNumber\":212,\"key\":\"role_id_14_abr\",\"tenantTerm\":\"REV\",\"frontiersDefaultTerm\":\"REV\",\"category\":\"User Role\"},{\"sequenceNumber\":213,\"key\":\"role_id_15_abr\",\"tenantTerm\":\"AUT\",\"frontiersDefaultTerm\":\"AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":214,\"key\":\"role_id_16_abr\",\"tenantTerm\":\"CORAUT\",\"frontiersDefaultTerm\":\"CORAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":215,\"key\":\"role_id_17_abr\",\"tenantTerm\":\"SAUT\",\"frontiersDefaultTerm\":\"SAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":216,\"key\":\"role_id_18_abr\",\"tenantTerm\":\"COAUT\",\"frontiersDefaultTerm\":\"COAUT\",\"category\":\"User Role\"},{\"sequenceNumber\":217,\"key\":\"role_id_20_abr\",\"tenantTerm\":\"POF\",\"frontiersDefaultTerm\":\"POF\",\"category\":\"User Role\"},{\"sequenceNumber\":218,\"key\":\"role_id_22_abr\",\"tenantTerm\":\"TSOF\",\"frontiersDefaultTerm\":\"TSOF\",\"category\":\"User Role\"},{\"sequenceNumber\":219,\"key\":\"role_id_24_abr\",\"tenantTerm\":\"RU\",\"frontiersDefaultTerm\":\"RU\",\"category\":\"User Role\"},{\"sequenceNumber\":220,\"key\":\"role_id_35_abr\",\"tenantTerm\":\"JOF\",\"frontiersDefaultTerm\":\"JOF\",\"category\":\"User Role\"},{\"sequenceNumber\":221,\"key\":\"role_id_41_abr\",\"tenantTerm\":\"SE-ADM\",\"frontiersDefaultTerm\":\"SE-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":222,\"key\":\"role_id_42_abr\",\"tenantTerm\":\"SE-REV\",\"frontiersDefaultTerm\":\"SE-REV\",\"category\":\"User Role\"},{\"sequenceNumber\":223,\"key\":\"role_id_43_abr\",\"tenantTerm\":\"SE-AUT\",\"frontiersDefaultTerm\":\"SE-AUT\",\"category\":\"User Role\"},{\"sequenceNumber\":224,\"key\":\"role_id_52_abr\",\"tenantTerm\":\"EVOF\",\"frontiersDefaultTerm\":\"EVOF\",\"category\":\"User Role\"},{\"sequenceNumber\":225,\"key\":\"role_id_53_abr\",\"tenantTerm\":\"EV-ADM\",\"frontiersDefaultTerm\":\"EV-ADM\",\"category\":\"User Role\"},{\"sequenceNumber\":226,\"key\":\"role_id_89_abr\",\"tenantTerm\":\"COMOF\",\"frontiersDefaultTerm\":\"COMOF\",\"category\":\"User Role\"},{\"sequenceNumber\":227,\"key\":\"role_id_98_abr\",\"tenantTerm\":\"AOF\",\"frontiersDefaultTerm\":\"AOF\",\"category\":\"User Role\"},{\"sequenceNumber\":228,\"key\":\"role_id_99_abr\",\"tenantTerm\":\"Projects\",\"frontiersDefaultTerm\":\"Projects\",\"category\":\"User Role\"},{\"sequenceNumber\":229,\"key\":\"role_id_103_abr\",\"tenantTerm\":\"CONFIG\",\"frontiersDefaultTerm\":\"CONFIG\",\"category\":\"User Role\"},{\"sequenceNumber\":230,\"key\":\"role_id_104_abr\",\"tenantTerm\":\"BETA\",\"frontiersDefaultTerm\":\"BETA\",\"category\":\"User Role\"},{\"sequenceNumber\":231,\"key\":\"role_id_106_abr\",\"tenantTerm\":\"WFCONF\",\"frontiersDefaultTerm\":\"WFCONF\",\"category\":\"User Role\"},{\"sequenceNumber\":232,\"key\":\"role_id_107_abr\",\"tenantTerm\":\"RTBETA\",\"frontiersDefaultTerm\":\"RTBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":233,\"key\":\"role_id_108_abr\",\"tenantTerm\":\"DEOBETA\",\"frontiersDefaultTerm\":\"DEOBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":234,\"key\":\"role_id_109_abr\",\"tenantTerm\":\"SEARCHBETA\",\"frontiersDefaultTerm\":\"SEARCHBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":235,\"key\":\"role_id_110_abr\",\"tenantTerm\":\"JM\",\"frontiersDefaultTerm\":\"JM\",\"category\":\"User Role\"},{\"sequenceNumber\":236,\"key\":\"role_id_111_abr\",\"tenantTerm\":\"MFBETA\",\"frontiersDefaultTerm\":\"MFBETA\",\"category\":\"User Role\"},{\"sequenceNumber\":237,\"key\":\"role_id_21_abr\",\"tenantTerm\":\"COPED\",\"frontiersDefaultTerm\":\"COPED\",\"category\":\"User Role\"},{\"sequenceNumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantTerm\":\"editorial board\",\"frontiersDefaultTerm\":\"editorial board\",\"description\":\"This is the label for the review editorial board\",\"category\":\"Label\"},{\"sequenceNumber\":239,\"key\":\"field_chief_editor\",\"tenantTerm\":\"Field Chief Editor\",\"frontiersDefaultTerm\":\"Field Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":240,\"key\":\"field_chief_editors\",\"tenantTerm\":\"Field Chief Editors\",\"frontiersDefaultTerm\":\"Field Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":241,\"key\":\"editor\",\"tenantTerm\":\"editor\",\"frontiersDefaultTerm\":\"editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":242,\"key\":\"editors\",\"tenantTerm\":\"editors\",\"frontiersDefaultTerm\":\"editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":243,\"key\":\"board\",\"tenantTerm\":\"board\",\"frontiersDefaultTerm\":\"board\",\"category\":\"Label\"},{\"sequenceNumber\":244,\"key\":\"boards\",\"tenantTerm\":\"boards\",\"frontiersDefaultTerm\":\"boards\",\"category\":\"Label\"},{\"sequenceNumber\":245,\"key\":\"article_collection\",\"tenantTerm\":\"article collection\",\"frontiersDefaultTerm\":\"article collection\",\"category\":\"Label\"},{\"sequenceNumber\":246,\"key\":\"article_collections\",\"tenantTerm\":\"article collections\",\"frontiersDefaultTerm\":\"article collections\",\"category\":\"Label\"},{\"sequenceNumber\":247,\"key\":\"handling_editor\",\"tenantTerm\":\"handling editor\",\"frontiersDefaultTerm\":\"associate editor\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":248,\"key\":\"handling_editors\",\"tenantTerm\":\"handling editors\",\"frontiersDefaultTerm\":\"associate editors\",\"description\":\"This terminology key is for the person assigned to edit a manuscript. It is a label for the temporary handling editor assignment.\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":249,\"key\":\"ae_accept\",\"tenantTerm\":\"recommend acceptance\",\"frontiersDefaultTerm\":\"accept\",\"category\":\"Process\"},{\"sequenceNumber\":250,\"key\":\"rtm\",\"tenantTerm\":\"RTM\",\"frontiersDefaultTerm\":\"RTM\",\"category\":\"Product\"},{\"sequenceNumber\":251,\"key\":\"frontiers_media_sa\",\"tenantTerm\":\"Frontiers Media S.A\",\"frontiersDefaultTerm\":\"Frontiers Media S.A\",\"category\":\"Customer\"},{\"sequenceNumber\":252,\"key\":\"review_editors\",\"tenantTerm\":\"Community Reviewers\",\"frontiersDefaultTerm\":\"Review Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantTerm\":\"Chief Editor\",\"frontiersDefaultTerm\":\"Chief Editor\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantTerm\":\"Chief Editors\",\"frontiersDefaultTerm\":\"Chief Editors\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":255,\"key\":\"call_for_papers\",\"tenantTerm\":\"Call for papers\",\"frontiersDefaultTerm\":\"Call for papers\",\"category\":\"Label\"},{\"sequenceNumber\":256,\"key\":\"calls_for_papers\",\"tenantTerm\":\"Calls for papers\",\"frontiersDefaultTerm\":\"Calls for papers\",\"category\":\"Label\"},{\"sequenceNumber\":257,\"key\":\"supervising_editor\",\"tenantTerm\":\"Supervising Editor\",\"frontiersDefaultTerm\":\"Supervising Editor\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editor\"},{\"sequenceNumber\":258,\"key\":\"supervising_editors\",\"tenantTerm\":\"Supervising Editors\",\"frontiersDefaultTerm\":\"Supervising Editors\",\"description\":\"A Chief or Assistant Chief editor who is assigned to a manuscript to supervise.\",\"category\":\"Role\",\"externalKey\":\"supervising_editors\"},{\"sequenceNumber\":259,\"key\":\"reviewer_endorse\",\"tenantTerm\":\"endorse\",\"frontiersDefaultTerm\":\"endorse\",\"category\":\"Label\"},{\"sequenceNumber\":260,\"key\":\"reviewer_endorsed\",\"tenantTerm\":\"endorsed\",\"frontiersDefaultTerm\":\"endorsed\",\"category\":\"Label\"},{\"sequenceNumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantTerm\":\"endorse publication\",\"frontiersDefaultTerm\":\"endorse publication\",\"category\":\"Label\"},{\"sequenceNumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantTerm\":\"endorsed publication\",\"frontiersDefaultTerm\":\"endorsed publication\",\"category\":\"Label\"},{\"sequenceNumber\":263,\"key\":\"editor_role\",\"tenantTerm\":\"editor role\",\"frontiersDefaultTerm\":\"Editor Role\",\"category\":\"Label\"},{\"sequenceNumber\":264,\"key\":\"editor_roles\",\"tenantTerm\":\"editor roles\",\"frontiersDefaultTerm\":\"Editor Roles\",\"category\":\"Label\"},{\"sequenceNumber\":265,\"key\":\"editorial_role\",\"tenantTerm\":\"editorial role\",\"frontiersDefaultTerm\":\"Editorial Role\",\"category\":\"Label\"},{\"sequenceNumber\":266,\"key\":\"editorial_roles\",\"tenantTerm\":\"editorial roles\",\"frontiersDefaultTerm\":\"Editorial Roles\",\"category\":\"Label\"},{\"sequenceNumber\":267,\"key\":\"call_for_paper\",\"tenantTerm\":\"Call for paper\",\"frontiersDefaultTerm\":\"Call for paper\",\"category\":\"Label\"},{\"sequenceNumber\":268,\"key\":\"research_topic_abstract\",\"tenantTerm\":\"manuscript summary\",\"frontiersDefaultTerm\":\"manuscript summary\",\"category\":\"Process\"},{\"sequenceNumber\":269,\"key\":\"research_topic_abstracts\",\"tenantTerm\":\"manuscript summaries\",\"frontiersDefaultTerm\":\"manuscript summaries\",\"category\":\"Process\"},{\"sequenceNumber\":270,\"key\":\"submissions_team_manager\",\"tenantTerm\":\"Journal Manager\",\"frontiersDefaultTerm\":\"Content Manager\",\"category\":\"Process\"},{\"sequenceNumber\":271,\"key\":\"submissions_team\",\"tenantTerm\":\"Journal Team\",\"frontiersDefaultTerm\":\"Content Team\",\"category\":\"Process\"},{\"sequenceNumber\":272,\"key\":\"topic_coordinator\",\"tenantTerm\":\"topic coordinator\",\"frontiersDefaultTerm\":\"topic coordinator\",\"category\":\"Process\"},{\"sequenceNumber\":273,\"key\":\"topic_coordinators\",\"tenantTerm\":\"topic coordinators\",\"frontiersDefaultTerm\":\"topic coordinators\",\"category\":\"Process\"},{\"sequenceNumber\":274,\"key\":\"frontiers_journal_team\",\"tenantTerm\":\"frontiers journal team\",\"frontiersDefaultTerm\":\"frontiers journal team\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantTerm\":\"RT:IC Submission\",\"frontiersDefaultTerm\":\"RT:IC Submission\",\"category\":\"Label (Role)\"},{\"sequenceNumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantTerm\":\"RT:IC Submission participant\",\"frontiersDefaultTerm\":\"RT:IC Submission participant\",\"category\":\"Label (Role)\"}]}'\n",impactGtmId:"GTM-NJF2ML9B",impactGtmAuth:"fYo-7NoDm9w37QgFMs03SA",impactGtmPreview:"env-1",impactGoogleMapsApiKey:"AIzaSyCTEhX2EU8PWfi86GW9FI00FTcyKk6Ifr8",qualtricsV4ToV3:"'{\"enabled\":true,\"interceptId\":\"SI_er0E2ze69Oz8Yn4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsUmux:"'{\"enabled\":false,\"interceptId\":\"SI_89fPHY3eTxQBwtU\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",qualtricsContinuousBrand:"'{\"enabled\":true,\"interceptId\":\"SI_9ZuT94UT81FcRh4\",\"projectId\":\"ZN_cLOy77JHkpc8Gai\",\"brandId\":\"frontiersin\"}'\n",defaultArticleTemplate:"v3"},app:{baseURL:"/",buildId:"ed555f16-85f7-4f41-8f2f-451827c59120",buildAssetsDir:"ap-2024/_nuxt",cdnURL:""}}</script>
<script src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6" type="text/javascript" async></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML" type="text/javascript" async></script>
<script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js" type="text/javascript" async></script>
<script src="https://api.altmetric.com/v1/doi/10.3389/fphar.2022.872645?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15" type="text/javascript" async></script>
<script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript" async></script></body></html>